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SUMMARY 
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IMMUNOCHEMICAL CHARACTERISATION OF PLASMA 
IMMUNOGLOBULINS IN IgA NEPHROPATHY 
by CHUI SHIU HON 
"IgA nephropathy" is the commonest primary 
glomerulonephritis worldwide and is characterised by 
mesangial deposition of IgA and C3 • It occurs in young 
subjects with synpharyngitic hematuria. The pathogenesis 
of IgA nephropathy remains unclear. 
The aims of the present study are two folds: 
(1) to determine the k/入 light chain ratios of different 
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immunoglobulins in serum of normal subjects and patients 
with 工 gA nephropathy, with the development of a novel 
enzyme-linked immunosorbent assay method and (2) to 
isolate plasma IgA from sera of normal subjects and IgA 
nephritic patients for studying and comparing the charge 
characteristics of total IgA(/c) and IgA(入）• 
In this study, immunoglobulins in sera of 11 
patients with IgA nephropathy at quiescence and during 
exacerbation were examined, and compared with those of 10 
normal subjects. All sera were screened by agarose 
electrophoresis to exclude paraproteinaemia before asssay 
for IgG, IgA and IgM by an enzyme-linked immunosorbent 
assay. They were then analysed for light chain ratios of 
individual immunoglobulins, and charge distribution of 
total IgA, IgA(K) and IgA(入）• 
For the study of k/\ ratios for IgG, IgA and 
IgM in serum, an enzyme-linked immunosorbent assay was 
developed. A commercial serum with known overall k and 入 
concentrations was used as standard. Antibodies to k , a 
and Id chains coated onto microtiter plates were used to 
capture the respective immunoglobulins. Peroxidase— 
conjugated anti-zc and anti-A chain antisera were reacted 
with light chains on the captured immunoglobulins, and 
the amount of enzyme bound was monitored with 
o-phenylenediamine and urea-H^O^ as substrates. 
S 2 
Calculation of absorbance ratios allowed determination of 
K and \ chain concentrations of individual 
immunoglobulins in the standard and samples. 
The developed assay was applied to determine 
the individual k/入 ratios of plasma IgG,工gA and IgM in 
normal subjects and patients with IgA nephropathy. 
Additional serum samples from patients with rheumatoid 
arthritis, systemic lupus erythematosus and hepatic 
cirrhosis were also examined (30 in each group) • The 
results showed that zc/入 ratios of IgA and IgM were 
significiantly different from that of IgG in normal 
subjects (both p < 0.01) . The ratios of individual 
immunoglobulins in patients with rheumatoid arthritis, 
lupus erythematosis and cirrhosis were similar to those 
of normal subjects. On the other hand, patients with IgA 
nephropathy displayed a distinctly lower IgA k/入 ratio (p 
< 0.01), suggesting a unique antibody response in the 
imnunopathogenesis of this disease. However, no 
significant difference in the ratio was observed for 
patients at quiescence and during exacerbation. 
The concentration of individual immunoglobulins 
and their light chain fractions, and the k/入 ratio were 
also determined in the supernate from peripheral blood 
mononuclear cell culture of 20 IgA nephritic patients and 
14 age-matched normal subjects. The k/\ ratio of 
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supernatant IgA from IgA nephritic patients was 
significantly lower than that of the normal subjects' 
both in the unstimulated (p < 0.01) and pokeweed mitogen 
stimulated peripheral blood mononuclear-cell culture (p < 
0.05) , further supporting that patients with IgA 
nephropathy displayed a unique immunological response 
characterized by a predominant synthesis of circulating 
IgA with A light chain. 
In order to study the charge of circulating IgA 
in IgA nephropathy； a Fast Protein Liquid Chromatography 
(FPLC) method was established for the purification of 
plasma IgA based on the specific binding of jacalin to 
IgA. The column was packed with 10 itiL of immobilised 
jacalin attached to cross-linked 6% beaded agarose. One 
to three luL of diluted serum (containing 1 to 6 mg IgA) 
was introduced into the column which was then flushed 
with phosphate buffer saline (PBS), pH 7.4. Elution was 
achieved with inelibiose in PBS. Five-mL fractions were 
collected with absorbance monitored simultaneously at 
280 nm. 
After the FPLC procedure, the yield of isolated 
IgA as well as the concentrations of IgG and IgM 
contaminants were measured by an enzyme-linked 
immunosorbent assay. Results showed that > 90% IgA could 
be recovered with < 0.5% total IgG and < 0.2% total IgM 
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remaining in the fractions containing purified IgA. The 
purity of jacalin-isolated IgA was also investigated by 
immunoelectrophoresis. Only one prominent precipitin arc 
was observed from reactions between purified IgA and 
antiserum to human serum, as well as antiserum to human 
IgA. 
The charges (pi) of purified IgA, IgA(/c) and 
IgA(入） were studied by isoelectric focusing and 
immunoblotting techniques using monospecific antisera, 
followed by densitometry. For total IgA, purified IgA was 
focused in polyacrylamide gel containing servalyte, from 
pH 4.4 to 6.8, followed by staining with Cooinassie blue 
of the resolved proteins. The stained bands were scanned 
with densitometer at 525 nm, using the transmitance mode. 
For IgA(/c) and IgA(入）， the focused 
immunoglobulins (predominantly IgA) were transferred to a 
nitrocellulose membrane, followed by detection reactions 
with rabbit antiserum to human /c or A chains, swine 
anti—rabbit, and rabbit anti-peroxidase antibodies, and 
peroxidase. Finally the bands were visualised by the 
peroxidase reaction with H^ O^  and diaminobenzidine. The 
developed membrane was dried and made transparent with 
Triton-X 114, and scanned with a densitometer at 485 nm, 
using the transmittance mode. 
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The anionic to cationic (A/C) ratios for total 
IgA, IgA(/c) and IgA (入） were computed from the 
densitometric patterns, with pH 5.6 as the dividing 
point. For total IgA, there was a significant increase of 
anionic charge in IgA nephropathy (p < 0.025 at 
quiescence and p < 0.01 during exacerbation) when 
compared to control. On the other hand, no difference in 
charge of I g A � and IgA(入）was observed between normal 
subjects and IgA nephritic patients. IgA(;v) , being more 
anionic than IgA(K) and produced in excess in blood 
circulation, is probably responsible for the increased 
negative charge distribution of total IgA in IgA 
nephropathy, as well as the mesangial deposition of 
anionic IgA/IgA-containing immune complexes. However, the 
lack of difference in k/X ratio and charge distribution 
for plasma IgA in patients at quiescence and during 
exacerbation indicated that the disease may be 
immunologically active throughout the entire process. 
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LIST OF ABBREVIATIONS 
BALT = bronchus-associated lymphoid tissues 
BSA = bovine serum albumin 
CIC = circulating immune complexes 
CR = cirrhosis 
CV = coefficient of variation 
DW = distilled water 
ELISA = enzyme-linked immunosorbent assay 
FPLC = fast protein liquid chromatography 
GALT = gut-associated lymphoid tissue 
HSP = Henoch-Sch^3nlein Purpura 
IC = immune complexes 
lEF 二 isoelectric focusing 
lEP = isoelectric point 
IF = immunofluorescence 
IgAN = 工gA nephropathy 
LE = lupus erythematosus 
mIgA = monomeric IgA 
NC = nitrocellulose 
NS = normal subjects 
PBS = phosphate buffer saline 
pIgA = polymeric IgA 
PWM = pokeweed mitogen 
RA = rheumatoid arthritis 
RF 二 rheumatoid factor 
SC = secretory component 
SD = standard deviation 
S-IgA = secretory IgA 
SLE == systemic lupus erythematosus 
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C H A P T E R 1 
I N T R O D U C T I O N 
1.1 IgA NEPHROPATHY 
1.1.1 History and Epidemiology 
Primary IgA nephropathy (IgAN), also known as 
Berger's disease, was first described in 1968 in France 
by Berger and Hinglais [1]. Using fluorescein-conjugated 
antibodies to human IgA in renal biopsies taken from 
patients with no overt systemic symptoms but suffering 
recurring bouts of macroscopic haematuria or persistent 
microscopic haematuria, Berger and Hinglais [1,2] 
observed that IgA fluorescence staining was mesangial in 
distribution and often accompanied by IgG and C3, with 
IgA as the predominant iitimunoglobulin. As 
immunofluorescence (IF) techniques were applied more 
widely, the high incidence of IgAN was confirmed, first 
in France, then later in many other countries. 
Since its first description, IgAN has become a 
well recognised clinicalpathological entity. It is 
recognised as the most common form of glomerulonephritis 
worldwide, accounting for 2 0 to 40% of patients with 
primary glomerulonephritis diagnosed by renal biopsy in 
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Western Europe, Asia and Australia [3] . The prevalence 
is highest in Japan - 30 to 40% of primary 
glomerulonephritis in the adult population [4,5]• By 
contrast, incidence rates in the United States and 
England are reported to be much lower at 2 to 10% [6]. 
The disease affects predominantly males who 
also have a worse prognosis than females [7]. The age 
and onset tend to be in the second or third decade of 
life [8]. 
1.1.2 Clinical Pathological Features 
Most clinical features of IgAN point to a renal 
problem. However, the nephrologic features are diverse. 
Patients with biopsy-proven IgAN could present with 
nephrotic syndrome, asymptomatic proteinuria, acute 
nephritis, acute renal failure, malignant hypertension, 
and chronic renal failure. The commonest presentations 
are recurrent "synpharyngitic" macroscopic haematuria and 
asymptomatic microscopic haematuria (more than five red 
blood cells per high power field)• The frequency of IgAN 
associated with nephrotic syndrome has been reported to 
be 6.0% by Clarkson et al [9] ; 9.6% by Sinniah et al 
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[10]； and 11.0% by Hood et al [11]； and in Japan, 4.5% by 
Soda et al [12]; and 5.5% by Yorioka et al [13]• 
The diagnostic features of primary IgAN are 
mesangial deposits of IgA, usually accompanied by C3 and 
sometimes by IgG, IgM and fibrinogen, mesangial expansion 
and proliferation with variable acute proliferation and 
sclerotic segmental glomerular lesions, and electron 
dense mesangial deposits in the absence of systemic 
disease [9]. Mesangial deposits are also seen in 
systemic diseases such as Henoch-Schonlein Purpura (HSP) 
[14] and systemic lupus erythematosus (SLE) [9,14] and in 
association with alcoholic cirrhosis [15]. A 
classification of mesangial IgAN (Table 1.1) has been 
proposed by Woodroffe et al [16] to differentiate primary 
IgAN from secondary forms, suggesting varying 
pathogenetic mechanisms. 
1.1.3 Laboratory Findings 
There is no specific serologic test for IgAN. 
Positive mesangial immunofluorescence for IgA as the 
predominant immunoglobulin in renal biopsy specimens is 
the diagnostic hallmark. 
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Table 1.1 Classification of Mesangial IgA Nephropathies [16] 
Primary Isolated or primary IgA nephopathy 
(Berger's disease) 
Associated with systemic disease : Henoch-Schonlein 
Purpura 
Secondary Alcoholic liver disease 
Portal systemic shunts 
Coeliac disease 
Dermatitis herpetiformis 









Serum concentrations of IgA are elevated in 
approximately 50 - 70% of patients [17], but no 
correlation between serum IgA concentration with any 
clinical, histological and immunological features has 
been observed. Furthermore, no specific HLA antigens 
seem to be linked to high IgA values except a few reports 
associating an HLA allele with the disease or its 
prognosis, such as HLA-B3 5 in France and HLA-DR4 in Japan 
[18] • In recent years, efforts have concentrated on the 
presence of IgA- containing immune complexes (IC), ratios 
of polymeric IgA (pIgA) to monomeric IgA (mlgA), IgAl and 
IgA2 subclasses, and regulation of IgA production etc. 
Some of these topics will be elaborated in more detail in 
later sections. 
1.1.4 Immunopathogenesis 
It has been shown that IgAN is associated with 
the activation of complement via alternative pathway 
[19] • Both C3, properdin [20] and /31H [21] are 
frequently found in glomerular IgA- containing deposits, 
while Clq and C4 which are involved in the classical 
pathway have been occasionally identified [22] • The 
presence of the late complement components such as C5 and 
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C9 is, however, rarely discussed [19,23,24]. 
On the other hand, Miyazaki et al [21] 
demonstrated the presence of C4-bp in glomerular deposits 
and higher serum C4-bp concentration in IgAN patients, 
suggesting that glomerular immune deposits in IgAN might 
be attributable to the activation not only of the 
alternative pathway but also of the classical pathway. 
However, Clq deposits being unusal in primary IgAN and 
the greater frequency of /31H than C4-bp glomerular 
deposits [21] indicate that the alternative pathway of 
complement activation predominates in this disease. 
The detection of C9 in glomeruli of patients 
with IgAN has prompted Tomino et al [25] to conclude that 
activation of terminal components of complement may be 
one of the exacerbating factors in patients with IgAN. 
Recently, Chen et al [26] suggested that the presence of 
abundant glomerular iminune deposits might be responsible 
for the fixation and the persistence of C5, which might 
reflect an active status in the renal injury of IgAN. 
They therefore recommended the use of C5 for renal 
tissues as an immunopathological index for the activity 
of IgAN. 
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The pathogenetic mechanism of IgAN remains 
unknown. Most available evidence, including the 
characteristic granular immunofluorescent pattern and the 
electron-dense deposits, point to an immune complex 
etiology [16]. Several observations support this 
hypothesis, they are : (1) the nature of the mesangial 
deposits, (2) the detection of similar deposits in skin 
and arterioles [27,28] (3) the similarities with HSP 
where circulating immune complexes (CIC) are commonly 
demonstrable [29,30] and (4) the recurrence of mesangial 
IgA deposits in renal grafts [31,32]• Serum IgA IC have 
been reported by several groups [15,32,33]• However, 
some other groups hold that pIgA may be responsible for 
the mesangial deposits. Gotze and Muller-Eberhard [34] 
claimed that aggregated IgA activated complement via the 
alternative pathway. In fact, high concentrations of 
circulating pIgA sometimes in the form of IC have been 
reported in IgAN [35]. Moreover, J-chain (a peptide 
linking IgA or IgM monomers together) is present in the 
mesangial IgA deposits in IgAN, indicating the presence 
of pIgA [36,37]• On the other hand, secretory component 
(SC, a glycoprotein facilitating the selective 
transepithelial transport of secretory IgA into external 
secretions) has not been detected in the mesangial 
deposits of primary IgAN [32,37], suggesting the 
non-secretory origin of the mesangial IgA deposits. All 
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the above observations favour the concept that 
circulating pIgA, mostly in the form of IC, may be 
responsible for the mesangial deposits. 
The responsible antigen(s) in this disease 
is(are) still unknown. However, patients with IgAN often 
have high serum concentrations of antibodies against a 
large array of exogenous antigens. These include some 
viral-like substances (Mycoplasma pneumonia, herpes 
virus, influenza) in the upper respiratory tract 
[38,39,40] or certain E coli serotypes in the 
gastrointestinal tract [41]. The possible role of 
common food antigens such as bovine serum albumin (BSA) 
in the pathogenesis of IgAN was first suggested by 
Woodroffe et al [42], who demonstrated elevation of serum 
antibodies against BSA in patients with IgAN. 
Subsequently, Sancho et al [43] showed a possible 
relationship between IgA CIC and specific antibody 
against ovalbumin in patients with IgAN. Yap et al [44] 
examined the relationship between IgA CIC and IgA 
anti-BSA antibodies in patients with IgAN, and identified 
the presence of specific BSA antigen in the IC. Coppo et 
al [41] reported the relationship between a gluten-rich 
diet and high concentrations of IgA-CIC, they suggested 
that the gluten-rich diet might play a role in the 
different geographical distribution of IgAN. However, 
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Yagame et al [45] failed to show any significant 
correlation between the amounts of dietary gluten and the 
concentrations of IgA-CIC in sera from Japanese patients 
with IgAN. 
Although the identity of the antigen remains 
unknown, the above data tend to suggest a defect in the 
antigen exclusion at the mucosal level or an abnormality 
in the regulation of IgA [46]. In addition, anti-BSA 
antibody idiotypes are elevated in some patients with 
IgAN, as reported by Gonzalez-Cabrero et al [47] . They 
also isolated autologous antiidiotypic antibodies 
specific to antibodies of IgG class against BSA in a 
patient with IgAN and observed the presence of shared 
idiotypes in a large number of IgAN patients [47]• 
Despite the exact identify and the pathogenic 
capacity of the IgA-antigen CIC, it is conceivable that 
the mesangial deposits are derived from large 
(antibody-excess) IgA-antigen complexes with glomerular 
injury being initiated by C3 activation. Such complexes 
are likely derived from pre-formed IgA antibodies to 
antigens commonly expressed at mucosal surfaces. 
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1.2 THE ROLE OF IgA IN THE PATHOGENESIS OF IgAN 
It is obvious that IgA plays a key role in 
IgAN. Therefore, an understanding of the molecular 
structure, biological role and immune regulation of IgA 
seems essential for exploring the pathogenesis of IgAN. 
1.2.1 Structure of IgA molecule 
IgA is the second most abundant immunoglobulin 
in serum, representing 15 一 20% of the human serum 
immunoglobulin pool, with a mean serum concentration of 
3.5 g/L. Some physicochemical properties of human IgA are 
shown in Table 1.2. 
An unusual structural feature of human IgA is 
the heterogeneity of the molecular forms with 
characteristic distribution in various body fluids. In 
man, more than 80% of serum IgA displays a typical 7S 
four-polypeptide chain structure of the basic molecule 
with two a heavy chains (H) and two light chains (L) 
[48], as shown in Fig.l.l. Approximately 10 _ 20% is 
normally composed of lis dimers or larger aggregates ** 
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Table 1.2 Physicochemical Properties of Human IgA 
IgAl IgA2 S-IgA 
Heavy chain subclass 1 2 1 or 2 
Light chain type k or 入 k or 入 /c or 入 
Mean serum 3.0 0.5 0.05 
concentration (g/1) 
Sedimentation constant IS 7S lis 
Molecular weight 160,000 160,000 385,000 
Molecular weight of 56,000 56,000 52,000 to 
heavy chain 56,000 
Number of heavy 4 4 4 
chain domains 
Carbohydrate (%) 7 - 1 1 7 - 1 1 7 - 1 1 
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[49] . In sero-mucous secretions such as saliva, 
tracheobronchial secretions, colostrum, milk and 
genitourinary secretions, IgA occurs as dimers or 
tetramers of both Al or A2 subclass, consisting of 
disulfide linked molecules associated with additional 
polypeptides - J (joining) chain and secretory component 
(Fig.1.2.) [48] • The latter glycoprotein is derived from 
various epithelial cells and binds to dimeric IgA from 
the mocosa when they move through the epithelium to reach 
the lumen. 
(i) Structure of a Chains - Al and A2 Subclasses 
The primary structure of all component chains 
of serum IgA has been determined. 
In IgAl, the 472 amino acid residues of the a 
chain are arranged in four domains (Va, Cal, Ca2 and 
Ca3) • The C region of both subclasses is composed of 3 
domains with relatively minor differences in the primary 
structure : only 22 of 365 amino acids differ in the 
entire C region of a_l and a-2 chains [49] • The most 
remarkable structure differences between IgAl and IgA2 
molecules are located in the hinge region. A 13 residue 








































Fig. 1.1 Polypeptide Chain Structure of Human IgAl* 
disulphide bond 
藝 carbohydrate 
N amino terminus 
C carboxyl terminus 
* The diagram was modified from "Roitt I, Brostoff 





















Fig. 1.2 Structure of Human Secretory IgAl* (S IgA) 
The secretory component is attached by 
disulphide bonds to the domain of each IgA 
monomer. The J chain joins two IgAl monomers via 
disulphide bonds. 
• The diagram was modified from "Roitt I, 
Brostaff J, Male (1985). Immunology, p.5.6, 
Churchill Livingstone, London. 
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results in the loss of the proteolytic cleavage site and 
a reduced susceptibility to enzymatic digestion by 
bacterial proteases to produce Fab and Fc fragments 
[50,51]• Further structural differences between IgAl and 
IgA2 molecules have been observed in their carbohydrate 
compositions. Galactosamine is present only in proteins 
of IgAl subclass, but IgA2 has significantly higher total 
carbodohydrate content due to higher concentrations of 
fucose, mannose and glucosamine [52]. In addition, most 
IgA2 molecules lack H-L interchain disulfide bonds； the 
molecule is stabilized instead by L-L and H-H interchain 
disulfide bonds as well as non-covalent interactions 
[53]. 
A feature of A chain shared with the IJL chain of 
IgM is the presence of an additional C-terminal 
octapeptide with a penultimate cysteine residue, which is 
able to bind covalently to the J chain in polymeric 
molecules [54] (Fig.1.3). The Cal and Ca2 domains posses 
an additional interchain disulphide bond and in each Ca2 
domain there are two cysteine residues. 
Monomeric subunits within pIgA appear to be 
linked by disulfide bridges found in three locations in 















































































































































































Fig. 1.3 Comparative Structures of C Termini of All 
Five Classes 
Alpha and u chains extend beyond the other 
3 classes. The site of J chain attached is shown 
by the arrow and identical portions along the 
chains are surrounded by rectangles. 
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disulfide bridge directly connecting two monomers, (2) 
penultimate cysteine residues are linked to J chain which 
in turn joins two monomers, and (3) an additional 
disulfide bridge formed between cysteine residues 311 
[55]. 
(ii) J Chain 
In 1970 Halpern and Koshland [56] suggested J 
chain was a component of p- but not in- IgA molecules and, 
therefore might be involved in joining itilgA molecules to 
form the corresponding polymers. Subsequently, J chain 
was found in IgM molecules [57]. 
J chain is a small glycopeptide with a 
molecular weight of approximately 25,000• There are 137 
residues with a high proportion of acidic amino acids, 
low numbers of glycine, phenylalanine, serine, and only 1 
methionine [58]. Also present are eight cysteine 
residues, six of which are involved in the formation of 
intrachain disulfides. Two cysteins are connected to 
penultimate cysteine residues of a and ii chains [59] • 
Being associated with pIgA and IgM, J chain 
represents less than 5% of the total polymer protein [60] 
(Table 1.3). Nevertheless, its presence indicates the ** 
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Table 1.3 J Chain Content in Immunoglobulin Polymers 
J chain by weight (%) 
Polymer Dimer Tetramer Pentamer 
S-IgA 3.5 1.9 -
Myeloma IgA 4.2 2.2 2.9 
IgM - - 1.6 
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polymeric nature of IgA molecules. Although only a small 
proportion of serum IgA is polymeric, there is good 
evidence that glomerular IgA in IgAN is polymeric, since 
it contains J chain [36,61,62,63] and has the capacity to 
bind secretory component [36,61,64] which is only found 
in dimeric secretory IgA(S-IgA)• 
(iii) Secretory Component and Secretory IgA 
Differences observed between the antigenic 
determinants of serum and S-IgA led to the identification 
and isolation of an additional polypeptide chain in the 
S-IgA molecule [65,66] which is now designated as SC. 
SC is produced by epithelial cells found in 
secretory glandular tissues and on mucosal surfaces of 
gastrointestinal and respiratory tracts [48,67]• Its 
essential role is in the selective transport of IgA into 
external secretions. It has a molecular weight of 
approximately 70,000 and consists of a single polypeptide 
chain with 549 to 558 amino acids and large amounts of 
carbohydrate (20%) with 2 0 cysteine residues involved in 
the formation of 10 intrachain disulfide bridges [48]• 
During the process of secretion, SC combines 
with the dimeric IgA, forming the S-IgA that constitutes 
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the principal immunoglobulin in human exocrine fluids. 
Structurally, the typical lis molecule contains two 
monomeric subunits, one J chain and one SC [68] . In 
addition to the dimeric lis S-IgA, human external 
secretions contain tetrameric 15.5S S-IgA molecules [69]• 
Both SC and J chains are covalently bound in human S-IgA 
to the Fc region [70]. 
Although J chain is present in the mesangial 
IgA deposits in IgAN [32,36] indicating the presence of 
polymeric IgA, SC has not been detected in the mesangial 
deposits of primary IgAN [39,40], suggesting that 
non-secretory IgA molecules (i.e. circulating IgA) are 
involved in the formation of CIC in the disease. 
1.2.2 IgA Biosynthesis and Immune Regulation 
Differentiation of cells of the B-cell lineage 
is accompanied by immunoglobulin class switching [71]. 
Primary immune responses generate clones of IgM-producing 
B cells. In the secondary immune response, following a 
strong primary response or resulting from a further dose 
of antigen, selected clones switch from IgM to IgA, or 
possibly to IgE production. This isotype switch is 
induced by signals from isotype-specific T cells or T 
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cell factors. 
IgA-producing plasma cells are distributed in 
various lymphoid tissues, in the lamina propria of the 
gut; in salivary, lacrimal, and lactating mammary glands; 
and in the human bone marrow [67] • In the intestine 
Peyer's pathches or other gut-associated lymphoid tissues 
(GALT) and in the bronchus-associated lymphoid tissues 
(BALT) mucosal lymphoid follicles aggregate. These 
follicles are primarily populated with IgA antibody-
producing precursors. Most of the IgA precusors present 
in the Peyer's patches are IgM-IgD double-bearing 
lymphocytes [72]. IgA-bearing cells are present in 
smaller numbers and there are very few IgA blasts. 
IgA-bearing cells either (1) mature into IgA blasts that 
migrate directly to the gut lamina propria via the 
mesenteric lymph nodes, the thoracic duct, and blood or 
(2) continue recirculating through GALT until they 
contact antigens in the gut lamina propria where they 
divide and differentiate into IgA-producing plasma cells. 
The IgM-IgD cells may differentiate to express surface 
IgA, during their migration through GALT, thoracic duct, 
blood, and spleen. They recirculate or mature as Peyer‘s 
patch IgA-bearing cells. Others may remain in a resting 
state and continue in the recirculating pool of GALT 
cells. It is clear that a proportion of IgA plasma cell 
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precursors circulate to mucosal associated urogenital, 
respiratory, and mammary lymphoid tissues [73]. 
Prior to specific antigen presentation to the 
intestinal mucosa, thymus-dependent helper (T alpha) 
cells specific for 工 g A - p r e c u r s o r lymphoblasts are found 
in Peyer's patches. These T helpers operate by causing 
class-specific effects on B-cell DNA switching events 
[74,75]• However, these "IgA class-specific switch T 
cells" located in Peyer's patches in small number do not 
result in the terminal differentiation of B cells. There 
is another population of GALT T-helper cells that operate 
on postswitch IgA B cells that may not be class specific, 
helping IgA secretion. T cells capable of suppressing 
IgA production has also been observed in Peyer's patches 
and spleen before antigen stimulation [76]. In the 
normal intestinal lamina propria, helper cells are 
balanced by the presence of functionally active 
suppressor cells. However, in disease states, such as 
inflammatory bowel disease or in patients with IgAN, the 
suppressor population is either reduced in number or 
functionally diminished in activity [46,77,78,79,80]• 
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1.2.3 Biological Role of IgA 
IgA appears to be the major mediator of local 
resistance. S一工gA can (1) inhibit adherence of bacteria 
to epithelial surface [81,82], and enhance the 
antibacterial effects of innate immune factors (2) 
neutralize biologically active antigens such as viruses, 
toxins, and enzymes and (3) prevent uptake of antigens 
from the intestinal tract [48,83]. 
In the normal gastrointestinal tract it appears 
that a small proportion of macromolecules such as 
chemicals, bacterial by products and inhaled and ingested 
materials encountered by epithelial cells are rapidly 
transported into the circulation [84] . Thus the 
intestinal epithelium is not a complete barrier against 
the absorption of macromolecules. These absorbed 
molecules may be complexed to a variable degree with IgA 
antibody, forming IgA immune complexes. These complexes 
may then be either secreted locally by the selective IgA 
transport system or enter the circulation to be 
transported to other mucosal tissues or the liver, and 
from there into external secretions. This "immune 
exclusion" mechanism blocks antigen uptake by epithelial 
cells, and prevents colonization by bacteria, or 
infection by virus [85], and retardation of antigen 
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uptake may facilitate more complete enzymatic degradation 
of the antigen at the epithelial surface. 
1.2.4 Circulating Immune Complexes in 
IgA Nepthropathy 
(i) The Concept of Immune Complex Diseases 
An immune complex is formed from the 
noncovalent combination of antigen with its respective, 
specific anitbody. The antibody can react with antigen 
that is fixed or localized in tissue or with antigen that 
is released or present in the circulation. Once formed 
in the circulation, the complex may or may not fix 
complement and is rapidly eliminated from the circulation 
by the mononuclear phagocytic system 
(reliculo-endothelial system)• The mononuclear 
phagocytic cells, by virtue of receptors for 
immunoglobulin or complement, bind, phagocytose, and 
dispose of or sequester IC. Under normal circumstances, 
this process does not lead to pathological consequences 
and is viewed as a major host defense against the 
invasion of foreign antigens. In some unusual 
circumstances, IC persist as soluble complexes in the 
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circulation, escape mononuclear phagocytic clearance, and 
deposit in endothelial or vascular structures where they 
elicit an inflammatory response - the hallmark of IC 
disease [86]. 
Once deposited, there are multiple mechanisms 
by which an immune complex initiates an inflammatory 
reaction, the most important being activation of the 
complement system. Immune complexes can activate the 
classical complement pathway as well as, indirectly or 
directly, the alternative complement pathway. The 
biological activities of complement activation which are 
relevent to tissue inflammation have been well documented 
[87,88,89,90,91,92]. 
(ii) Circulating Immune Complexes in IgA Nephropathy 
IgAN is generally considered to be an 
immune-complex-inediated glomerulonephritis [14]• Early 
immunohistological studies performed on kidney biopsy 
specimens of IgAN patients showed mesangial deposits of 
IgA with a granular pattern, similar to that observed in 
other glomerulonephritis in which CIC are thought to play 
a major inflammatory role [93]. Electron microscopy has 
also shown electron-dense deposits in the mesangium just 
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below the glomerular basement membrane in a pattern often 
found in immune complex-mediated renal diseases [94]. 
Furthermore, the frequent presence of complement 
components in these deposits [95], the inability to 
demonstrate convincingly antimesangial antibodies in the 
sera of IgAN patients [9], and the recurrence of IgAN in 
renal allografts [31] are compatible with the view that 
工 g A - c o n t a i n i n g CIC are deposited in the glomeruli. This 
hypothesis has gained further support from recent studies 
demonstrating elevated concentrations of CIC containing 
IgA and C3 not only in patients with primary IgAN 
[30,32,96,97,98,99,100], but also in patients with HSP 
[29,30,101,102], dermatitis herpetiformis [102,103], and 
IgAN associated with liver cirrhosis [103]• These 
findings suggest that IgA—containing CIC may play a role 
in the pathogenesis of IgA nephropathy. 
In addition to IgA-CIC, CIC that contain IgG 
have been detected in patients with IgAN [30,99,100], HSP 
[30,99] and alcoholic liver cirrhosis [104,105,106,107]• 
Although conflicting results were reported concerning the 
frequency of IgG-CIC [29,98], the pathogenic relevance of 
these CIC has not yet been adequately explained. 
Besides, IgM-containing CIC has also been demonstreated 
in some patients with IgAN [98], with much less frequency 
than IgA-CIC. 
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(iii) Polymeric IgA and IgA Rheumatoid Factor 
Several lines of evidence suggest the presence 
of large amount of pIgA, partially as IC, in the serum of 
patients with IgAN [35,108]• In an experimental model of 
IgAN, the existence of pIgA IC was considered critical 
for the induction of nephritic histological changes 
[109]• In contrast, mlgA IC failed to produce glomerular 
deposits [109]. 
Increased rates of synthesis of pigA by 
circulating lymphocytes have been reported in patients 
with mesangial IgA glomerulonephritis [110]• 
Consequently, the renal deposits of IgA in IgAN might 
consist predominantly of pIgA. Further evidence was 
obtained by Komatsu et al [63 ] who employed a direct 
enzyme-labelled antibody immunocytochemical technique to 
show that IgA deposits in some patients with IgAN 
consisted of IgA polymers linked by J chain. Based upon 
the specific binding affinity of SC for pIgA, Sancho et 
al [111] developed an assay for determining pIgA IC. The 
method was adopted in the detection of specific pIgA IC 
[100,112]. 
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Molecular weight analysis of the IgA—containing 
CIC revealed that complexes range in size from 9S to 2IS 
[30] . Woodrof fe et al [99] found that in these patients 
all complexes detected were of intermediate (9S-17S) 
size. 
In addition to the presence of IC and high 
concentrations of pIgA, IgA rheumatodid factor (RF) has 
been found by some investigators [113,114] in serum 
samples from patients with IgAN. Within immunoglobulin 
aggregates and certain IC, the structure of the 
Fc-fragment of the immunoglobulin may undergo certain 
modifications, thus being transformed to an autoantigen 
which, as a result of a decreased tolerance, may give 
rise to the production of anti-iminunoglobulin-
autoantibodies (rheumatoid factor) and to a consecutive 
formation of iirununoglobulin-anti-immunoglobulin IC. 
Furthermore, IgAl RF activity was also demonstrated in 
patinets with IgG-IgAl-CIC, suggesting that at least a 
portion of these CIC consists of IgAl RF iinmunologicallly 
complexed with autologus IgG [114]. Moreover, pIgA with 
RF activity has been decribed in these patients [115]. 
Recently, Schena et al [116] showed that pIgA and IgA RF 
decreased the capacity of serum to solubilize circulating 
IC in patients with IgAN, suggesting that pIgA and IgA RF 
are responsible for the presence of insoluble 
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nephritogenic IC in the blood of patients with IgAN. 
1.2.5 IgA Subclasses in IgA Nephropathy 
Normal serum IgA contains approximately 90% 
IgAl and 10% IgA2 [117] . As for the IgA subclass in the 
glomerular IgA deposits in IgA nephropathy, two 
conflicting reports have been published. Andre‘ et al 
[118], using monospecific antisera demonstrated 
preponderance of IgA2 in the glomeruli of patients with 
IgAN. Conley et al [119] and Tomino et al [28], using 
subclass specific monoclonal antibodies, found selective 
deposition of IgAl, but no IgA2 • In view of these 
conflicting results, Murabami et al [120] studied the IgA 
subclass of the glomerular deposits in the patients with 
IgAN. They found that the glomerular IgA deposits 
consisted mainly of monomeric IgAl, with a minor share of 
IgA2, suggesting that the serum IgA is deposited 
irrespective of subclass in the glomeruli of the patients 
with IgAN. 
Now most investigators agree that IgAl is the 
predominant, if not exclusive, subclass in the deposits 
[119,121,122]. Recently, van den Wall Bake [123] studied 
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the IgA subclass production in peripheral blood 
mononuclear cell culture. Their results indicated that 
patients with IgAN preferentially produce antibodies of 
the IgAl subclass. They further proposed that the bone 
marrow was the site of long-term overproduction of igAl 
antibodies in patients with IgAN, and a disturbance in 
immune regulation in patients with IgAN resulted in an 
increased production of IgAl in the bone marrow, leading 
to abnormally elevated levels in the circulation and 
secondary deposition in the kidney [124,125]. 
1.2.6 Light Chain Composition of IgA in 
IgA Nephropathy 
Immunoglobulin light chains comprise k and \ 
isotypes. They have no recognised adjunctive functions 
besides idiotypic specificity. However, the ratio 
between the two light chains in serum might have some 
predictive clinical value. Physiological variations of 
the zc/入 ratio occur in infancy [126] • Moderate 
imbalances may be found in primary immune deficiency 
disorders [126,127]• Abnormal serum k/X ratios have been 
reported in light chain deficiency [128], amyloidosis 
[129] and acute lymphoblastic leukaemia [130]• Altered 
K/入 ratios have also been found in the CSF and serum of 
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patients with neurological disorders [131,132,133,134]• 
The recent development of quantitative assays for k- and 
入 - c o n t a i n i n g immunoglobulins has led to the proposal that 
disturbance of the normal k to 入 ratio may provide 
objective information that can be used in conjunction 
with iininunoelectrophoresis or iininunof ixation to screen 
for monoclonal proteins in most immunoglobulin 
abnormalities [130,134,135,136,137,138,139]• However, 
all these studies measured only total ic and X 
concentrations, with results therefore essentially 
representing the light chain ratio of the most abundant 
serum immunoglobulin, usually IgG. 
It is a well-known fact that in man, the normal 
ratio of K to 入 containing immunoglobulin is 
approximately 2 to 1, but in antibodies with a given 
specificity, this ratio is frequently altered [140]• Lai 
et al [141,142] observed that predominant 入 light chain 
immunofluorescence occurred in the mesangial 
immunoglobulin deposits in IgAN, despite the fact that 
the normal ratio of k to 入 light chain immunoglobulin in 
human sera is approximately two to one [140] • These 
observations inferred that mesangial IgA deposits in IgAN 
consisted mostly of IgA with X light chain [141,142]• 
However, the light chain IF staining may arise from the 
concomitant mesangial IgM and IgG deposits, a definitive 
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immunochemical charaterization of the light chains in the 
mesangial IgA deposits in IgAN could be difficult. 
The findings in the immunochemical 
characterization of the light chains in IgA deposits in 
IgAN may have implications on the immunopathogenesis of 
primary IgAN. The predominance of IgAl subclass in 
glomerular deposits and in circulation would suggest that 
the circulating IgA IC is deposited irrespective of 
subclass in the glomeruli of the patients with IgAN. As 
inferred from the IgAl and IgA2 findings, predominant k 
chain IgA deposits should be expected since fc containing 
immunoglobulins predominate in normal plasma. The 
findings of predominant 入 light chain IgA deposits in 
glomerular mesangiim, as observed by Lai et al, could 
indicate that the deposition of circulating IC in IgAN is 
highly selective, probably due to differences in the 
multimeric nature, size of the IC and anionic charge of 
different subclasses of IgA [143]• Alternatively, the 
altered ratio of light chains may be derived from a given 
specificity to an unidentified antigen leading to 
excessive production of normal IgA containing normal X 
light chain. 
The ic/X ratio of individual immunoglobulins 
have not been studied in detail in normal subjects or in 
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disease. Moreover, the ic/X ratio of plasma IgA in IgAN 
has not been studied previously, mainly due to lack of 
available assays suitable for the determination of light 
chain concentrations of individual immunoglobulin 
classes. The predominance of mesangial IgA with \ light 
chain is likely to be related to the assumption that IgAN 
patients may have a significantly higher serum 
concentration of \ light chain—工gA and an alteration of 
K/X ratio. However, such hypothesis is entirely based on 
immunofluorescence results obtained from renal tissue 
studies. Little is known about the circulating IgA 
molecules as far as the light chain status is concerned. 
Thus, further clarification of the findings of Lai et al 
by studying the immunochemical nature of plasma 
immunoglobulins in IgAN, with particular emphasis on IgA 
light chains and their ratios is warranted. 
1.3 AIM OF THE PRESENT STUDY 
The aims of the present study are two fold: (1) 
to determine the k/入 light chain ratios of different 
immunoglobulins in serum of normal subjects (NS) and 
patients with IgAN, with the development of a novel 
enzyme-linked immunosorbent assay (ELISA) method and (2) 
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to isolate plasma IgA from sera of NS and IgAN patients 
for studying and comparing the charge characteristics of 
total IgA, IgA(/c) and IgA(;v) • 
1.4 DESIGN OF EXPERIMENTS 
Serum was used in all experiments. Before the 
actual investigations, all serum samples were screened by 
agarose electrophoresis to exclude paraproteinaemia. 
Concentrations of serum IgG, IgA and IgM were measured by 
an ELISA method as described in one of the author's 
publications on related work [144, Appendix 1]. For the 
determination of k and 入 chain concentrations of 
individual plasma immunoglobulins very few methods are 
available. Most of them measure total /c and X chain 
concentrations of all immunoglobulins by radial 
immunodiffusion [145] or immunonephe1ometry [130]• 
Therefore, an ELISA method was developed [146,147 
Appendix 2 & 3] for the determination of ic and X light 
chain concentrations of IgG, IgA and IgM in serum. The 
method employed commercial reagents including a human 
serum standard with known overall k, and X chain 
concentrations (Standards with known k and X chain 
concentrations of individual immunoglobulin classes were 
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not available)• It was applied to determine the 
individual k/\ ratios of serum IgG, IgA and IgM in NS 
and patients with IgAN, rheumatoid arthritis (RA), 
systemic lupus erythematosus (LE) and hepatic cirrhosis 
(CR) - 30 in each group* [148, Appendix 4]. 
For the isolation of IgA and IgA-containing IC 
from serum, an affinity chromatography technique using a 
"jacalin" column was established [149, Appendix 5]. 
Jacalin is an a-D-galactose-specific lectin extracted 
from the seeds of Artocarpus Integra, or jack fruit. It 
is a glycoprotein containing 3% carbohydrate and has a 
molecular weight of 39,500. Its unique biospecific 
binding properties to IgA was first reported by 
Reque-Barreria and Campos-Neto [150]. 
Because jacalin is a D-galastose-binding 
lectin, it is expected to react with other classes of 
immunoglobulins containing this sugar. However, the 
basis of the apparent specificity of jacalin may be 
related to the oligosaccharide sequence rather than 
composition. For example, IgM apparently does not have 
* 
The results have been presented at the 25th Annual 
Conference of the Australian Association of Clinical 
Biochemists [148, appendix 4]• 
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D-galactose in the outer chain; IgG has it, but the 
oligosaccharide sequence differs from that of IgA. in 
IgA, D-galastose is the terminal sugar, and in IgG, 
N-acetylneuramic acid is the terminal sugar [150,151]• 
Thus, the presence of D-galactose as the terminal sugar 
only in IgA could be the basis of the selective binding 
of jacalin to IgA. 
It has been reported that jacalin reacts with 
human IgA of IgAl subclass but not that of IgA2 subclass 
[152,153,154,155]• However, the IgA2 reactivity of 
jacalin has been a matter of controversy. Some other 
workers [156,157,158,159] have confirmed the ability of 
jacalin to bind IgA2 weakly but significantly. In view 
of the weak reactivity between jacalin and IgA2, the 
amount of jacalin packed in the column was in far excess 
of the minimal required quantity — about 8 times of the 
recommended dose. 
After the jacalin column, the recovery and 
purity of the isolated IgA were checked by the ELISA 
method for IgA, IgG and IgM to ensure a representative 
portion of serum IgA was used for all experiments. 
Immunoelectrophoresis of purified IgA was also carried 
out to assure purity. The k and \ light chain 
concentrations were determined by ELISA. The IgAl 
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concentration was also determined to show the unchanged 
ratio of IgAl to total IgA before and after jacalin 
purification. Isoelectric focusing (lEF) and 
immunoblotting techniques, followed by densitometry, were 
adopted to study the lEP and charge distribution of the 
isolated total IgA, /c-containing IgA (IgAfc) , and 
入 - c o n t a i n i n g IgA (IgAA) to see if there was any 
difference in charge distribution between IgA isolated 
from NS and from serum of patients with IgAN at 
quiescence and during exacerbation. This approach could 
give a clue to the hypothesis of selective deposition of 
circulating IgA in the mesangium of patients with IgAN. 
An overall plan of the experimental design is 
shown in Fig.1.4. 
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Fig. 1.4 Design of Experiments in This Study 
Human Serum 
JACALIN 
Isolated IgA ) 
lEF** 




lEP*** of [IgA] [IgAl] [IgA(/c)] 
igA(/c) & IgA(入） 丄 [IgG] [igA(A)] 
lEP*** of figM] 
IgA 
^ Enzyme-1 inked immunosorbent assay 
关* I so-electric focusing 
••并 Iso-electric point 
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C H A P T E R 2 
MATERIALS & METHODS 
2.1 MATERIALS 
2.1.1 Patients 
Eleven patients with clinical and renal 
immunopathologic diagnosis of primary IgAN were selected 
for the study. They had been symptomatic for 12 months 
or more, proteinunia of at least 1.5 g/day, and aged 
between 16 and 60 years. IgAN was diagnosed by the 
presence of predominant granular IgA deposits mainly in 
the glomerular mesangiim and occasionally along the 
peripheral capillary basement membrane in 
immuunofluorescent studies and mesangial electron dense 
deposits in ultrastructural examination. Systemic lupus 
erythematosus, Henoch-Schonlein purpura and hepatic 
disease were excluded by detailed clinical history, 
examination and negative laboratory tests for 
hypocomplementemia, anti-DNA antibody or hepatitis B 
virus surface antigen. Significant renal impairment in 
these patients with IgAN was defined as an endogenous 
creatinine clearance ：^  40 mL/min/l. 73 m^. 
Blood samples were collected from each patient 
at two different disease stages, one during clinical 
quiescence, i.e. remission. The other sample was taken 
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when the patient was presenting synpharyngitic 
macroscopic haematuria, i.e. during exacerbation 
(relapse). 
2.1.2 Controls 
Ten age-matched healthy subjects with normal 
renal function were used as donors of control sera. 
2.1.3 Additional Specimens 
An additional 120 patients with biopsy-proven 
IgAN, rheumatic arthritis (RA), systemic lupus 
erythrematosis (LE), and hepatic cirrhosis (CR), 30 in 
each group were included in the studies of light chain 
ratios of serum immunoglobulins and 30 age-matched 
medical and nursing personnels served as controls. 
Lymphocyte culture supernates (20 IgAN patients 
and 14 age-matched normal subjects) obtained from Dr. 
K.N. Lai were also included as collaborative studies of 
in vitro immunoglobulin production in IgA nephropathy 
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[146], and lymphocyte subpopulations [144]. 
2.1.4 Serum Samples 
Venous blood samples from subjects were allowed 
to clot at 37°C for 2 h and were centrifuged at 2000 rpiti 
at room temperature for 2 0 min. Serum samples were 
stored in small aliquots at -4o''c until tested. 
2.1.5 Chemicals 
The following chemicals/kit were obtained from 
Sigma Chemical Co., St. Louis, MO 63178, USA : 






- 3 , 3 ' Diaminobenzidine tetrahydrochloride 
-Hydrogen peroxide, 32% 
-Horseradish peroxidase (EC 1.11.1.7) 
-Coomassie brilliant blue R 
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Fetal calf serum was obtained from Flow 
Laboratories, Rockville, MD, Australia. 
The Paragon Serum Protein Electrophoresis (SPE) 
kit was obtained from Beckman Instruments, Inc., Brea, 
CA, USA. 
Urea hydrogen peroxide was purchased from 
British Drug House Ltd., Poole, England. 
The Titan IV lEP plates (8 wells, 7 troughs 
configuration containing 1.5% agarose) and albumin marker 
were obtained from Helena Laboratories, Beaumount, Texas, 
USA. 
Immobilized jacalin attached to cross-linked 6% 
beaded agarose was obtained from Pierce Chemical Company, 
Rockford, IL, USA. 
The Bio-Rad Protein Assay was obtained from 
Bio-Rad Labs., Richmond, CA, USA. 
Servalyte, pH 4.0 - 7.0, was purchased from 
Serva Feinbiochemica, Heidelberg, New York, USA. 
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Triton X 114 was also obtained from Serva 
Feinbiochemica. 
Probind 45 nitrocellulose membrane, 0.45 ^m in 
diameter, was obtained from LKB Produkter AB, Bromma, 
Sweden. 
All other biochemicals and reagents were of 
'Analar' or equivalent grades. 
2.1.6 Immunoglobulins 
Human IgAl standard was obtained from 
Calbiochem Corporation, San Diego, CA, USA. 
Standard-Human-Serum (Lot No. 04 1022) was 
purchased from Behringwerke AG, Marburg, France. 
Pure human IgA, IgG and IgM were obtained from 
Dakopatts Laboratory (Copenhagen, Denmark)• 
The ICS control Serum with known concentration 




The following anti-sera were purchased from 
Dakopatts Laboratory. All anti-sera were purified by gel 
filtration and ion-exchange chromatography. Their 
monospecificity was ascertained by crossed 
immunoelectrophoresis at the Dakopatts Laboratory and 
confirmed by Ouchterlony double immunodiffusion in 
agarose gel. It was also counterchecked by ELISA of IgA, 
IgG, IgM, K, and X chains. 
-Rabbit anti-human a chain 
-Rabbit anti-human a chain, 
horseradish peroxidase-conjugated 
-Rabbit anti-human 飞 chain 
-Rabbit anti-human r chain, 
horseradish peroxidase一conjugated 
-Rabbit anti-human chain 
-Rabbit anti-human u chain, 
horseradish peroxidase-conjugated 
-Rabbit anti-human /c chain 
-Rabbit anti-human k chain, 
horseradish peroxidase-conj ugated 
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-Rabbit anti-human 入 chain 
-Rabbit anti-human 入 chain, 
horseradish peroxidase-conjugated 
- S w i n e anti-rabbit serum 
-Rabbit anti-horseradish peroxidase serum 
-Rabbit anti-human serum 
Mouse anti-human IgAl monoclonal antibody was 
obtained from Becton Dickinson Immunocytoinetry Systems, 
Mountain View, CA, USA. It was tested by two dimensional 
gel electrophoresis and enzyme-linked immunosorbent assay 
at Becton Dickinson Laboratory. 
2.1.8 Solutions and Buffers 
Solutions and buffers were prepared using glass 
distilled, de-ionized water, and 'Analar'-grade 
chemicals. The formulae and abbreviations of the buffers 
are listed below. In every case, the pH of the buffer 
was checked before use. 
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Sodium Carbonate-Bicarbonate Buffer (Coating 
Buffer) 
0.05 mol/L sodium carbonate-biocarbonate, 
pH 9.6 : 
Na^CO^ 1.59 g/L 
NaHCO^ 2.94 g/L 
Phosphate Buffer Saline (PBS) 
0.01 mol/L phosphate buffer, 0.15 mol/L sodium 
chloride, pH 7.5 : 
K^HPO^.SH^O 1.74 g/L 
KH^PO^ 0.40 g/L 
NaCl 8.77 g/L 
PBS-Tween (Wash Solution) 
PBS 1000 ml 
Tween-2 0 0.5 ml 
Phosphate-Citrate Buffer 
0.20 mol/L phosphate, 0.10 mol/L citric acid, 
pH 5.0 : 
Na^HPO^ 28.4 g/L 
Citric acid 21.0 g/L 
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FPLC Binding Buffer 
0.02 mol/L phosphate, 0.15 mol/L NaCl, pH 7•4 : 
NaH^PO^ 1.21 g/L 
Na^HPO^ 1.42 g/L 
NaCl 8.77 g/L 
NaN^ 0.20 g/L 
FPLC Elution Buffer 
0.1 mol/L melibiose, 0.02 mol/L phosphate, 0.15 
mol/L NaCl, pH 7.4 : 
Melibiose 34.23 g/L 
NaH^PO^ 1.21 g/L 
Na^HPO^ 1.42 g/L 
NaCl 8.77 g/L 
NaN^ 0.20 g/L 
Barbitone buffer 
0.08 mol/L barbitone, pH 8.2 : 
Sodium barbitone 12.00 g/L 
Bartitone 4.40 g/L 
Merthiolate o.20 g/L 
Tris-Borate Buffer 
0.05 mol/L tris, 0.05 mol/L boric acid, pH 8.3: 
Tris 6.05 g/L 
Boric acid 3.10 g/L 
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Tris-HCl Buffer 
0.1 mol/L tris, pH adjusted to 7.0 with HCl : 
Tris 12.1 g/L 
2.1.9 Apparatus and Equipment 
Serum protein electrophoresis (SPE) was carried 
out with the Beckman Paragon Electrophoresis Apparatus 
(Beckman). 
Microtiter plates (96 wells) purchased from Lab 
System OY, Finland were used for all ELISA work. 
A Titertek Microplate Washer, Model 120 (Flow 
Laboratories, Rockville, MD, USA) was used to wash 
microtiter plates. 
A Model 2550 EIA Reader (Bio-Rad Labs., 
Richmond, CA, USA) was used to read the absorbance of 
developed microtiter plates. 
An Elma Transsonic T460 ultrasonic bath was 
used for degassing of all FPLC buffers. 
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The chromatographic equipment used for the 
purification of IgA from serum was the Fast Protein 
Liquid Chromatography (FPLC) system manufactured by 
Pharmacia Fine Chemicals, Uppsala, Sweden. It consisted 
of a LCC 500 programmer controlling two P—500 
reciprocation pumps and one peristaltic pump. Each pump 
delivered one buffer into a dynamic mixing chamber where 
the buffers passed through a V-7 injection valve for the 
introduction of sample via a lO-mL superloop onto the 
jacalin column. A HR 10/10 column (10 cm X 10 mm I.D.) 
packed with approximately 8 mL of immobilized jacalin 
suspended in binding buffer was used. From the column the 
eluate was monitored by a single-path UV-1 monitor at 280 
nm in a 10-itmi path length high-resolution flow cell, and 
the chromatogram was recorded on a REC-482 two-channel 
recorder. Eluted fractions were collected with a FRAC-100 
fraction collector. 
Isoelectric focusing was performed with the 
Pharmacia ECPS 3000/150 power supply with constant 
voltage, constant current and constant power regulation, 
and the Pharmacia FBE-3000 Flat Bed Apparatus. The 
electrophorectic transfer and blotting were carried out 
by the Bio-Rad Trans-Blot SD semi-dry transfer cell and 
the Shandon 600 x 100 electrophoresis tank. (Shandon 
52 
Southern Instruments Ltd., Camberley, Surrey, England). 
The Helena Laboratories CliniScan 2 Scanning 
Densitometer (Helena Laboratories) coupled with an IBM PC 
compatible was used to evaluate the electro-focusing 
patterns for the study of the charge distribution of the 
purified IgA. The scanning and integration were carried 
out with the dedicated software, MS-DOS Version 3.3. 
A Coulter Mixer of the Coulter Electronics 
Limited, Luton, UK was used to roll plastic tubes to 
facilitate immunoadsorption by anti-K or anti-A antibody 
coated on the tubes. 
To concentrate FPLC eluates for gel filtration 
HPLC, the Amicon apparatus (Amicon Corporation, Danvers, 
MA, USA) containing a Stirred Ultrafiltration Cell (Model 
8010), a Concentration/Dialysis Selector (Model CDSIO) 
and a RC800 Mini-Reservoir were used. The Amicon YMIO 
membrane (molecular weight cut-off is around 10,000 D) 
was used to retain molecules > 10,000 D. 
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2.2 METHODS 
2.2.1 Serum Protein Electrophoresis (SPE) 
Before the immunochemical investigation began, 
each serum sample was electrophoresed with the Paragon 
Serum Protein Electrophoresis (SPE) Kit (Beckman) to 
exclude paraproteinaemia. The Paragon SPE kit provided 
the electrophoretic sparation of proteins in a buffered 
agarose gel. After electrophoresis, the proteins in the 
gel were immobilized in a fixation pattern and was 
visualized by staining the film with a protein—specific 
stain, 8-ainino-7-(3-nitrophenylazo)-2-(phenylazo)-1-
napthol-3, 6-disulfonic acid disodium salt. 
2.2.2 Immunochemical Techniques 
(i) Enzyme-Linked Immunosorbent Assays (ELISA) 
(A) Quantitation of Immunoglobulins 
Concentrations of IgA, IgG, and IgM in serum 
were determined by double sandwich ELISA methods modified 
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from Hale et al [160]. 
Purified immunoglobulin fractions of rabbit 
antisera to human IgA, IgG and IgM were diluted 1/2000 in 
sodium carbonate- bicarbonate buffer, pH 9.6 (coating 
buffer)• Microtiter plates were coated by adding 100 uL 
(approximately 0.5 ug) of the diluted antiserum to each 
well. The plates were incubated overnight at 4°C and 
then washed 10 times with PBS-Tween (wash solution)• The 
non-specific binding sites of each coated well were then 
blocked by the addition of 100 jitL of PBS containing 10 
g/L BSA with further incubation at ST^ 'c for 1 h. The 
plates were washed 10 times again. Test and control 
(Beckman) samples, and standards (Behringwerke) 
appropriately diluted (from 0 to 200 ng/iriL for IgG, IgA 
and IgM) in PBS containing 5 g/L BSA (assay buffer) were 
then introduced, 100 juL/well in duplicate. After 
incubation at Zl^C for 3 h, the plates were again washed 
10 times with PBS-Tween. The same antisera as used for 
coating, but conjugated with horseradish peroxidase and 
diluted 1/6000 (IgA), 1/6000 (IgG), and 1/2000 (IgM) in 
PBS-Tween, were then added, 100 /LtL/well as appropriate. 
Incubation at 37°C was continued for another 2 h and the 
washing repeated. A freshly prepared peroxidase 
substrate solution containing 20 mg of urea hydrogen 
peroxide and 70 mg of o-phenylene-diamine dihydrochloride 
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in 100 mL of 2 0 mmol/L phosphate-citrate buffer, pH 5.0 
was then added, 100 juL/well, and the plates were 
incubated at 37°C for 15 min. Finally, the reaction was 
terminated by addition of 50 uL/well of 4 mol/L sulphuric 
acid, and the absorbances were measured at 450 nm 
wavelength using a Bio-Rad EIA Reader. Dose-response 
curves were constructed by plotting the absorbance values 
against concentrations of standards. IgA, IgG, and IgM 
concentrations of samples were read out from 
corresponding curves. 
(B) Determination of K/\ Ratios of Individual 
Immunoglobulins 
(a) Standardization 
Working standards for K and X light chains of 
individual immunoglobulins were prepared from Standard 
Human Serum (Behringwerke) containing IgG, IgA and IgM 
with known concentrations for overall K (3.24 g/L) and 入 
(1-72 g/L) chains determined by the manufacturer by 
radial immunodiffusion using WHO reference materials. 
Using the assay protocol described in (b) below, six 
absorbance (A) values each corresponding to the light 
chain concentration of individual immunoglobulin i.e. 
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^igG^ ‘ AigGX, AigAK, ^gAX ‘ Aig狀 and , in the same 
diluted standard solution were obtained. By calculation 
of absorbance ratios, i . e . A /(A + A + A ) 
IgGK, ^  IgG/C IgAK IgM/C^  
etc, the percentage of K and \ chains of each 
immunoglobulin class was determined. Thus the K and A 
chain concentrations of individual immunoglobulins in the 
standard were known. The reliability of such further 
calibration was counterchecked with pure IgG, IgA and IgM 
standards (Dakopatts), the Kf\ ratio of which had been 
determined by ELISA of individual immunoglobulin 
containing only one light chain type after the other type 
had been removed by immunoadsorption with anti-/c or 
anti-X antibody (Dakopatts) coated on polystyrene tubes. 
The immunoadsorption procedure is described in Section 
2.2.2.ii. 
(b) Assay Procedure 
Microtiter plates were coated by overnight 
exposure to 100 iiL (approximately 0.5 jixg) of rabbit 
antisera to human IgA, IgG and IgM (Dakopatts), diluted 
2000-fold in coating buffer, at Before use, the 
plates were washed 10 times with wash solution, followed 
by blocking with lOg/L BSA in PBS at for 1 h. The 
plates were washed again. Samples and standards 
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appropriately diluted (from 0 to 200 ng/L for IgG, IgA 
and IgM) in assay buffer were introduced, 100 uL/well in 
duplicate. After incubation at 37°C for 3 h, the plates 
were washed. Peroxidase-conjugated anti-fc and anti-A sera 
(Dakopatts), both diluted 1/500 in wash solution, were 
added to appropriate wells. Incubation was continued at 
for 2 h and the same peroxidase substrate solution 
as used in Section 2.2.2.i.A. was added to each well, 
100 jLtli/well followed by 15-inin reaction at room 
temperature. The reaction was stopped by adding 50 /iL of 
4 mol/L H^SO^. The color developed in each well was 
measured at 450 nm. Dose-response curves were 
constructed by plotting the absorbance values against 
concentrations of standards and /c and 入 light chain 
concentrations of each immunoglobulin class were read out 
from corresponding curves. 
(C) Quantitation of IgAl by ELISA 
Microtiter plates were coated with mouse 
anti-human IgAl monclonal antibody (Becton-Dickinson) 
diluted 1/50 (3/Lig) in coating buffer, at 4°C overnight. 
Before use, the plates were washed 10 times with wash 
solution, followed by BSA blocking at 37°C for 1 h. The 
plates were washed again. Samples and IgAl standards 
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(Calbiochem) appropraitely diluted (from 0 to 200 ng/mL) 
in assay buffer were introduced, 100 /nL/well in 
duplicate. After incubation at 4°C overnight, the plates 
were washed. Peroxidase- conjugated anti-a serum, 
diluted 1/2000 in wash solution was added. Incubation 
was continued at 37°C for 2 h and the washing repeated. 
One hundred /liL of the same peroxidase substrate solution 
as used in Section 2.2.2.i.A. was added to each well, 
followed by 15-min reaction at room temperature. The 
reaction was stopped by adding 50 jliL of 4 mol/L H SO • 
2 4 
The color developed in each well was measured at 450 nm. 
A dose-response curve was constructed by plotting the 
absorbance values against concentrations of standards and 
sample values were read out from the curve. 
(ii) Immunoadsorption 
Polystyrene tubes (12 X 75 mm) were coated by 
incubating with 2 itiL of rabbit anti-human k or 入 antibody 
(Dakopatts) , both diluted 1/200 in coating buffer, at 
overnight (The amount of antibody in each tube is 
approximately 10 uq)• The antibody-coated tubes were 
washed 10 times with wash solution, followed by BSA 
blocking at 37°C for 1 h. The tubes were washed again. 
Three hundred and fifty /iL of pure immunoglobulin 
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standards diluted to contain about 100 ng of each 
immunoglobulin was added to the tubes which were then 
rolled on a Coulter Mixer at room temperature for 3 h. 
The content of each tube was then transferred to a second 
set of K and X antibody-coated tubes and the 
immunoadsorption was continued at 4°C overnight. 
The completeness of K, and X immunoadsorption 
was checked by ELISA of K, and 入 light chains of 
individual immunoglobulin, using the protocol described 
in Section 2.2.2.i.B.b. 
(iii) Immunoelectrophoresis 
The purity of the jacalin-isolated IgA was 
investigated by a standard immunoelectrophoresis 
technique [161], using Titan IV lEP PLATES (Helena 
Laboratories), rabbit anti-human serum (Dakopatts) and 
rabbit anti-IgA (Dakopatts) antisera. Three serum samples 
(1 NS and 2 IgAN patients) together with the 
corresponding purified IgA solution (concentrated) were 
examined. Five /liL of each sample and the albumin marker 
(Helena Laboratories) was applied to the appropiate wells 
in the agarose gel plate. The electrophoresis was carried 
out with barbitone buffer at pH 8.2, at 150 Volts for 
60 
about 90 min. After electrophoresis, 90 uh of the 
appropiate antisera was added to the appropiate trough. 
The plate was allowed to stand overnight at room 
temperature in a moist chamber. Precipitin arcs were 
observed. Excessive antisera in the gel were removed by 
washing the plate with PBS, with constant shaking for 48 
hours. The plate was then stained with Coomassie 
brilliant blue R with the procedure described in Section 
(iv) Isoelectric Focusing (lEF) and Immunoblotting 
The lEF and transfer procedures are essentially 
modifications of the Lewis and Sun's method for specific 
antigen detection by immunoelectroendosmosis [162]• 
Polyacrylaitiide gels for isoelectric focusing were 
formulated as follows: 
一 19.1% acrylamide plus 3.38% 
N,N'-diallyl-tartardiainide 3.8 mL 
-2.14% (w/v) sucrose 4.2 mL 
-Servalyte, pH range 4.0 - 7.0 0.7 mL 




The mixture was put under reduced pressure for 
degassing, then polymerization was initiated by the 
addition of 0.36 mL of freshly prepared 1% (w/v) ammonium 
persulphate and the solution transferred to a 220xl00x 
0.42 mm mould. Focusing was carried out using a 
Pharmacia flat bed apparatus, with sodium hydroxide (0.5 
mol/L) and phosphoric acid (0.25 mol/L) as the cathodal 
and anodal electrode solutions, respectively. Gels were 
prefocused for 1 h at 700 V. Jacalin-purified IgA 
samples, neat and diluted 1/2 or 1/4 with distilled 
water (D.W.), were applied to the gel using 2 layers of 
Whatman No. 1 chromatography paper (8x5 mm) as 
applicators. After focusing for 50 min at 500 V, the 
applicators were removed and focusing was continued at 
1200 V for 20 min, 2000 V for 1.5 h, and 2500 V for 0.5h. 
When isoelectric focusing was completed, the 
immunoglobulins (predominantly IgA) in the gel were 
stained with 0.03% Coomassie brilliant blue R in 0.1% 
cupric sulphate for 1 h, followed by overnight exposure 
in a second staining solution of 0.01% Coomassie 
brilliant blue R in a mixture of H O, ethenol and acetic 
2 
acid (65:25:10). The gel was destained with a mixture of 
H^O, ethanol, and acetic acid (10:10:80) until the 
background was clear. It was allowed to dry at room 
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temperature, and was scanned with the CliniScan 2 
Densitometer (Helena) at 525 nm, using the transmittance 
mode. 
For the study of charge distribution of igA/c 
and IgAX, the focused immunoglobulins (predominantly IgA) 
were transferred to 220x100 mm nitrocellulose (NC) 
membranes (LKB Probind 45, pore size, 0.45 “m) • A 
cellulose acetate membrane was inserted between the gel 
and the NC to prevent adhesion of the acrylamide gel to 
the latter membrane. The proteins were allowed to 
transfer passively for 0.5 h under pressure, followed by 
electrophoretic transfer in the Bio-Rad Trans-Blot SD 
Semi-Dry Cell (Bio-Rad) at 40 V for 5 min and 100 V for 1 
h. The transfer buffer was 0.05 mol/L tris-borate 
buffer, pH 8.3, containing 20% v/v methanol. After 
completion of the transfer of the proteins to the NC 
membrane, the residual binding sites on the NC membrane 
were blocked by immersion in 0.1% (w/v) Tween 80 in 
transfer buffer with shaking for 2 h. 
Electroendosmosis of antibodies [162] was 
carried out in a Shandon horizontal electrophoresis tank 
at room temperature using 0.05 mol/L tris-borate buffer, 
pH 8.3. The NC membrane was connected to the elecrode 
vessels with Whatman 3 mm filter paper. The first 
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antibody (either rabbit anti-human K chain or anti-human 
入 chain, both diluted 1/100 in DW) was applied to the 
surface of the NC membrane about 10 mm from the anodal 
side using a cellulose acetate membrane strip 200x3 mm, 
200 mL in each case. A voltage of 250 V was applied for 
1 h. The process was repeated for swine anti-rabbit 
(1/100 dilution in DW) and rabbit anti一peroxidase (1/50 
dilution in DW) antibodies. Peroxidase was used at 0.04 
mg/mL and was allowed 0.5 h for its migration. Finally 
the NC membrane was rinsed once with DW and stained with 
the peroxidase staining solution containing 0.1 mL of 32% 
(v/v) H^O^ and 10 mg of diaminobenzidine HCl in 100 mL of 
0.1 mol/L Tris-HCl buffer, pH 7.0 until the bands were 
clearly visible. The membrane was washed with several 
changes of DW and was allowed to dry at room temperature. 
Densitometric scanning of the stained membranes 
was also carried out with the CliniScan 2 Desitometer. 
Before scanning, the membrane was soaked in Triton X 114 
to make it transparent, then placed between two pieces of 
glass and scanned at 485 nm, using the transmittance 
mode. 
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2.2.3 Fast Protein Liquid Chromatography (FPLC) 
for Isolation of Serum IgA 
(A) Sample Preparation 
1-3 iriL of serum (approximately 2 to 6 mg of 
IgA) was diluted 1/2 with binding buffer (0.02 mol/L 
phosphate buffer containing 0.15 mol/L NaCl, pH 7.4) 
prior to its application to the jacalin column. The 
iminunobilized jacalin has a maximal binding of about 3 mg 
of human IgA per itiL of gel. For optimal purification and 
recovery, it is recommended that a sample size should be 
chosen such that the expected IgA load on the column is 
less than 80% of the maximum binding capacity [163]• 
(B) FPLC Protocol 
Table 2 • 1 shows the gradient programme 
implemented by the FPLC system for each separation. 
The chromatography consisted of 3 stages 
lasting 2 hours. The first hour (fractions 1-12) was the 
binding phase. Elution of the bound IgA was initated by 
switching to the elution buffer (0.1 mol/L melibiose in 
binding buffer) at the end of the first hour. The 
elution took 30 min to complete and the eluted IgA was 
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monitored at 280 nm. Thirty two sera have been subject 
to the same FPLC system and similar chromatograms (Fig. 
5.1) were obtained from all samples. During elution 5-mL 
fractions were collected in test tubes. Fractions 13-17 
were pooled for ELISA of IgA, IgG, IgM, fc, X, and IgAl 
concentrations. When elution was completed, the column 
was regenerated with distilled water for 30 min. 
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TABLE 2.1 FPLC Programme for the Purification of Serum IgA 
Method base : min 
Method No. : 2 
Time (min) Function Value 
0.0 CONC %B 0.0 
0.0 FLOW C 0.00 
0.0 VALVE.POS 1.1 
0.0 ML/MIN 0.00 
0.0 ML/MIN 1.00 
0.0 CM/MIM 0.20 
0.0 CLEAR DATA 
0.0 MONITOR 1 
0.0 LEVEL % 5.0 
0.0 MIN/MARK 5.0 
0.0 ALARM 0.1 
0.0 HOLD 
0. 0 INTEGRATE 1 
60.0 CONC %B 0.0 
60.0 CONC %B 100 
90.0 ML/MIN 1.00 
90.0 CONC %B 100 
90.0 ML/MIN 0.00 
90.0 CONC %B 0.0 
90.0 VALVE.POS 1.2 
90.0 FLOW C 1.00 
120.0 INTEGRATE 0 
120. 0 FLOW C 0.00 
12 0.0 VALVE.POS 1.1 
120.0 CONC %B 0.0 
120.0 ML/MIN 1.00 
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C H A P T E R 3 
SERUM PROTEIN ELECTROPHORESIS 
AND 
IMMUNOGLOBULIN CONCENTRATIONS 
3.1 SERUM PROTEIN ELECTROPHORESIS 
All 32 serum samples used for full 
investigation showed visually normal serum protein 
pattern without the presence of a paraprotein band when 
screened by agarose gel electrophorsis • Some typical 
patterns on the Beckman Paragon Gel are shown in Fig. 
3.1. 
3.2 SERUM IMMUNOGLOBULIN CONCENTRATIONS 
As mentioned in Section 1.1.3., serum 
concentrations of IgA were elevated in 50 - 70% of IgAN 
pateients. Serum samples were assayed for IgG, IgA and 
IgM by the ELISA methods published by Hales et al [160], 
as described in Section 2.2.2.i.A. Because of the high 
sensitivity of ELISA all samples had to be appropriately 
diluted (usually 1/50,000 for IgA and IgM, and 1/300,000 
for IgG) . Table 3.1 shows the precision of the ELISA 
methods for immunoglobulins at different levels. It was 
found that the within-run coefficients of variation (CV) 
at different concentration levels were below 10% for IgG, 
IgA and IgM. The same diluted samples were also used for 
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Fig. 3.1 Serum Protein Electrophoresis on the Beckman 
Paragon Gel. Samples 1 and 10 were normal human 
sera included for comparison and interpretation. 
2 - 9 were patient samples. 
I 
BECKMAN Paragon-M ® 
l i i m n n 
• 1 2 9 4 8 • 7 • • 10 • ^ (D 
I 
Paragon- SPE Gel 气 
！iiPniil 
• 1 2 3 4 S 6 7 雄 ^ l O * 
• • C K M A N 0 
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Table 3.1 Precision of ELISA methods for immunoglobulins. 
The within-run coefficients of variations (CV) at 
3 concentration levels (n=25 each) for IgG, IgA 
IgM are shown. 
IgG IgA IgM 
19.4 3.52 2.84 
Concentration, 14.3 2.08 l.31 
g/L 10.7 1.69 0.91 
5.9 5. 1 6,2 
CV, % 7.3 6.2 7.8 
9 . 1 8 . 3 9 . 0 
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the determination of k/入 ratios of individual 
immunoglobulins by a newly developed ELISA method as 
described in Section 2.2.2.i.B. The mean immunoglobulin 
concentrations of 32 serum samples of 3 groups: 10 NS and 
11 IgAN patients at quiescence and during exacerbation 
are shown in Table 3.2 and the IgA concentrations of 
individual samples are shown in Table 3.3. 
As indicated in Table 3.2, no significant 
difference in IgG and IgM concentrations was observed 
between NS and IgAN patients during quiescence and 
exacerbation. Only IgA concentration was significantly 
higher in patients (3.53 ±0.41 g/L at quiescence and 3.27 
±0.47 g/L during exacerbation) vs NS (2.49 ±0.56 g/L), 
both p < 0.01. As shown in Table 3.3, 10 patients at 
quiescence (7 during exacerbation) had IgA concentration 
above 3 g/L which was seen in only two normal subjects. 
However, no difference in immunoglobulin concentrations 
(including IgA) was observed in IgAN patients between 
quiescence and during exacerbation. These findings are 
consistent with the observations made by other workers 
[17] who found no correlation between serum IgA 
concentration and any clinical, histological and 
immunological features. 
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Table 3.2 Serum Immunoglobulin Concentrations as Mean (SD) 
of 3 Groups : 10 Normal Subjects (NS) and 11 IgAN 




IgG (g/L) 13.0 (2.74) 12.7 (2.71) 13.1 (3.01) 
IgA (g/L) 2.49 (0.56) 3.53 (0.41)* 3.27 (0.47)* 
IgM (g/L) 1.52 (0.62) 1.72 (0.72) 1.89 (0.70) 
• compared with NS, p < 0.01 (t test) 
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TABLE 3.3 IgA Concentration of Individual Samples in 
3 Groups: 10 NS and 11 IgAN Patients at 
Quiescence and durine Exacerbation 
IgAN 
Normal At During 
No. Subjects Quiescence Exacerbation 
1 2.72 3.30 2.92 
2 1.85 3.71 3.40 
3 1.72 3.50 3.67 
4 2.21 4.10 4.24 
5 2.98 3.20 2.98 
6 2 .26 3.28 3.03 
7 2.83 3.61 3.13 
8 1.98 4.24 3.80 
9 3.08 2.80 2.64 
10 3.28 3.72 3.31 
11 - 3.37 2.88 
Mean (SD) 2.49 (0.56) 3 . 53 (0.41)* 3 . 27 (0.47)* 
• Compared with NS, p < 0.01 (t test) 
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3.3 DISCUSSION 
As shown by the serum protein electrophoretic 
results, all test samples contained no paraprotein and 
other obvious abnormality. They were considered suitable 
for futher studies of immunoglobulin concentrations, k/入 
light chain ratios of IgG, IgA, and IgM, as well as the 
immunocheinical properties of IgA(K：) and IgA(A) • 
The cause of elevated serum IgA concentrations 
in IgAN remains unclear, although disorder in the 
immunoregulatory activity has been suggested. Increased 
spontaneous and stimulated IgA synthesis by peripheral 
blood lymphocytes [164] as well as absolute reduction in 
T suppressor cells [164, 165] and increase in T helper 
cells [166] have been reported. Defective suppressor 
cell activity and B cell hyperactivity has also been 
suggested with observations of a decrease in IgA specific 
T suppressor cell activity [167] and increased IgA 
production by stimulated lymphocytes [160, 164, 166, 168, 
169] • Contrary to these findings, Linne and Wasserman 
[170] failed to demonstrate a shift in the 
immunoregulatory T-lymphocyte subpopulations during an 
infection-free interval. Furthermore, increased 
spontaneous and stimulated IgA synthesis by peripheral 
blood lymphocytes in patients with IgAN was not observed 
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by the author in collaborative studies with Lai et al 
[144,146] on lymphocyte subpopulations and immunoglobulin 
production in IgAN (see Chapter 5) , and other workers 
[170,171, 172]• On the other hand, elevated serum IgA 
concentrations are also seen in alcoholic cirrhosis and 
have been attributed to a state of hyperimmunization 
secondary to defective hepatic sequestration of antigens 
[173]• Nevertheless, the high frequency of serum IgA 
elevation in most series [9, 17, 174] has contributed to 
focus attention on potential IgA abnormalities and its 
role in the pathogenesis of IgAN. 
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C H A P T E R 4 
LIGHT CHAIN RATIOS OF 
INDIVIDUAL IMMUNOGLOBULINS 
4.1 ELISA FOR LIGHT CHAIN CONCENTRATIONS 
In order to investigate the previous finding of 
predominant lambda light chain IF staining in the 
mesangial immunoglobulin deposits in IgAN [141,142], an 
ELISA method (Section 2.2.2.i.B) was developed to 
determine the K/\ light chain ratio of different 
immunoglobulins in sera from NS and patients with immune 
complex disease including rheumatoid arthritis (RA), 
systemic lupus erythematosus (LE), hepatic cirrhosis (CR) 
and IgAN. 
The performance of the newly developed ELISA 
was evaluated before it was applied to assay samples. 
Fig. 4.1 illustrates ELISA standard curves for 
/c and \ chains of IgG, IgA and IgM. The measurable 
ranges were up to approximately 100 ng/mL. 
Table 4.1. summarizes the coefficients of 
variation (CV) for 25 measurements at "high", "normal" 
and "low" /c/入 ratios. In general, IgG K/X ratio had the 
lowest and IgM K/X ratios the highest CV. However, both 












































































































TABLE 4.1 Assay Reproducibility 
Immunoglobulin 
IgG IgA IgM 
Within-run 
/c/入 ratio 3.77 2 . 28 1.40 2.56 1.64 0.97 2.40 1. 50 1. 00 
CV, % 9.5 5.9 7.2 12.3 6.9 8.2 13.0 11.8 10.2 
Between-run 
K/入 ratio 2.35 1.90 1.41 2.30 1.60 1.18 2.33 1. 60 1. 10 
CV, % 9.4 7.5 8.4 12.8 8.5 10.8 13.6 12.8 7.3 
n = 25 each 
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since no quality control sample with known 
light chain concentrations of each immunoglobulin was 
available, the additivity (or cumulative accuracy) of the 
method was studied. It was defined as (IgG/c + 
IgG入"（total IgG), (IgA/c + IgA入"（total IgA), and (IgMK + 
IgMA)/(total IgM). One hundred and fifty normal and 
pathological sera (5 subject groups including NS, RA, LE, 
CR and IgAN; 30 in each group) were studied and it has 
been found that these ratio values ranged from 91% to 
110% • This reflects the satisfactory accuracy of the 
assays because the sum of determined K and A chain 
concentrations associated with a specific heavy- chain 
class did not deviate from the total individual 
immunoglobulin class concentrations. 
4.2 LIGHT CHAIN RATIOS OF INDIVIDUAL SERUM 
IMMUNOGLOBULINS IN NS AND IN DISEASE 
The results of k/A ratios of 5 subject/patient 
groups are presented as mean (SD) in Table 4.2. 
The results showed that the K/X ratios of IgA 
and IgM were significantly different from that of IgG in 
NS and the four groups of patients studied (P < 0.01). ** 
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TABLE 4.2 The Mean (SD) of Light Chain Ratios of Serum 
Immunoglobulin in Health and Disease 
(n = 30 in each group). 
NS RA LE 
IgG K/入 2.26 (0.56) 2.22 (0.66) 2.15 (0.79) 
IgA K/入 1.64 (0.42) 1.84 (0.61) 1.45 (0.28)* 
IgM K/入 1.87 (0.45) 1.76 (0.54) 1.77 (0.65) 
CR IgAN 
IgG K/入 2.52 ( 0 . 9 6 ) 2.21 (0.64) 
IgA K/入 1.54 (0.33) 1.20 (0.19)** 
IgM K/入 1.83 (0.69) 1. 64 (0.46)* 
• compared with NS, p < 0.05 (t test) 
•• compared with NS, p < 0.01 (t test) 
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The K/入 ratios of individual immunoglobulins in patients 
with RA, LE and CR were similar to those of NS. However, 
patients with IgAN displayed a distinctly lower IgA K/\ 
ratio (P < 0.01) and an IgM K/\ ratio which was also 
lower than those of other groups (P < o.05). 
Table 4.3 shows the IgA K/\ ratio of 10 NS and 
11 selected IgAN patients at quiescence and during 
exacerbation, and a scattergram of the IgA K/\ ratio is 
shown in Fig. 4.2. Similar difference in K/\ ratio was 
observed between NS and IgAN patients but no difference 
was observed between the two disease stages in patients. 
4.3 DISCUSSION 
The results shown in Fig. 4.1, Tables 4.1 and 
4.2 show that the performance of the ELISA method for K 
and 入 chain concentrations was satisfactory. Hence the 
derived K/X ratios should be valid. In addition, the 
method is an improvement on previous assays because it 
measures K and X chain concentrations of individual 
immunoglobulin classes rather than the overall light 
chain concentrations. As indicated by the results of NS 
in Table 4.2, the K/X ratios of the three major serum 
81 
TABLE 4.3 IgA K/\ Ratio of 10 Normal Subjects and 11 IgAN 
Patients at Quiescence and during Exacerbation 
IgAN 
Normal At During 
No. Subjects Quiescence Exacerbation 
1 1.36 0.89 0.84 
2 1.34 1.48 1.38 
3 1.37 1.08 1.19 
4 1.78 1.08 1. 06 
5 1.48 1.12 1. 15 
6 1.41 1.20 1. 16 
7 1.40 1.05 1.15 
8 1.70 1.11 1.20 
9 1.56 1.09 1.20 
10 1.69 1.11 0.86 
11 - 0.98 0.97 
Mean (SD) 1.51 (0.16) 1.11 (0.15)* 1.11 (0.16)* 
• Compared with NS, p < 0.01 (t test) 
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immunoglobulins differ. Under normal circumstances, the 
overall serum k/入 ratio is dictated by that of IgG (2.34 
±0.80) because its concentration is much greater than 
those of IgA and IgM. This method therefore offers a 
more specific and sensitive means of studying diseases 
that involve predominant synthesis of one type of light 
chains, e.g. IgAN. 
As indicated in Table 4.2 and Table 4.3, the 
IgA K/X ratio of IgAN patients was significantly lower 
than that of NS (P < 0.01). This finding indicated there 
was over production of X chain containing IgA in the 
serum of patients with IgAN. The k/入 ratio of serum IgM 
in IgAN patients was also lower than that of normal. The 
reason for this finding is not clear. Furthermore, the 
K/A. ratios of individual immunoglobulins in patients with 
RA and CR were similar to those of normal subjects. LE 
patients had a slightly reduced K,/X ratio, the cause of 
which remains unknown. 
As mentioned earlier, Lai et al [141] 
demonstrated that predominant 入 light chain IF staining 
occurred in glomerular immunoglobulin deposits in primary 
IgAN and these findings inferred that mesangial IgA 
deposits comprised predominantly X chain IgA. In a 
collaborative study of in vitro IgA synthesis in IgAN 
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[146], we have repeated the IF staining with three 
different antisera in renal tissues from another 15 
patients with mesengial IgA deposits alone, and obtained 
similar results. The higher incidence of positivity and 
the greater intensity of 入 light chain IF staining over K 
light chain confirm the original observation [141] that 
the glomerular IgA deposits in IgAN are composed 
predominantly of A light chain IgA, and only partially of 
fc light chain IgA. 
The observation in the nature of the light 
chains in IgA deposits in IgAN has an interesting bearing 
on the immunopathogenesis of primary IgAN. The findings 
of predominant 入 light chain IgA deposits in glomerular 
mesangium could indicate that selective deposition of 
IgA(入）and IgA(X) containing CIC occurs in IgAN due to 
IgA abnormalities such as difference in charge 
distribution of different types of IgA (defined by light 
chain)• The other possible immunopathological mechanism 
is the altered ratio of light chains with a given 
specificity to an unidentified antigen leading to 
excessive production of \ light chain IgA. The present 
data on the K/X ratio of serum IgA tend to support the 
latter hypothesis, i.e., a unique antibody response in 
the immunopathogenesis of IgAN. Hence the predominance 
of mesangial IF staining was mainly due to deposition of 
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入 - c o n t a i n i n g IgA or IgA IC formed by excessive A chain 
IgA, which may or may not have abnormal physico-chemical 
properties. Since similar IgA k/入 ratios were observed 
for most of the patients at different disease stages, it 
may be possible that the immunological processes 
associated with the disease are active throughout the 
entire disease process, not just during exacerbation. 
Nevertheless, further studies of the charge 
characteristics of circulating IgA, IgA(/c) and IgA(;v) in 
IgAN are warranted to clarify the immunopathological 
findings. 
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C H A P T E R 5 
IN VITRO SYSNTHESIS OF IgA 
WITH A LIGHT CHAIN IN IgA NEPHROPATHY 
5.1 LYMPHOCYTE CULTURE AND IN VITRO IMMUNOGLOBULIN 
PRODUCTION 
This was to further study the support of 
predominance of 入 light chain IgA in the circulation of 
patients with IgAN, and to determine whether an altered 
antibody response is present in such patients. 
Spontaneous and pokeweed mitogen (PWM) - stimulated IgA 
synthesis by peripheral blood lymphocytes was 
investigated in collaboration with Dr. K.N. Lai who 
conducted the preparation of lymphocyte culture 
supernates from peripheral blood mononuclear cells 
culture of 20 IgA nephritic patients and 14 age-matched 
normal subjects. The procedure of lymphocyte culture has 
been detailed in a paper published on the stated and 
relevant studies [146]• The concentration of individual 
immunoglobulins and their light chain fractions, and the 
K/入 ratio in the supernate were determined by ELISA 
methods. 
5.2 IN VITRO IMMUNOGLOBULIN PRODUCTION AND 
PREDOMINANT SYNTHESIS OF IgA WITH X LIGHT 
CHAIN IN IgA NEPHROPATHY 
The concentrations of individual 
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immunoglobulins and their light chain fractions are shown 
in Fig. 5.1. There was no difference observed in the 
numbers of B cells in the peripheral blood mononuclear 
cell cultures from normal subjects and patients with 
IgAN. The individual immunoglobulin concentrations in 
supernate from the unstimulated (spontaneous) and 
PWM-stimulated lymphocyte cultures were similar in the 
patients and the normal subjects. The concentrations of 
IgG and IgM in the supernate increased significantly when 
the peripheral blood mononuclear cells from IgA nephritic 
patients or controls were cultured with PWM (P<0.01 for 
IgG, and P<0.05 for IgM). Similarly, in vitro production 
of IgA increased when the peripheral blood mononuclear 
cells from the patients or the controls were stimulated 
with mitogen, but these changes failed to reach 
statistical significance.On the other hand the K/\ ratio 
of supernatant IgA in patients was significantly lower 
than that of normal subjects in both unstimulated 
(P<0.01) and stimulated lymphocyte culture (P<0.05). A 
significant difference of k/入 ratio in supernatant IgM 
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Fig. 5.1 Supernate Studies of Individual Immunoglobulins 
and their Light Chain Fractions in Patients with 
IgA Nephropathy (_, N=20) and Normal subjects 
(•, N=14). The Immunoglobulin Concentrations 
are expressed as ng per 0.5x10^ Perpherial 
Mononuclear Cells. Results are expressed as 
mean ±SEM. 
• • • P < 0. 01, P < 0. 05 
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5.3 DISCUSSION 
The in vitro production of immunoglobulins by 
cultured lymphocytes was further investigated to 
determine whether an altered antibody response was 
present in patients with IgAN. Although other workers 
had demonstrated a significant increase in in vitro 
production of IgA by patients with IgAN [160, 164, 169], 
the present results showed that IgA production by 
peripheral blood mononuclear cells was the same as that 
of the controls. Three other studies had also failed to 
demonstrate an increase of in vitro production of IgA in 
patients with IgAN [78, 170, 175]. Inconsistencies in 
abnormalities of the IgA immune system found in IgAN may 
have some basis in methodological variations although a 
similar ELISA method has been used in these studies. 
However, variability in patients selection, clinical 
setting and study design may also contribute. Notably, 
the earlier series consisted of only small sample of 
patients. As the inter individual values of the T cell 
subpopulations and in vitro immunoglobulin production are 
extremely variable, it is understandable that a definite 
conclusion could hardly be drawn. Moreover, no clinical 
data describing the activity of the desease were 
presented in most studies and the renal functions were 
not recorded. Longitudinal studies are not available so 
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that the consistency of these findings with the clinical 
progress can not be ascertained. 
The failure to demonstrate a significant rise 
of IgA in the supernatant compared with findings in serum 
could also be explained by the following possibilities. 
First, proliferation of T lymphocytes occurs following a 
complex cascade of T-lymphocyte activation involving 
antigens, antigen-presenting cells, HLA glycoproteins, 
and growth factors [176]. A prerequisite event in this 
cascade is the interaction of interleukin 2 (IL2) with 
specific receptors on the T-lymphocyte surface [177]. 
These IL2 receptors (IL2R) appear only after interaction 
of the T cell with antigen and are up-regulated by IL2 in 
an autocrine fashion [178, 179]. In a study of 
activation of T lymphocytes in IgAN, Lai et al [180] 
failed to demonstrate a significant rise of soluble IL2R 
(sIL2R) in the supernatant of cultured PBMC from IgA 
nephritic patients. One possible explanation was that 
the increased release of sIL2R from activated T helper 
cells may be negated by the decreased amount of sIL2R 
released from reduced members of or defective T 
suppressor cells. Hence, the activation of IgA—producing 
B lymphocytes from IgAN patients could be indirectly 
affected. Second, the in vivo stimulation by bacterial 
infection leading to systemic illness with loin pain and 
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haematuria is obviously a stronger stimulant than the in 
vitro mitogenic stimulation by lectins. Third, the 
overall changes of IgA concentrations in supernatant from 
1 million lymphocytes studied in vitro may not be obvious 
as compared with in vivo synthesis in serum where IgA 
concentrations corresponding to five million-fold of 
lymphocytes were measured. 
Although the study of in vitro IgA production 
failed to demonstrate an IgA specific B cell 
hyperactivity as suggested by Hale and coworkers [160], 
nevertheless, the immunoglobulin production by cultured B 
cells from the IgAN patients was quite specific as a 
significant quantity of lambda chain IgA in response to 
an unidentified antigen was produced. The k/入 ratios of 
supernatant IgA obtained from both unstimulated and 
stimulated cultures were significantly different from 
those of normal subjects. Similar changes in supernatant 
IgA and IgM were not observed. 
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C H A P T E R 6 
PURIFICATION OF SERUM IgA 
BY AFFINITY CHROMATOGRAPHY 
6.1 FAST PROTEIN LIQUID CHROMATOGRAPHY 
In order to investigate the charge distrubution 
of circulating IgA (including IgA(/c) and IgA(入）in plasma 
of patients with IgAN, it was necessary to isolate IgA 
from serum samples. As mentioned in Section 1.4., the 
specific IgA-binding property of jacalin was used to set 
up an automated purification programme with the Pharmacia 
FPLC system. The thirty two sera (10 NS, 11 IgAN patients 
with 2 samples each, 1 taken at quiescence and 1 during 
exacerbation) were subjected to the same FPLC procedure 
and similar chromatograms were obtained for all samples. 
Fig. 6.1 shows a typical FPLC gradient elution 
chromatogram of serum IgA. Five-mL fractions were 
collected throughout the whole programme and the 
concentration of IgA in each fraction was measured by 
ELISA. As indicated by the chromatogram as well as the 
ELISA results, fractions 14-17 contained the majority of 
serum IgA. They were pooled together (including fraction 
13) and concentrated about 10 times using the Amicon 
concentrator (Section 2.1.9). The concentrate was then 










































































































































































6.2 RECOVERY OF ISOLATED IgA 
With the use of the ELISA method mentioned in 
Section 2.2.2.i, the IgA concentration of the purified 
aliquots and the corresponding serum samples were 
measured, and the amount of recovered IgA was expressed 
as percentage of total serum IgA loaded onto the jacalin 
column. Table 6.1 shows the recovery of IgA from 32 
serum samples, ranging from 1 to 3 mL. All samples 
showed a yield of IgA of approximately 90% or over. 
Therefore, the isolated IgA could be regraded as an 
accurate representation of the serum IgA molecular 
population. 
6.3 PURITY OF ISOLATED IgA 
(i) Immunoelectrophoresis of Purified IgA 
Fig. 6.2. shows the result of 
immunoelectrophoresis of 3 sera with corresponding 
purified IgA solutions. Multiple precipitin arcs were 













































































































































































































































































































































Fig. 6.2 Immunoelectrophoresis of Purified IgA 
Antigen wells : 2,5, and 7 contained unpurified serum samples 
3, 4, and 6 contained corresponding purified 
IgA 
1 and 8 contained albumin marker. 
Antiserum trough : A, C, E, and G contained antiserum to human 
IgA 
B, D, and F contained antiserum to 
complete human plasma proteins 
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raised against human serum. The only prominent precipitin 
arc was observed in areas between the purified IgA and 
antiserum to human serum, which appeared at the same 
location as the single line formed from purified IgA and 
anti-IgA. These patterns indicated that the purified IgA 
solutions consisted predominantly (if not exclusively) of 
IgA. 
(ii) ELISA of Isolated IgA for IgG and IgM 
The purity of the isolated IgA with respect to 
other immunoglobulin classes has also been assessed by 
measuring IgG and IgM concentrations in both the standard 
serum and the eluted peak fractions. Table 6.1 also 
shows amounts of IgG and IgM in IgA fractions. Only 
approximately 0.04 mg of IgG and 0.03 mg of IgM were 
bound and recovered, representing an average of 0.22% IgG 
and 1.88% IgM in the starting material respectively. 
With reference to IgA recoverd, IgG was 1.88 % and IgM 
was 1.41%. In terms of total protein concentration, IgA 
accounted for 83.7% while IgG was 1.57% and IgM, 1.18%. 
Thus, the isolated IgA was highly purified with very 
little contamination of IgG and IgM. 
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6.4 k/A ratio of IgA BEFORE AND AFTER FPLC 
Although more than 90% IgA was recovered in the 
purified samples, the fc/X ratio has also been determined 
to ensure that the purification step did not change the 
ratio, and further investigation could be carried out 
with these samples. Table 6.2 shows the IgA ic/X ratio of 
8 serum samples randomly selected from the 32 test sera 
before and after jacalin purification. No significant 
change in IgA K/\ ratio after purification was observed 
in individual samples or the mean of the group. 
6.5 SUBCLASS OF IgA BEFORE AND AFTER FPLC 
The IgAl concentration of 8 serum samples 
randomly selected from the 32 test samples before and 
after jacalin purification was determined by the ELISA 
method as described in Section 2.2.2.i.e. 
Table 6.3. shows the percentage of IgAl in 
total IgA of 8 serum samples before and after jacalin 
purification. The mean percentage of IgAl of the sample 
group, before and after purification, was 80.3% 
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Table 6.2 Serum IgA K/\ Ratio of 8 Samples Before and 
After Jacalin Purification 
No. Before After 
1 1.57 1.44 
2 1.50 1.44 
3 1.27 1.20 
4 1.13 1.22 
5 1.20 1.21 
6 1.05 1.16 
7 0.89 0.84 
8 0.97 0.86 
Mean (SD) 1.20 (0.24) 1.17 (0.23) 
“paired t test, not significant “ 
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Table 6.3 Percentage of IgAl in Total IgA of 8 Serum 
Samples — Before and After Jacalin Purification 
No. BEFORE AFTER 
1 89.6 84.0 
2 63.9 67.2 
3 75.5 79.0 
4 81.3 80.4 
5 97.2 93.6 
6 90.1 93.6 
7 73.4 68.4 
8 71.4 70.8 
Mean (SD) 80.3 (11.3) 79.6 (10.5) — 
“paried t test, not significant ” 
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and 79.7% ±10.5% respectively, indicating that the ratio 
of IgAl to total IgA remained unchanged after 
purification by jacalin. 
6.6 DISCUSSION 
For the investigation of the distribution of 
electrical charge (iso-electric point) of serum IgA in 
IgAN, it is necessary to isolate a sufficient amount of 
IgA which is free from contamination with other 
immunoglobulin classes. The isolation of 
immunochemically pure IgA from serum has been difficult, 
with relatively low yield and heavy contamination with 
IgG. 
Since its discovery as a potent and selective 
stimulator of detinctive human T and B cell function 
[181], jacalin has been used as an affinity adsorbent for 
the isolation of human serum and colostrum secretory IgA 
[150,152,156,159]. The basis of the apparent specificity 
of jacalin towards IgA due to the presence of D-galactose 
as the terminal sugar only in IgA has been elucidated 
[150,151]• It has been demonstrated that jacalin binds 
apparently only three proteins, one of them is IgA and 
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the other two have not yet been identified but proved to 
be non-immunoglobulin proteins [150]. As revealed by the 
immunoelectrophoresis results on jacalin-purified samples 
the component present in purified samples was IgA. 
Furthermore, over 90% of the IgA was recovered from all 
sera with no obvious change in K/X ratio. Although it 
has been reported that jacalin bound preferentially to 
IgAl [152,153,154,155], it was demonstrated by the IgAl 
ELISA results that the ratio of IgAl to total IgA 
remained unchanged after purification. It was therefore 
certain that the jacalin- purified IgA truly represented 
serum IgA and was suitable for the investigation of the 
charge characteristics of circulating IgA. 
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C H A P T E R 7 
ANALYSIS CHARGE DISTRIBUTION 
OF PLASMA IgA, IgA(K) and IgA(入） 
7.1 ISO-ELECTRIC FOCUSING, IMMUNOBLOTTING AND 
DENSITOMETRY OF PURIFIED IgA FOR TOTAL IgA, 
IgA(/c) AND IgA(入） 
In order to examine the possible role of the 
electrical charge of IgA in the pathogenesis of IgAN, the 
charge distribution of affinity chromatography purified 
plasma IgA (including IgA(/c) & IgA(入））in patients with 
this disease was studied by IEF/iitmiunoblotting followed 
by densitometry. 
For the densitometry of total IgA, the focused 
material was stained with Coomassie brilliant blue R. 
The total length of each strip scanned was approximately 
7 cm, covering the pH range of 4.4 to 6.8, which 
contained all visible bands. The densitometric pattern 
was then divided arbitrarily into 10 equal segments by 
the computer, with pH 5.6 as the mid-point. The area 
percentage of the individual segments and their 
proportional contribution to the IgA spectrotype were 
determined by computer. The charge distribution in terms 
of area percentage over the scanned range was first 
analysed visually. Consequently,pi 5.6 was chosen as the 
dividing point for the calculation of the 
anionic/cationic (A/C) ratio with the following 
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considerations ： 
(i) It was in the middle of the range. 
(ii) It was the upper limit of pi found 
in the glomerular eluates from patients 
with IgAN [143]. 
(iii) It was chosen by Harada et al [182] in 
a study of charge distribution of 
plasma total IgA. 
The A/C ratio was calculated as follows: 
Total IgA area (pi < 5.6) 
A/C ratio = 
Total IgA area (pi > 5.6) 
The same scanning and calculation procedures 
were used for IgA(K) and IgA(X) after the peaks were 
transferred to NC, detected by anti-ic and anti-X antisera 
coupled with the peroxidase staining system, and made 
transparent with Triton X 114 (Section 2.2.2. iii). 
7.2 CHARGE DISTRIBUTION OF PLASMA TOTAL IgA, 
IgA(K), AND IgA(入） 
7.2.1 A/C Ratio of Total IgA 
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The same groups of NS (n = 10) and IgAN 
patients (n = 11) were studied. An example of a Coomassie 
blue-stained gel is shown in Fig. 7.1. The bulk of IgA 
was focused in the pi range 4.7 to 6.6 in patients and 
NS. 
Fig. 7.2 shows typical examples of the charge 
distribution of IgA in a NS (A) and in a patient at 
quiescence (B) and during exacerbation (C) , analysed by 
densitometry. The A/C ratio of all samples was 
calculated, using 5.6 as a diving pi. The precision of 
the lEF was studied by focusing and scanning each sample 
in duplicate. Table 7.lA shows the duplicate results of 
IgA A/C ratios of 32 samples in 3 groups. Each single 
result was obtained from a separate lEF gel and the 
precision in terms of overall standard deviation (SD) was 
derived from the difference of 32 duplicate pairs. Table 
7. IB shows the means of duplicates of the 3 groups. As 
demonstrated by the scattergram in Fig. 7.3, there was a 
significantly greater A/C ratio of plasma total IgA in 
patients at quiescence (p < 0.025) and during 
exacerbation (p < 0.01) when compared with NS. This 
implied a significant increase in the anionic region at 
isoelectric points 4.4 - 5.6 in patients. However, no 
significant difference in A/C ratio was observed between 
patients at quiescence and during exacerbation. 
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Fig. 7.1 An Example of Coomassie Blue-stained lEF Gel 
for IgA. T h e， • - • ’ sign represents the cathode 
and the ,' + ,，sign represents the anode. 
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Fig. 7.2 Examples of Desitometry Read-out of lEF Gel of 
Total IgA. The fraction number runs from the 
cathodic end (pi 6.8). The relative charge 
distribution in the 11 fractions is shown below 
the spectrotype. 
(A) Normal subject 
(B) IgAN patient at quiescence 
(C) The same patient during exacerbation 
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Table 7.lA Duplicate Results on IgA A/C Ratio of Samples in 
Table 7.lA. The precision is expressed as SD 
calculated from difference of duplicate (d) of 




1 1.41 , 1.43 2.17 , 1.87 1.02 , 1.22 
2 1.19 , 1.15 1.26 , 1.44 1.56 , 1.62 
3 1.16 , 1.30 1.45 , 1.47 1.64 , 1.73 
4 1.28 , 1.40 1.80 , 1.65 1.89 , 1.65 
5 1.30 , 1.18 2.13 , 1.99 1.59 , 1.38 
6 1.34 , 1.22 1.65 , 1.83 1.26 , 1.48 
7 0.96 , 0.94 1.74 , 1.38 1.46 , 1.40 
8 1.83 , 2.11 1.31 , 1.27 1.57 , 1.53 
9 1.31 , 1.51 1.14 , 1.28 2.42 , 2.64 
10 1.65 , 1.47 2.19 , 1.95 2.76 , 2.42 
11 - , - 1.93 , 1.75 2.25 , 2.43 
S D = ± / E d = ±0. 174 
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Table 7.IB A/c Ratio of Total IgA of NS (n = 10) and IgAN 
Patients at Quienscence (n = 11) and during 
Exacerbation (n=ll). Each pair of data refers 
to the same patient and each figure represents 
the mean of duplicate determinations of the same 
sample on separate lEF gels (see Table 7.IB). 




1 1.42 2.02 1.12 
2 1.17 1.35 1.59 
3. 1.23 1.46 1.69 
4 1.34 1.73 1.77 
5 1.24 2.06 1.49 
6 1.28 1.74 1.37 
7 0.95 1.56 1.43 
8 1.97 1.29 1.55 
9 1.41 1.21 2.53 
10 1.56 2 . 07 2 .59 
11 - 1.84 2.34 
Mean (SD) 1.36 (0.27) 1.67 (0.31)* 1.77 (0.49)** 
1 
1 I 
• compared with NS, p < 0.025 (t test) 
•* compared with NS, p < 0.01 (t test) 
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7.2.2 A/C Ratio of IgA(/c) 
The same groups of NS ( n = 10) and patients (n 
= 1 1 for quiescence and n = 11 for exacerbation ) were 
studied. Examples of immunoblot and densitometry 
read-out of IgA(K) are shown in Fig. 7.4 and Fig. 7.5 
respectively. The A/C ratio (mean of duplicates) of all 
samples were calculated, using 5.6 as a diving pi again • 
The duplicate results of each sample and the precision 
derived in the same way as for total IgA are shown in 
Table 7.2A, and the means of duplicates of the 3 groups 
are shown in Table 7.2B. A scattergram of the IgA(K) A/C 
ratios of the 3 groups is shown in Fig. 7.6. No 
difference in the ratio was observed between NS and IgAN 
patients at different disease stages. 
7.2.3 A/C Ratio of IgA(入） 
Similar study for IgA(入） as for IgA(/c) was 
carried out for the same groups of NS (n = 10) and IgAN 
patients (n = 11) • Examples of immunoblot and 
densitometry read-out of IgA(入）are shown in Fig. 7.7 and 
Fig. 7.8 respectively. The A/C ratio was calculated with 
pi 5.6 as the dividing point . Table 7.3A shows the 
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Fig. 7.4 An Example of lEF Blot for IgA(K). 
The , , - , ， s i g n represents the cathode and the 
"+，• sign represents the anode. 
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Fig. 7.5 Examples of Desitometry Read-out of lEF Blot 
for IgA(/c). The fraction number runs from the 
cathodic end (pi 6.8). The relative charge 
distribution in the 11 fractions is shown below 
the spectrotype. 
(A) Normal subject 
(B) IgAN patient at quiescence 
(C) The same patient during exacerbation 
122 
Table 7.2A Duplicate Results on IgA(^) A/C Ratio of Samples 
in Table 1.2h. The precision is expressed as SD 
calculated from difference of duplicate (d) of 




1 1.01 , 1.21 0.98 , 1.24 0.63 , 0.81 
2 0.65 , 0.59 1.08 , 1.07 0.99 , 0.75 
3 0.67 , 0.66 1.01 , 1.23 0.71 , 0.63 
4 0.91 , 1.07 1.61 , 1.68 1.58 , 1.76 
5 1.01 , 0.85 1.82 , 2.02 1.07 , 0.93 
6 1.05 , 1.01 0.78 , 0.87 1.40 , 1.22 
7 0.55 , 0.71 1.50 , 1.58 1.10 , 1.14 
8 1.75 , 1.94 0.88 , 1.10 0.83 , 1.08 
9 0.91 , 1.15 1.07 , 0.93 1.20 , 1.39 
10 1.55 , 1.48 0.87 , 1.01 1.49 , 1.68 
11 - , 1.82 , 1.66 1.29 , 1.48 
SD = ± / Z d 二 ±CK143 v/ _ — 
123 
Table 7.2B A/c Ratio of IgA(K) of NS (n = 10) and IgAN 
Patients at Quienscence (n = 11) and during 
Exacerabtion (n = 11). Each pair of IgAN data 
refers to the same patient and each figure 
represents the mean of duplicate dterminations 
of the same sample on separate lEF blots (see 





1 1.11 1.11 0.72 
2 0.62 1.08 0.87 
3 0.57 1.12 0.67 
4 0.99 1.64 1.67 
5 0.93 1.92 1.00 
6 1.03 0.83 1.31 
7 0.63 1.54 1.12 
8 1.85 0.99 0.96 
9 1.03 1.00 1.30 
10 1.52 0.94 1.59 
11 - 1.74 1.39 
Mean (SD) 1.04 (0.39) 1.26 (0.37) 1.15 (0.36) 
* 
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Fig. 7.7 An Example of lEF Blot for IgA(入）• 
The , , - • ，sign represents the cathode and the 
’,+,’ sign represents the anode. 
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Fig. 7.8 Examples of Desitometry Read-out of lEF Blot 
for IgA (入）• The fraction number runs from the 
cathodic end (pi 6.8). The relative charge 
distribution in the 11 fractions is shown below 
the spectrotype. 
(A) Normal subject 
(B) IgAN patient at quiescence 
(C) The same patient during exacerbation 
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Table 7. 3A Duplicate Results on IgM 入 ） V C Ratio of Samples 
in Table 7.lA. The precision is expressed as SD 
calculated from difference of duplicate (d) of 




1 2.89 , 2.98 1.99 , 2.10 1.07 , 1.29 
2 2.56 , 2.80 2.97 , 3.22 2.88 , 3.19 
3 2.37 , 2.13 1.82 , 2.05 2.23 , 2.57 
4 2.32 , 2.44 1.75 , 1.79 1.72 , 1.60 
5 2.23 , 2.01 2.09 , 2.03 2.31 , 2.15 
6 2.13 , 2.42 3.45 , 3.27 1.72 , 1.51 
7 1.55 , 1.74 1.48 , 1.64 2.18 , 2.40 
8 2.40 , 2.62 1.34 , 1.67 1.19 , 1.42 
9 2.64 , 2.85 1.33 , 1.17 2.78 , 2.87 
10 2.03 , 2.25 3.39 , 3.61 3.79 , 4.01 
11 - , - 2.26 , 2.38 2.60 , 2.84 
SD = ± / Z d = ±0.238 
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duplicates of A/C ratios of 10 NS and 11 IgAN patients at 
quiescence and during exacerbation, and the similarly 
derived precision as for IgA(K)• Table 7.3B shows the 
means of respective duplicates of the 3 groups. A 
scattergram of the IgA(入）A/C ratios of the 3 groups is 
shown on Fig. 7.9. Like the IgA(K) A/C ratios, no 
difference was observed between NS and IgAN patients, and 
between quiescence and exacerbation. 
7.3 DISCUSSION 
For the densitometry of lEF for IgA as well as 
immunoblots for IgA(/c) and IgA (入）， the purified IgA 
samples had been subjected to many analytical steps which 
were bound to incorporate errors. In order to support 
the validity of the data on charge characteristics of 
IgA, IgA(K), and IgA(入），each sample was processed in 
duplicate. Tables 7. lA, 7.2A, and 7. 3A show the SD's 
calculated from difference of duplicate of all samples. 
As judged from the paired results and the relatively low 
SD's, the precision of the approach should be considered 
acceptable. Hence the charge patterns of IgA, I g A � ， 
and IgA (X) of NS and IgAN patients at quiescence and 
during exacerbation could be regarded as genuine 
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Table 7.3B A/c Ratio of IgA(入）of 10 NS and 11 IgAN Patients 
at Quienscence and during Exacerabtion. Each 
pair of data refers to the same patient and 
each figure represents the mean of duplicate 
determinations of the same sample on separate 
lEF blots (see Table 7.3B). The Mean and SD of 




1 2.94 2.05 1.18 
2 2.68 3.10 3.04 
3 2 .25 1.95 2.40 
4 2.38 1.77 1.66 
5 2.12 2.06 2.23 
6 2 . 28 3.36 1.62 
7 1.65 1.56 2.29 
8 2.51 1.51 1.31 
9 2.61 1.25 2.83 
10 2.14 3.50 3.90 
11 - 2.32 2.72 
Mean (SD) 2.36 (0.36) 2.22 (0.77) 2.29 (0.82) 
133 
F I G . 7 . 9 
Anionicicationic (A:C) ratio of lambda-IgA in lEF blot 
pi - 5.6 A:C ratio 
41 — , N.S. . 
N.S. N.S. 
3.5 - 女 
女 兹 T 
3- • T I 
5 套 T ‘ 
2 - 丄 宾 
• = 丧 
1.5- 丧 丄 丄 
女 I 
1 ‘ 
Healthy control IgAN-QuIescence IgAN-Excerbatlon 
(n • 10) (n - 11) (n • 11) 
134 
findings, not the result of analytical variation. 
It has been noted that two to three patients 
showed inconsistant A/C ratio between quiescence and 
exacerbation phases, e.g. 2.02 (quiescence) vs 1.12 
(exacerbation) and 1.21 (quiescence) vs 2.53 
(exacerbation) for IgA (see Table 7. IB) as well as 2.05 
(quiescence) vs 1.18 (exacerbation) and 1.25 (quiescence) 
vs 2.83 (exacerbation) for IgA (X) (see Table 7.3B). The 
differences could be explained by the wide range of 
clinical manifestations and different degrees of 
immunopathological stimulation in patients with IgAN. 
Unfortunately, such in vivo variations are difficult to 
identify and they might contribute to inconsistencies of 
results in in vitro studies. 
It has been demonstrated by experimental models 
that the charge of immunoglobulins can play a role in 
their glomerular deposition [165,166]. However, in human 
glomerulonephritis very little data have been reported. 
The heterogeneous isoelectric points (pi) of 
normal serum IgA have been studied by Monteiro et al 
[143] to be in the broad range of 4.7 - 6.8. Harada et al 
[182], in their study for the charge distribution of 
plasma total IgA in IgAN, found that there was an 
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increased proportion of anionic (pi < 5.6) IgA, coupled 
with a reduced cationic proportion (pi > 5.6) in the 
plasma of IgAN patients. This shift in charge of total 
IgA was confirmed by the finding in the present study. 
IgAN patients at quiescence showed a significant increase 
in the A/C ratio when compared to NS (p < 0.025). 
Patients during exacerbation also showed a significant 
increase (p < 0.01). This shift in charge occured mainly 
within the reference range of pi of IgA. However, no 
diference was observed between patients at quiescence and 
during exacerbation. 
So far no data concerning the charge of serum 
IgA(K) and IgA(X) in NS and in IgAN patients have been 
described. The findings of predominant X chain 
iirimunoflurorescence in mesangial deposits and the reduced 
IgA /c/X ratio in IgAN patients suggested that there was 
excessive amount of IgA(入） in the plasma of these 
patients, which might lead to depositor! of IgA(A) in the 
mesangium. The questions of whether the IgA(入）molecules 
are normal as far as charge is concerned, and whether the 
depostion is selective because of the abnormal charge 
distribution, or non-selective merely as a result of 
overproduction have not been explored. Therefore the pi 
of IgA(K) and IgA(X) in IgAN patients were investigated 
in the present study. As indicated in Table 7.2B and Fig. 
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7.6, IgA(K) of NS has similar charge as those of IgAN 
patients at quiescence and during exacerbation (l.04 
±••39, 1.26 ±0.37 and 1.15 ±0.36 respectively). 
Similarly, I g A ( 入 ” s of both NS and IgAN patients at 
different disease stages, as indicated in Table 7.3B and 
Fig. 7.9, show no difference in charge (2.36 ±0.36, 2.22 
±0.77 and 2.29 ±0.82 respectively). Furthermore, by 
comparing the charge of IgA(K：) with that of IgA ( 入 ），it is 
clearly seen that IgA(入）is more anionic than IgA(K：), 
with A/C ratio greater than 2 while the A/C ratio of 
IgA(K) is between 1 to less than 1.3. Apparently, as 
judged from the A/C ratios of IgA, IgA(/c) and IgA(;v) of 
individual samples, the charge of total IgA results from 
combination of the charges of IgA(K) and IgA(入）• Hence, 
it is obvious that the increased A/C ratio of total IgA 
in IgAN is not related to the nature of either K, or X 
chains, but is most probably due to an absolute increase 
of IgA(入）in the circulation. 
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C H A P T E R 8 
G E N E R A L D I S C U S S I O N 
The work described in Chapters 3 to 7 
represents a study of plasma immunoglobulins (mainly IgA) 
in normal subjects and in patients with IgA nephropathy 
at quiescence and during exacerbation. 
Most studies in IgA nephropathy have been 
cross-sectional, investigating cohorts of patients at a 
single time point, using patients who may have a range of 
clinical mainifestations at the time of study. Very few 
studies have related IgA immune abnormalities to disease 
activity. It has been suggested that striking 
abnormalities in IgA immunity may be found when disease 
is very active, i.e. during exacerbation. In the present 
work, serum samples of individuals at different stages of 
disease were studied in order to identify important 
disease-related phenomena. However, as indicated by the 
results on IgA(fc)/IgA(;v) ratio, and charge distribution 
of total IgA, IgA(K), and IgA (入）， no significant 
difference was observed between the two stages of disease 
as far as circulating IgA is concerned. Thus, it is 
likely that the disease is immunologically active 
throughout different disease stages, despite the lack of 
correlation with the clinical process. 
The actual investigation began with the 
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development of an ELISA method which was used for the 
determination of ic/X ratio of plasma immunoglobulins. It 
is demonstrated that the zc/入 ratios of plasma IgA and IgM 
are different from that of IgG. Patients with IgA 
nephropathy have a higher plasma concentration of lambda 
chain IgA compared with normal subjects, and their K/X 
ratio of serum IgA is significantly lower (p < 0.01). 
Nevertheless, the predominance of kappa chain IgG and IgM 
is demonstrated in patients with IgA nephropathy as 
observed in normal subjects. These findings indicate 
that there is an excessive production of lambda chain IgA 
in the circulation of patients with IgA nephropathy, 
presumably due to a specific antibody response. The 
distinct reduction of zc/入 ratio of plasma IgA in IgA 
nephropathy, together with the preliminary observation 
made by Lai et al [141,142] that mesangial IgA deposits 
in IgA nephropathy consisted mainly of lambda chain IgA 
tend to support the hypothesis that deposition of IgA/IgA 
immune complexes in mesangium in IgA nephropathy 
could be non-selective. 
The investigation of k/入 ratio of individual 
immunoglobulin class was a new attempt and the developed 
ELISA method was a novel approach. The performance of the 
method has been validated. Its applicability can also be 
further evaluated by comparision with a different 
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technique capable of determining the K/X ratio of a known 
immunoglobulin class. A rare example of such method 
would be a cytofluorometric technique known as the 
"kappa-lambda test" described by Weinberg et al [185], 
which was based on the comparision of surface 
immunofluorescent staining of kappa and lambda light 
chains within a single population of cells (e.g. lymphoma 
B cells with known heavy chain type)• It is not included 
in the present study. 
The findings of predominant lambda light chain 
IgA deposits in glomerular mesangium reported by Lai et 
al [141,142] could also indicate that the deposition of 
circulating immune complexes in IgA nephropathy is highly 
selective due to differences in multimeric nature and 
anionic charge of plasma IgA. Therefore following the 
quantitative determination of serum concentration of K 
and X light chain IgA and the K/X ratio of serum IgA, the 
possible abnormal physico-chemical properties of 
circulating IgA in IgA nephropathy were studied. The 
investigation was focused at the charge characteristic of 
circulating IgA in IgA nephropathy, particularly the 
possible abnormality anticipated for IgA ( 入 ），and perhaps, 
IgA(K)• The isoelectric focusing study of plasma total 
IgA revealed a similar pattern as observed by Harada et 
al [182] ; ie, there was an increased proportion of 
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anionic IgA in the plasma of patients with IgA 
nephropathy. This shift in charge occured mainly within 
the normal range of pi of IgA. The charge of IgA eluted 
from renal biopsies from patients with IgA nephropathy 
has been found to be in the pi range 4.5 - 5.6 [143] • 
Consequently, it has been assumed that the mesangial 
deposition of IgA was selective for the more negatively 
charged molecules. The data on the charge of total IgA 
as reported by Harada et al [182] and obtained in the 
present study, together with a report on the increased 
amount of preferential binding of anionic serum IgA to 
cationic polypeptides in IgA nephropathy [186], suggest 
that a factor predisposing to mesangial deposition of 
anionic IgA is an increased avaiability of negatively 
charged IgA in the plasma. 
According to the results obtained in the first 
half of the present study, IgA(A) was produced in excess 
in the circulation of IgA nephritic patients as compared 
with normal subjects. It would be useful for the 
understanding of the pathogensis of the disease if the 
charge of the two types of IgA (particularly IgA(X) could 
be known. The charge of IgA(/c) and IgA(入）has never been 
investigated before. The isoelectric 
focusing/immunoblotting studies revealed several 
important findings: (1) IgA(入）was more anionic than 
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IgA(/c), (2) there was no difference in the charge 
distribution of IgA(入）and IgA(K) between normal subjects 
and patients with IgA nephropathy, and (3) there was no 
difference in the charge distribution of IgA(入）and 
IgA(/c) between IgA nephritic patients at quiescence and 
during exacerbation. 
Several possible explanations for the 
alteration in charge of plasma IgA have been suggested 
[182], including (1) it may represent an antibody 
response to an antigen(s) of predominantly positive 
charge, (2) the predominance of polymeric/dimeric forms 
of IgA would result in a shift of charge from cationic to 
anionic, and (3) there may be an increased proportion of 
sialic acids present in patients' IgA, or there may be an 
increased content of acidic amino acid residues. The 
present results on the charge of IgA(K) and IgA(入）would 
therefore appear to rule out these possibilities as the 
sole pathogenetic factor since in the subjects of this 
study at least the increased negative charge of total 
plasma IgA in IgA nephropathy is a quantitative effect 
due to the increased amount of the more anionic IgA(A)• 
The charge difference between normal IgA and 
IgA in IgA nephropathy could be one of the factors that 
affects the capacity of the latter to activate complement 
142 
via alternative pathway . It could also be possible that 
a proportion of more negatively charged IgA(入），probably 
in the form of immune complexes, is preferentially 
sequestered into the glomeruli of patients with IgA 
nephropathy. In fact, experimental work has shown that 
anionic antigens, antibodies, and immune complexes are 
more likely to be deposited in the glomerular mesangium 
[183, 184, 187] • Therefore, it is reasonable to assume 
that the excess amount of anionic IgA(入）may contribute 
to the pathogenesis of IgA nephropathy by giving rise to 
a selective mesangial deposition of polyclonal IgA immune 
complexes, or by binding with antigens in situ after its 
being trapped in the mesangium. It would be possible to 
confirm such hypothesis by studying the charge nature of 
the mesangium, as well as the charge of desposited IgA 
(presumably IgA(入）） eluted from the kidney of IgA 
nephritic patients. 
143 




N E R E 
. . . 
F




























 - o ^ 、 -
 r ^ —
 -
 - I T
 K














1. Berger J, Hinglais N (1968). Les depots 
intercapillaries d'IgA-IgG. Joural d'Urologie 
et de Nephrologie 74; 694- 695. 
2. Clarkson AR, Woodroffe AJ, Seymour AE (1982). 
IgA Nephropathy in Recent Advances in Renal 
Medicine, 2nd edn, p.167-175. Churchill 
Livingstone, London. 
3. Smith JD, Arrons I (1984). The syndrome of IgA 
nephropathy. Clinical Nephrology 21; 7-14. 
4. Nakamoto Y, Asano Y, Dohish K, Fujuioka M, lida 
H, Kibe Y, Hattori N, Takeuchi J (1978). 
Primary IgA glomerulonephritis and 
Schonlein-Henoch purpura nephritis: 
clinicopathological and iininuno-histological 
characteristics. Quarterly Journal of Medicine 
4 7 ； 4 9 5 - 5 1 6 . 
5. Hiki Y, Kobayashi Y, Tateno S, Sada M, 
Kashiwagi N (1982). Strong association of 
HLA-DR4 with benign IgA naphropathy. Nephron 
32; 222-226. 
144 
6. Julian BA, Waldo FB, Rifai A, Mestecky J 
(1988)• IgA nephropathy, the most common 
glomerulonephritis worldwide. The American 
Journal of Medicine 84; 129-132. 
7. Wyatt RJ, Julian BA, Bhathena DB, Mitchell BL, 
Holland NH, Malluche HH (1984) . IgA 
Nephropathy: presentation, clinical course, and 
prognosis in children and adults. American 
Journal of Kidney Diseases 4; 192-200• 
8. Levy M, Gonzalez-Burchard G, Broyer M, 
Dommergues JP, Foulard M, Sorez JP, Habib R. 
(1985). Berger's disease in children, natural 
history and outcome. Medicine 64; 157-180• 
9. Clarkson AR, Seymour AE, Thompson AJ, Haynes 
WDG, Chan YL, Jackson B. (1977) IgA 
nephropathy: a syndrome of uniform morphology, 
diverse clinical features and uncertain 
prognosis. Clinical Nephrology 8; 459-471. 
10. Sinniah R, Javier AR, Kug G. (1981) . The 
pathology of mesangial IgA nephritis with 
clinical correlation. Histopathology 5; 
469-490. 
145 
11. Hood SA, Velosa JA, Holley KE, Donadio Jr JV 
(1986)• IgA-IgG nephropathy: predicative 
indices of progressive disease. Clinical 
Nephrology 16; 55-62. 
12. Soda K, Sugawara M, Nishimuna S, Kohmoto J, 
Ogura T, Mino Y, Takaoka M, Hiramatsu M, 
Takahashi K, Ota Z (1986) • 
Clinico-pathological study of IgA nephropathy 
with nephrotic syndrome. Japanese Journal of 
Nephrology 28; 721-728. 
13. Yorioka N, Wada K, Kanahara K, Ogawa T, 
Takahashi YN, Oda H, Hirabayashi A, Kobayashi 
M, Okushin S, Yamakido M (1987)• A 
clinicohistopathological study of IgA 
nephropathy associated with nephrotic syndrome. 
Hiroshima Journal of Medical Sciences 36; 
261-265. 
14. Berger J (1969). IgA glomerular deposits in 
renal disease. Transplantation Proceedings 1; 
939-944. 
15. Woodroffe AJ, Gormly AA, Mckenzie PE, Wooton 
146 
AM, Thompson AJ, Seymour AE, Clarkson AR 
(1980)• Immunologic studies in IgA nephropathy. 
Kidney International 8; 366-374. 
16. Woodroffe AJ, Clarkson AR, Seymour AE, 
Lomax-Smith JD (1982)• Mesangial IgA 
nephritis. Springer Seminars in 
Inmiunopathology 5; 321-332. 
17. Van der Pect J, Anisz L, Brentjens, Marrink J, 
Hoedemaeker P.J. (1977). The clinical course 
of IgA nephropathy in adults. Clinical 
Nephrology 8； 335-340 
18. Egido J, Julian BA, Wyatt RJ (1987) . Genetic 
factors in primary IgA nephropathy. 
Nephrology, Dialysis, Transplant 2; 134-142• 
19. Tomino Y, Endoh M, Nomoto Y, Sakai H (1981). 
Activation of complement by renal tissues from 
patients with IgA nephropathy. Journal of 
Clinical Pathology 34; 35-40. 
20. Roy LP (1975). Properdin and recurrent 
macroscopic haematuria. Australian & New 
Zealand Journal of Medicine 5; 191-194. 
147 
21. Miyazaki R, Kurda M, Akiyama T, Otani I, Tofuku 
Y, Takena R (1984)• Glomerular deposition and 
serum levels of complement control proteins in 
patinets with IgA nephropathy. Clinical 
Nephrology 21; 335-340. 
22. Waldherr R, Raitibausek M, Rauterberg W, Andrassy 
K, Ritz E (1984)• Iirnnunohistochemical features 
of mesangial IgA glomerulonephritis. 
Contributions to Nephrology 40; 99- 106. 
23. Mariot A, Bene MC, Hurault de Ligny B, Faure G, 
Martin JM, Kessler M, Duheille J (1984)• C9 
deposits in renal tissue. Nephron 37; 69. 
24. Bene MC, Faure GC (1987) . Composition of 
mesangial deposits in IgA nephropathy: 
complement factors. Nephron 46; 219. 
25. Tomino Y, Yagame M, Eguchi K, Nomato Y, Sakai 
H. Iitmiunof luorescent studies on S-protein in 
glomeruli from patients with IgA nephropathy. 
American Journal of Patholgy 129; 402-406 
26. Chen A, Ho YS, Tu YC (1988) . C5 component: 
148 
immunopathological index for the activity of 
IgA nephropathy. Nephron 49; 255. 
27. Thompson AJ, Chan YL, Woodrof fe AJ, Clarkson 
AR, Seymour AE (1980) • Vascular IgA deposits 
in clinically normal skin of patients with 
renal disease. Pathology 12; 407-413. 
28. Tomino Y, Nomoto Y, Endoh M, Sakai H (1981). 
Deposition of IgA-dominant immune-complexes in 
musclar vessels from patients with IgA 
nephropathy. Acta Pathogica Japonica 31; 
361-365. 
29. Kauffman RH, Herrmann WA, Meyer CJLM, Deha MR, 
Van Es LA (1980)• Circulating IgA-immune 
complexes in Henoch-Schenlein purpura. The 
American Journal of Medicne 69； 859- 866. 
30. Coppe R, Basolo B, Martina G, Rollino C, De 
Marchi M, Giacchino F, Mazzucco G, Messina M, 
Piccoli G (1982). Circulating immune complexes 
containing IgA, IgG and IgM in patients with 
primary IgA nephropathy and with Henoch-
Schoenlein nephritis• Correlation with 
clinical and histologic signs of activity. 
149 
Clinical Nephrology 18; 230- 239. 
31. Berger J, Yaneva H, Nabarra B, Babanel C 
(1975)• Recurrence of mesangial depostion of 
IgA after renal transplantation. Kidney 
International 7; 232-241. 
32. Lesavre PH, Digeon M, Bach JF (1982). Analysis 
of circulating IgA and detection of immune 
complexes in primary IgA nephropathy. Clinical 
and Experimental Immunology 48; 61-69. 
33. Ooi YM, Ooi BS, Pollak VE (1977). Relationship 
of levels of circulating immune complexes to 
histological pattern of nephritis: a 
comparative study of membranous glomerulopathy 
and diffuse proliferative glomerulonephritis. 
Journal of Laboratory & Clinical Medicine 90; 
891-898. 
34. Gotze O, Muller-Eberhard HJ (1971) . The C3 
activator sys tem: an alternate pathway of 
complement activation. The Journal of 
Experimental Medicine 134; 90-108. 
35. Lopez-Trascasca M, Egido J, Sancho J, Hernando 
150 
L (1980). IgA glomerulonephritis (Berger's 
Disease): evidence of high serum levels of 
polymeric IgA. Clinical and Experimental 
Immunology 42; 247-254. 
36. Tomino Y, Sakai H, Miura M, Endok M, Nomoto Y 
(1982)• Detection of polymeric IgA in glomeruli 
from patients with IgA nephropathy. Clinical 
and Experimental Immunology 49; 419-425. 
37. Lomax-Smith JD, Zabrowarny LA, Howarth GS, 
Seymour AE, Woodroffe AJ (1983)• The 
immunochemical characterization of mesangial 
IgA deposits. American Journal of Pathology 
1 1 3 ； 3 5 9 - 3 6 4 . 
38. Finlayson G, Alexander R, Juncos L, Schlein E, 
Teague P, Waldman R, Cade R (1975)• 
Immunoglobulin A glomerulonephritis. A 
clinicopathologic study. Laboratory 
Investigation 32； 140-148. 
39. Tomino Y, Sakai H, Miura M, Suga T, Endoh M, 
Nomoto Y, Umehara K, Hashimoto K (1986). 
Cytopathic effects of antigens in patients with 
IgA nephropathy. Nephron 42; 161-166. 
151 
40. Yagame M, Tomino Y, Miura M, Suga T, Endoh M, 
Nomoto Y, Sakai H (1987)• Correlation between 
the pharyngeal secretion of IgA, secretory-IgA 
(s一IgA) and free secretory component (FSC) and 
the upper respiratory tract infections in 
patients with IgA nephropathy. Japanese 
Journal of Nephrology 29; 1101-1105. 
41. Coppo R, Basolo B, Rollino C, Roccatello D, 
Martina G, Amore A, Bongiorno G, Piccoli G 
(1986). Mediterranean diet and primary IgA 
nephropathy. Clinical Nephrology 26; 72-82. 
42. Woodroffe AJ, Border VIA, Theof ilopoulos AN, 
Gotze O, Glassock RJ, Dixon FJ, Wilson CB 
(1977).Detection of circulating immune 
complexes in patients with glomerulonephritis. 
Kidney International 12； 268-278. 
43. Sacho J, Egido J, Rivera F, Hernando L (1983). 
Immune complexes in IgA nephropathy : presence 
of antibodies against diet antigens and delayed 
clearance of specific polymeric IgA immune 
complexes. Clinical and Experimental Immunology 
54; 194-202. 
152 
44. Yap HK, Sakai RS, Woo KT, Lira CH, Joedan SC 
(1987) • Detection of bovine serum albumin in 
the circulation IgA immune complexes of 
patients with IgA nephropathy. Clinical 
Immunology and Immunopathology 43; 395-402. 
45. Yahame M, Tomino Y, Eguchi K, Miura M, Suga T, 
Endoh M, Nomoto Y, Sakai H (1988) . Levels of 
circulating IgA immune complexes after 
Gluten-Rich diet in patients with IgA 
nephropathy. Nephron 49; 104-106. 
46. Egido J, Sancho J, Blasco R, Lozano L, Hernando 
L (1984)• Immunologic aspects of IgA 
nephropathy in humans. In : Nephrology, Vol.1, 
p.652-664. Proceeding of IXth International 
Congress of Nephrology, Los Angeles. 
47. Gonzalez-Cabrero J, Egido J, Sancho J, 
Moldenhauer H (1987), Presence of shared 
idiotypes in serum and immune complexes in 
patients with IgA nephropathy. Clinical and 
Experimental Immunology 68; 694-702• 
48. Putnam FW, Liu YVN, Low TLK (1979) . Primary 
153 
structure of a human IgA^ immunoglobulin. The 
Journal of Biological Chemistry 254； 2865-2784. 
49. Plaut AG, Genco RJ, Tomasi TB Jr (1974). 
Isolation of an enzyme from Streptococcus 
Sanguis which specifically cleaves IgA. The 
Journal of Immunology 113； 289-291. 
50. Mestecky J, Kilian M (1985). In: Methods in 
Enzymology, Vol. 116, p. 37, Eds. Di Sabato G, 
Langone JJ, van Vunakis H. Academic Press, New 
York. 
51. Fujiyama Y, Kobayaski K, Senda S, Benno Y, 
Baitiba T, Hosoda S (1985) . A novel IgA protease 
from Clostridium sp. capable of cleaving IgA^ 
and IgA� A^ , . allotype but not IgA A , � 
2 2m(l) ^ 2 2m(2) 
allotype paraproteins. The Journal of 
Immunology 134； 573-576. 
52. Tomana M, Niedermeier W, Mestecky J, Skvaril F 
(1976)• The differences in carbohydrate 
composition between the subclass of IgA 
immunoglobulins. Immunochemistry 13； 325-328. 
53. Mestecky J, Russell MW, Jackson S, Brown TA 
154 
(1986). The human IgA system : a reassessment. 
Clinical and Immunology Immunopathology 40; 
105-114. 
54. Lin LC, Putnam FW (1981). Primary structure of 
the Fc region of huuman immunoglobulin D : 
implications for evolutionary origin and 
biological function. Proceedings National 
Academy of Sciences, United States of America 
7 8 ； 5 0 4 - 5 0 8 . 
55. Garcia-Pardo A, Lamm ME, Plaut AB, Frangione B 
(1981)• J chain is covalently bound to both 
monomer subunits in human secretory IgA. 
Journal of Biological Chemistry 256; 
11734-11738. 
56. Halpern MS, Koshland ME (1970). Novel subunit 
in Secretory IgA. Nature 228; 1276-1278. 
57. Mestecky J, Zikan J , Butler WT (1971). 
Immunoglobulin M and scretory immunoglobulin A 
: presence of a common polypeptide chain 
different from light chains. Science 171; 
1163-1165. 
155 
58. Koshland ME (1985) . The coining of age of the 
iitimunoglobulin J chain. Annual Review of 
Immunology 3； 425-453. 
59. Mestecky J, Schrohenloher RE (1974). Site of 
attachment of J chain to human immunoglobulin 
M. Nature 249; 650-652. 
60. Koshland ME (1975). Structure and Function of 
the J Chain. Advances in Immunology 20; 41-67. 
61. Bene MC, Faure G, Duheille J (1982) . IgA 
nephropathy : characterisation of the polymeric 
nature of mesangial deposits by in vitro 
binding of free secretory component. Clinical 
and Experimental Immunology 47; 527-534. 
62. Donini V, Casanova C, Maletta G, Zucchelli P 
(1982). The presence of J chain in mesangial 
immunodeposits of IgA nephropathy. Proceedings 
of the European Dialysis and Transplant 
Association 19; 655-662. 
63. Komatsu N, Nagura H, Watanabe K, Nomoto Y, 
Kobayashi K (1983)• Mesangial deposition of J 
chain-linked polymeric IgA nephropathy. 
156 
Nephron 33; 61-64. 
64. Egido J, Sancho J, Mampaso F, Lopez-Trascasa M, 
Sanchez Crespo M, Blasco R, Hernando L (1980)• 
A possible common pathogensis of the mesangial 
IgA glomerulonephritis in patients with 
B e r g e r d i s e a s e and Schonlein-Henoch syndrome. 
Proceedings of the European Dialysis and 
Transplant Association 17; 660-667. 
65. Hanson LA (1961)• Comparative immunological 
studies of the immune globulins of human milk 
and of blood serum. International Archives of 
Allergy and Applied Immunology 18; 241-267. 
66. Tomasi TB, Tan EM, Solomon A, Prendergast RA 
(1965)• Characteristics of an immune system 
common to certain external secretions. The 
Journal of Experimental Medicine 121; 101-125• 
67. Brandtzaeg P (1985). Role of J chain and 
scretory component in receptor-mediated 
glandular and hepatic transport of 
immunoglobulins in man. Scandinavian Journal of 
Immunology 22； 111-146. 
157 
68. Mestecky J, Kulhavy R, Kraus FW (1972). Studies 
on human secretory immunoglobulins A. The 
Journal of Immunology 108； 738-747. 
69. Halpern MS, Koshland ME (1973). The 
stoichiometry of J chain in human secretory 
IgA. The Journal of Immunology ill; 1653-1660. 
70. Mestecky J, Schrohenloher RE, Kulhavy R, Wright 
GP, Tomana M (1974). Site of J chain attachment 
to human polymeric IgA. Proceedings National 
Academy of Sciences, United States of America 
7 1 ； 5 4 4 - 5 4 8 . 
71. Zola H (1985). Differentiation and maturation 
of human B lymphocytes: a review. Pathology 
17; 365-381. 
72. Tseng J (1984). A population of resting 
IgM-IgD double- bearing lymphocytes in Peyer‘s 
patches: the major precursor cells for IgA 
cells in the gut lamina propria. The Journal 
of Immunology 132; 2730-2735. 
73. Bieninstock J, Befus AD (1980)• Mucosal 
immunology. Immunology 41; 249-270. 
158 
74. Elson CO, Weiserbs DB, Ealding W, Machelski E 
(1983). T-helper cell activty in intestinal 
lamina propria. Annals. New York Academy of 
Sciences 409; 230-237. 
75. Kawaniski H, Strober W (1983). Regulatory T 
cells in murine Peyer's patches directing 
IgA-specific isotype switching. Annals. New 
York Academy of Sciences 4 09; 243-257. 
76. Koshland ME (1983). Presidential address: 
molecular aspects of B cell differentiation. 
The Journal of Immunology 131; 1-9 
77. Bene MC, Faure G, Hurault de Ligny B, Kessler 
M, Duheille J (1983). Immunoglobulin A 
nephropathy. Quantitative inununohistomorpho-
metry of the tonsillar plasma cells evidences 
and inversion of the immunoglobulin A versus 
immunoglobuin G secreting cell balance. 
Journal of Clinical Investigation 71; 1342-
1347. 
78. Rothschild E, Chatenoud L (1984) . T cell 
subset modulation of immunogloblin production 
159 
in IgA nephropathy and membranous glomerulo-
nephritis. Kidney International 25; 557-564. 
79. Sieber G, Herrmann F, Zeitz M, Teichmann H, 
Riihl H (1984) . Abnormalities of B-cell 
activation and immunoregulation in patients 
with Crohn's disease. Gut 25; 1255-1261. 
80. Danis VA, Harries AD, Heatley RV (1984). In 
vitro immunoglobulin secretion by normal human 
gastrointestinal mucosal tissues, and 
alterations in patients with inflammatory bowel 
disease. Clinical and Experimental Immunology 
56; 159-166. 
81. Smith H (1977). Microbial surfaces in relation 
to pathogenicity. Bacteriological Reviews 41; 
475-500. 
82. Williams RC, Gibbons RJ (1972). Inhibition of 
bacterial adherence by secretory immunoglobulin 
A : a mechanism of antigen disposal. Science 
1 7 7 ； 6 9 7 - 6 9 9 . 
83. Underdown BJ, Schiff JM (1986). Immunoglobulin 
A : strategic defense initiative at the mucosal 
160 
surface. Annual Review of Immunology 4; 
389-417. 
84. Walker VIA, Isselbacher KJ (1974) . Uptake and 
transport of itiacromolecules by the intestine: 
possible role in clinical disorders. 
Gastroenterology 67; 531-550. 
85. Eden CS, Eriksson B, Hanson LA (1977). 
Adhesion of Escherichia Coli to human 
uroepithelial cells in vitro. Infection and 
Immunity 18; 767-774. 
86. McDougal JS, McDuffie FC (1985). Immune 
complexes in man: Detection and clinical 
significance. Advances in Clinical Chemistry 
24; 1-39. 
87. Hugli TE, Muller-Eberhard HJ (1978). 
Anaphylatoxins: C3a. and C5a. Advances in 
Immunology 26; 1-55 
88. Taylor JC, Crawford I, Hugli TE (1977). 
Limited degradation of the third component (C3) 
of human complement by human leukocyte elastase 
(HLE): Partial characterization of C3 
161 
fragments. Biochemistry 16； 3390-3396. 
89. Thompson RA, Lachmann PJ (1970)• Reactive 
lysis: The complement mediated lysis of 
unsensitized cells. I. The Characterization of 
the indicator facator and its iden tification 
as C7. The Journal of Experimental Medicine 
1 3 1 ； 6 2 9 - 6 4 1 . 
90. Ghebrehiwet B, Muller-Eberhard HJ (1979). C3e: 
An acidic fragment of human C3 with 
leukocytosis inducing activity. The Journal of 
Immunology 12 3; 616-621. 
91. Gotze O, Bianco C, Cohn Z (1979) . The 
induction of macro phage spreading by factor B 
of the properdin system. The Journal of 
Experimental Medicine 149; 372-386. 
92. Czop J, Pussenzweig V (1976) . Studies on the 
mechanism of solublization of immune 
precipitates by serum. The Journal of 
Experimental Medicine 143; 615-630. 
93. Emancipator SN, Gallo GR, Lamm ME (1981). IgA 
nephropathy : clinical, morphologic and 
162 
immunologic features. Surgical Pathology 
Quarterly Index 3； 179-190. 
94. Alexander F, Barabas AZ, Jack RGJ (1977). IgA 
nephropathy. Human Pathology 8; 173-185. 
95. D'Amico G, Imbasciati E, Barbiano di Belgiojoso 
GB, Bertoli S, Fogazzi G, Ferrario G, Fellin G, 
Ragni A, Colasanti G, Minetti L, Ponticeli C 
(1985)• Idiopathic IgA mesangial nephropathy: 
clinical and hisotogical study of 374 patients. 
Medicine (Baltimore) 64； 49-60. 
96. Stachura I, Singh G, Whiteside TL (1981). 
Immune abnormalites in IgA nephropathy 
(Berger's disease). Clinical Immunology and 
Immunopathology 20; 373-388. 
97. Doi T, Kanatsu K, Sekita H, Yoshida H, Naga, H, 
Hamashima, Y (1982). Circulating immune 
complexes of IgG, IgA and IgM classes in 
various glomerular diseases. Nephron. 32; 
335-341. 
98. Hall RP, Stachura I, Cason J, Whiteside TL, 
Lawley TJ (1983). IgA containing circulating 
163 
immune complexes in patients with IgA 
nephropathy. The American Journal of Medicine 
7 4 ; 5 6 - 6 3 . 
99. Valentijn RM, Kauffmann RH, Brutel de la 
Riviere G, Daha MR, van Es LA (1983)• Presence 
of circulating macro-molecular IgA in patients 
with hematuria due to primary IgA nephropathy. 
The American Journal of Medicine 74; 375-381. 
100. Egido J, Sancho J, Rivera F, Hernando L 
(1984). The role of IgA and IgG immune 
complexes in IgA nephropathy. Nephron 36; 
52-59. 
101. Levinsky RJ, Barratt TM (1979). IgA immune 
complexes in Henoch-Schoenlein purpura. Lancet 
2; 1100-1103. 
102. Hall RP, Lawley TJ, Heck JA, Katz SI (1980). 
IgA containing circulating immune complexes in 
dermatitis herpetiformis, Henoch-Schoenlein 
purpura, systemic lupus erythematosus and other 
diseases. Clinical and Experimental Immunology 
4 0 ； 4 3 1 - 4 3 7 . 
164 
103. Zone JJ, LaSalle BA, Provost TT (1980). 
Circulating immune complexes of IgA type in 
dermatitis herpetiformis. Journal Investigative 
Dermatology 75; 152-155. 
104. Penner E, Albini B, Milgrom F (1978). 
Detection of circulating immune complexes in 
alcoholic disease. Clinical and Experimental 
Immunology 34； 28-31. 
105. Coppo R, Arico S, Piccoli G, Basolo B, 
Roccatello D, Amore A, Tabone M, de la Pierre 
M, Sessa A, Delacroix DL, Vaerman JP (1985)• 
Presence and origin of IgA^- and IgA^-
containing circulating immune complexes in 
chronic alcoholic liver diseases with and 
without glomerulonephritis• Clinical 
Immunology and Imimnopathology 35; 1-8. 
106. Thomas HC, DeVilliers D, Potter B, Hodgson H, 
Jain S, Jewell DP, Sherlock S (1978)• Immune 
complexes in acute and chronic liver disease. 
Clinical and Experimental Immunology 31; 
150-157. 
107. Abrass CK, Border WA, Hepner G (1982). 
165 
Non-specificity of circulating immune complexes 
in patients with scute and chronic liver 
disease. Clinical and Experimental Immunology 
4 0 ； 2 9 2 - 2 9 8 . 
108. Lopez Trascasa M, Egido J, Hernando L (1979). 
Evidence of high polymeric IgA levels in serum 
of patients with Berger's disease and its 
modification with phenytoin treatment. 
Proceedings of the European Dialysis and 
Transplant Association 16; 513-519. 
109. Rifai A, Small PA, Tesgue PO, Ayoub E (1979). 
Experimental IgA nephropathy. The Journal of 
Experimental Medicine 150; 1161-1173• 
110• Egido J, Sancho J, Blasco R, Rivera F, Hernando 
L (1982)• Actualite's Ne‘phrologiques de 
L'Ho'pital Necker, eds., p.147. Hamburger J, 
Crosnier J, Gru"nfeld, Flammarian, Paris. 
111. Sancho J, Egido J, Gonza'lez E (1983). A 
simple method for determining polymeric 
IgA-containing immune complexes. Journal of 
Immunological Methods 60; 305-317. 
166 
112. Egido J, Sancho J, Hernando P, Gonza'lez J, 
Hernando L (1984)• Presence of specific IgA 
immune complexes in IgA nephropathy. 
Contributions to Nephrology 40; 80-86. 
113. Endoh M, Suga T, Sakai H (1985). IgG, IgA and 
IgM rheumatoid factors in patients with 
glomerulonephritis. Nephron 39; 330-335• 
114. Czerkinsky C, Koopman WJ, Jackson S, Collins 
JE, Crago SS, Schorhenloher RE, Julian BA, 
Galla JH, Mestecky J (1986)• Circulating 
immune complexes and immunoglobulin A 
rheumatoid factor in patients with mesangial 
immunoglobulin A nephropathies. Journal of 
Clinical Investigation 77; 1931-1936. 
115. Sinico RA, Fornasieeri A, Oreni N, Benuzzi S, 
D'Amico, G. (1986). Polymeric IgA rheumatoid 
factor in idiopathic IgA mesangial nephropathy 
(Berger's disease). The Journal of Immunology 
1 3 7 ； 5 3 6 - 5 4 1 . 
116. Schena PF, Pastore A, Sinico RA, Montinaro V, 
Fornasieri A (1988)• Polymeric IgA and IgA 
rheumatoid factor decrease the capacity of 
167 
serum to solubilize ciruclating immune 
complexes in patients with primary IgA 
nephropathy. The Journal of Immunology 141; 
125-130. 
117. Grey HM, Abel CA, Yount WJ, Kunkel HG (1968). 
A subclass of human rA globulins (yA2) which 
lacks the disulfide bonds linking heavy and 
light chains. The Journal of Experimental 
Medicine 128; 1223-1236. 
118. Andre C, Berhoux FC, Andre F, Gillon J, Gein C, 
Sabatier J-C (1980). Prevalence of IgA2 
deposits in IgA nephropathies: a clue to their 
pathogenesis. New England Journal of Medicine 
3 0 3 ； 1 3 4 3 - 1 3 4 6 . 
119. Conley ME, Cooper MD, Michael AF (1980)• 
Selective deposition of immunoglobulin Al in 
immunoglobulin A nephropathy, anaphylactoid 
purpura nephritis, and systemic lupus 
erythematosus. Journal of Clinical 
Investigation 66; 1432-1436. 
120. Murakami T, Furuse A, Hattori S, Kobayashi K, 
Matsuda I (1983). Glomerular IgAl and IgA2 
168 
deposits in IgA nephropathies. Nephron 35; 
120-123. 
121. Tomino Y, Endoh M, Nomoto Y (1981). 
Immunoglobulin Al in IgA nephropathy. New 
England Journal of Medicine 305; 1159-1160. 
122. Valentijn RM, Radl J, Haaijman JJ, Vermeer BJ, 
Weening JJ, Kauffmann RH, Daha MR, Van Es LA 
(1984).Circulating and mesangial secretory 
component-binding IgAl in primary IgA 
nephropathy. Kidney International 26; 760-
766. 
123. van den Wall Bake AWL, Daha MR, van der Ark A, 
Hiemstra PS, Radl J, van Es LA (1988) . Serum 
levels and in vitro production of IgA 
subclasses in patients with primary IgA 
nephropathy. Clinical and Experimental 
Immunology 74; 115-120. 
124. van den Wall Bake AWL, Daha MR, Haaijman JJ, 
van der Ark A, Valentijn RM, van Es LA (1988)• 
The bone marrow as production site of the IgA 
deposited in the kidneys of patients withlgA 
nephropathy. Clinical and Experimental 
169 
Immunology 72; 321-325. 
125. van de Wall Bake AWL, Daha MR, Evers-Schouten 
J, van Es LA (1988) • Serum IgA and the 
production of IgA and peripheral blood and bone 
marrow lymphocytes in patients with primary IgA 
nephropathy: evidence for the bone marrow as 
the source of mesangial IgA. American Journal 
of Kidney Diseases 7； 410-414. 
126. Skvaril F, Barandun S, Morell A, Kuffer F, 
Probst M (1975)• In : Twenty-Second 
Colloquium, Bruges, Protides of the Biological 
Fluids, p.121, Ed. Peeters H. Pergamon Press, 
New York. 
127. Yount WJ, Hong R, Seligmann M, Good R, Kunkel 
HG (1970)• Imbalances of gamma globulin 
subgroups and gene defects in patients with 
primary hypogammaglobulinemia. Journal of 
Clinical Investigation 49; 1957-1966. 
128. Barandun S, Morell A, Skvaril F, Oberdorfer A 
(1976) • Deficiency of k一 or X- type 
immunoglobulins. Blood 47; 79-88. 
170 
129. soiling J, S0lling K (1979). Free light chains 
of immunoglobulins in amyloidosis. Acta Medica 
Scandinavica 206; 283-287. 
130. Reckens ALJM, Jansen MJH, van Muster PJJ, 
Weemaes CMR, Bakkeren JAJM (1986)• 
Nephelometry of the kappa/lambda light-chain 
ratio in serum of normal and diseased children. 
Clinical Chemistry 32; 2147-2149. 
131. Iwashita H, Grunwald F, Bauer H (1974). Double 
ring formation in single immunodiffusion for 
kappa chains in multiple selerosis 
cerebrospinal fluid. Journal of Neurology 207; 
45-52. 
132. Mckelvey EM, Fahey JL (1965). Immunoglobulin 
changes in disease : quantitation on the basis 
of heavy polypeptide chains, IgG (yG), IgA (rA) 
and IgM (yM), and of light polypeptide chains, 
type K(I) and type L(II) • Journal of Clinical 
Investigation 44; 1778-1787. 
133. Bollengier F (1979) . Bound and free light 
chains in serum from patients affected with 
various neurological diseases. Journal of 
171 
Clinical Chemistry Clinical Biochemistry 17; 
45-49. 
134. Normansell DE (1987) . Use of kappa and lambda 
chain quan tition for the detection of 
immunoglobulin abnormalities in serum. 
Diagnostic and Clinical Immunology 5; 100-103. 
135. Rees J, Ohrmundt J (1986) . The usefulness of 
quantifying kappa and lambda light chains [Tech 
Brief]. Clinical Chemistry 32; 899. 
136. Wallage MJ, Whicher JT (1987). "Quantimetric" 
kappa:lambda ratio test [Letter]. Clinical 
Chemistry 33; 448. 
137. Whicher JT, Wallage M, Fifield R (1987). Use 
of immunoglobulin heavy- and light-chain 
measurements compared with existing techniques 
as a means of typing monoclonal 
immunoglobulins. Clinical Chemistry 33; 
1771-1773. 
138. Schultz AL, Fink LM (1986) . What is the most 
efficient way to evaluate immunoglobulins? 
Clinical Chemistry 32; 391-392. 
172 
139. Keren DF, Warren JS, Lowe JB (1988) . Strategy 
to diagnose monoclonal gammopathies in serum: 
high-resolution electrophoresis, immunofixation 
and K/X quantification. Clinical Chemistry 34; 
2196-2201. 
140. Andrew DW, Capra JD (1980). In: Clinical 
Immunology, P.1-18 Ed. Parker CW, W.B. 
Saunders, Philadephia• 
141. Lai KN, Chan KW, Mac-Moune Lai F, Ho CP, Yan KW 
(1986) • The immunocheinical characterization of 
the light chains in the mesangial IgA deposits 
in IgA nephropathy. American Journal of 
Clinical Pathology 85; 548-551. 
142. Lai KN, Lai FMM, Lo STH, Lam CWK (1988). Light 
Chain Composition of IgA in IgA Nephropathy. 
American Journal of Kidney Diseases ii； 
425-429. 
143. Monteiro RC, ha Ibwachs -Mecar e H i L, 
Roque-Barreira MC, Noel L-H, Berger J, Lesavre 
P (1985)• Charge and size of mesangial IgA in 
IgA nephropathy. Kidney International 28; 
173 
666-671. 
144. Lai KN, Lai FM, Chui SH, Chan YM, Tsao GSW, 
Leung KN, Lam CWK (1987) . Studies of 
lymphocyte subpopulations and immunoglobulin 
production in IgA nephropathy. Clinical 
Nephrology 28; 281-287. 
145. Barandun S, Skvarill F, Morell A (1976). 
Imbalances of K/X ratio of human 
immunoglobulins. Clinical Immunology Biology 
3; 57-69. 
146. Lai KN, Chui SH, Lai FM, Lam CWK (1988). 
Predominant synthesis of IgA with lambda light 
chain in IgA nephropathy. Kidney International 
3 3 ； 5 8 4 - 5 8 9 . 
147. Chui SH, Lam CWK, Lai KN (1990) . Light chain 
ratios of immunoglobulins G, A, and M 
determined by enzyme immunoassay. Clinical 
Chemistry 36; 501-502. 
148. Lam CWK, Chui SH, Lai KN (1987) • Light chain 
ratios of serum immunoglobulins in disease 
[Abstract]. Clinical Biochemists Review 8; 
174 
132. 
149. Chui SH, Lam CWK, Lewis WHP, Lai KN (1990). 
Fast protein liquid chromatography for the 
purification of IgA from human serum using 
jacalin. Journal of Chromatography (accepted 
for publication). 
150. Roque-Barreira MC, Campos-Neto A (1985). 
Jacalin: An IgA-binding lectin. The Journal of 
Inmiunology 134 ； 1740- 1743 . 
151. Sharon N, Lis H (1982). Glycoproteins: 
research booming on long-ignored ubiquitous 
compounds. Molecular and Cellular Biochemistry 
4 2 ； 1 6 7 - 1 8 7 . 
152. Kondoh H, Kobayashi K, Hagiwara K, Kaji T 
(1986)• Jacalin, a jackfruit lectin, 
precipitates IgAl but not IgA2 subclass on gel 
diffusion reaction. Journal of Immunological 
Methods 88; 171-173. 
153. Zehr BD, Litwin SD (1987) . Human IgD and IgAl 
compete for D-galactose-related binding sites 
on the lectin jacalin. Scandinavian Journal of 
175 
Immunology 26; 229-236. 
154. Skea DL, Christopoulos P, Plaut AG, Underdown 
BJ (1988) . Studies on the specificity of the 
工 g A - b i n d i n g lectin, jacalin. Molecular 
Immunolgy 25; 1-6. 
155. Hagiwara K, Collet-Cassart D, Kobayashi K, 
Vaerman JP (1988). Jacalin: isolation, 
characterization and influence of various 
factors on its interaction with human IgAl, as 
assessed by precipitation and latex 
agglutination. Molecular Immunolgy 25: 69-83. 
156. Kondoh H, Kobayashi K, Hagiwara K (1987). A 
simple procedure for the isolation of human 
secretory IgA of IgAl and IgA2 subclass by a 
jackfruit lectin, jacalin, affinity 
chromatography. Molecular Immunology 24; 
1219-1222. 
157. Gregory RL, Rundegren J, Arnold RR (1987). 
Sparation of human IgAl and IgA2 using 
jacalin-agarose chromatography. Journal of 
Immunological Mehods 99; 101-106• 
176 
158. Aucouturier P, Mihaesco E, Mihaesco C, 
Preud'homme JL (1987)• Characterization of 
jacalin, the human IgtA and IgD binding lectin 
from jackfruit. Molecular Immunology 24; 
503-511. 
159. Aucouturier P, Duarte F, Mihaesco E, Pineau N, 
Preud'hoitime JL (1988) . Jacalin, the human IgA^ 
and IgD precipitating lectin, also binds IgA^ 
of both allotypes. Journal of Immunological 
Methods 113; 185-191. 
160. Hale GM, Mcintosh SL, Hiki Y, Clarkson AR, 
Woodroffe AJ (1986)• Evidence for IgA-specific 
B cell hyperactivity in patients with IgA 
nephropathy. Kidney International 29; 718-724. 
161. Johnstone A, Thorpe R (1987). Immunochemistry 
in Practice, 2nd Edn, p.140. Blackwell 
Scientific Publications, Oxford. 
162. Lewis WHP, Sun KKY (1988). Specific antigen 
detection by immunoelectroendosinosis. 
Electrophoresis 9; 354-355. 
163. Instructions of ImitiunoPure IgA Buffers and 
177 
Immobilized Jacalin. Pierce Chemical Company, 
Rockford, Illinois 61105, USA. 
164. Bannister KW, Drew PA, Clarkson AR, 
Woodroffe AJ (1983). Immuno-regulation in 
glomerulonephritis, Henoch-Schonlein purpura 
and lupus nephritis. Clinical and Experimental 
Immunology 53； 384-390. 
165. Chatenoud L, Bach M (1981) . Abnormalities of 
T-cell subsets in glomerulonephritis and 
systemic lupus erythematosus• Kidney 
International 20; 267-274. 
166. Egido J, Blasco R, Sancho J, Lozano L (1983). 
T-cell dysfunctions in IgA nephropathy : 
Specific abnormalities in the regulation of IgA 
synthesis. Clinical Immunology and 
Immunopathology 26; 201-212. 
167. Sakai H, Nomoto Y, Animori S (1979). Decrease 
of IgA - specific suppressor T cell activity in 
patients in IgA nephropathy. Clinical and 
Experimental Immunology 38; 243-248. 
168. Casanueva B, Rodriguez — Valverde V, Arias M, 
178 
Vallo A, Garcia 一 Fuentes M, Rodriguez -
Soriana J (1986)• Immunoglobulin - producing 
cells in IgA nephropathy. Nephron 43; 33-37. 
169. Waldo FB, Beischel L, West CD (1986) . IgA 
synthesis by lymphocytes from patients with IgA 
nephropathy and their relatives. Kidney 
International 29; 1229-1233• 
170. Linne T, Wasserman J (1985). Lymphocyte 
subpopulations and immunoglobulin production in 
IgA nephropathy. Clinical Nephrology 23; 
109-111. 
171. Fiorini G, Fornasieri A, Sinico R, Colasanti G, 
Gibelli A, Corneo R, D'Amico G (1982)• 
Lymphocyte populations in the peripheral blood 
from patients with IgA nephropathy. Nephron 
3 1 ； 3 5 4 - 3 5 7 . 
172. Cosio FG, Lam S, Folami AO, Conley ME, Michael 
AF (1982)• Immune regulation of immunoglobulin 
production in IgA nephropathy. Clinical 
Immunology and Immunopathology 23; 430-436• 
179 
173. Thomas HC (1977) . The role of the liver in 
immunological disease. Proceedings of the 
Royal Society of Medicine 70; 521-525. 
174. Droz D (1976) Natural History of primary 
glomerulonephiritis with mesangial deposits of 
IgA. Contributions to Nephrology 2: 150-158. 
175. Feehally J, Beattie TJ, Brenchley P, Coupes B, 
Mallick N, Postlethwaite R (1986)• Sequential 
study of the IgA system in relapsing IgA 
nephropathy. Kidney International 39; 924-931. 
176. Robb RJ (1984) . Interleukin 2 : The moelcule 
and its function. Immunology Today 5; 203-209• 
177. Robb RJ, Greene WC, Rusk CM (1984) . Low and 
High affinity cellular receptors for 
interleukin 2. Implications for the level of 
Tac antigen. Journal of Experimental Medicine 
160; 1126-1146. 
178. Uchiyama T, Broder S, Waldmann T (1981). A 
monoclonal antibody (anti-Tac) reactive with 
activated and functionally mature human T 
180 
cells. I. Production of anti-Tac monclonal 
antibody and distribution of Tac(+) cells. The 
Journal of Immunology 126; 1393-1397. 
179. Williams JM, Abbud-Filho M, Kelley VE, Strom 
TB (1985). Interleukin 2 apparently 
upregulates its receptor and induces 
proliferation of various mononuclear leukocytes 
in the absence of antigen. Cell Immunology 94; 
383-393. 
180. Lai KN, Leung JCK, Lai FMM, Tam JS (1989). 
T-lymphocyte activation in IgA nephropathy : 
Serum - soluble interleukin 2 receptor level, 
interleukin 2 production, and interleukin 2 
receptor expression by cultured lymphocytes. 
Journal of Clinical Immunology 9; 485-492. 
181. Buno-Moreno MM, Campos-Neto A (1981). 
Lectin(s) extracted from seeds of Artocarpus 
integrifolia (jackfruit) : potent and selective 
stimulator(s) of distinct human T and B cell 
functions. The Journal of Immunology 127; 
427-429. 
182. Harada T, Hobby M, Courteau JF, Knight D, Gwyn 
181 
w (1989)• Charge distribution of plasma IgA in 
IgA nephropathy. Clinical and Experimental 
Immunology 77; 211-214. 
183. Gallo GR, Caulin-Glaser T, Emancipator SN, Lamm 
ME (1983). Nephritogenicity and differential 
distribution of glomerular immune complexes 
related to immunogen charge. Laboratory 
Investigation 48; 353-362. 
184. Gauthier VJ, Striker GE, Mannik M (1984). 
Glomerular localization of preformed immune 
complexes prepared with anionic antibodies or 
with cationic antigens. Laboratory 
Investigation 50; 636-644. 
185. Weinberg DS, Pinkus GS, Ault KA (1984). 
Cytofluorometric detection of B cell clonal 
excess : a new approach to the diagnosis of B 
cell lymphoma. Blood 63； 1080-1087. 
186. Monteiro RC, Chevallar A, Noel L-H, Lesavre P 
(1988). Serum IgA preferentially binds to 
cationic polypeptides in IgA nephropathy. 
Clinical and Experimental Immunology 73; 
300-306. 
182 
187. Isaacs KL, Miller F (1987)• Role of antigen 
size and charge in immune complex 
glomerulonephritis• Laboratory Investigation 
47; 198-205. 
183 
A P P E N D I C E S 
�/"‘•“.�/ A:厂’N>/‘’x>. Vol. :s \'o. 6 一 19S7 (pp. :S!-2S7) Appendix 1 
Studies of lymphocyte subpopulations and 
immunoglobulin production in IgA nephropathy 
K . N . L A I ' , F. M . LAI\ S. H . C H U I \ Y. M . C H A N ' , G . S. W . T S A O \ K . N . LEUNG^ and 
C. W. K. Lam3 
Departments of 'Medicine, ^Morbid Anatomy, ^ChemicalPathology, *Anatomy, and 
^Biochemistry, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong 
Abst ract . This work was undertaken to examine the immunoregulaiion of T lymphocytes in 
patients wi th IgA nephropathy. Fi f ty patients and thirty-seven control subjects were studied 
in an infection-free interval. T lymphocyte subpopulations were determined using O K T 
monoclonal antibodies against helper ( O K T 4 ) and suppressor ( 0 K T 8 ) T cell subsets. The 
proport ions of T lymphocyte subpopulations did not differ between patients and controls. 
Patients w i th significant renal impairment demonstrated a reduced OKT4 /T8 ratio (p <0.001) 
due to an absolute reduction of T helper cells (p <0.02) and an increase of T suppressor cells 
(p <0.001). Longitudinal studies performed in 13 patients revealed consistent findings during 
clinical quiescence. However, synpharyngitic macroscopic haematuria was associated wi th a 
rise in T4 positive cells and a simultaneous reduction of T8 positive cells; these changes 
reverted to pre-infection values when the infection subsided. Functional studies assessing T 
lymphocyte activities including in vi tro immunoglobul in synthesis by cultured peripheral 
b lood mononuclear cells, thymidine uptake by cultured lymphocytes and T lymphocytes 
activation w i th expression of interIeukin-2 receptors were measured in unstimulated and 
mitogen stimulated cultures. N o significant difference between patients wi th IgA nephro-
pathy in clinical quiescence and the control subjects was demonstrated. Our results failed to 
support a shift in the immuno-regulatory T lymphocyte subpopulations during clinical 
quiescence but a more profound defect in immunoregulation may probably occur during 
clinical exacerbation. 
Key words: T lymphocyte - immunoglobul in interIeukin-2 receptor 一 IgA nephropathy 一 
lymphocyte subpopulations 
In t roduc t ion no clinical data describing the disease activity were 
- presented in these studies except a recent study which 
IgA nephropathy characterized by mesangial demonstrated that the disturbance of cellular 
deposition of IgA has been recognized to be the immunoregulation was not present during the infec-
commonest pr imary glomerulonephritis in many tion-free period [Linne and Wasserman 1985]. In 
countries [Clarkson et al. 1977, D 'Amico 1985，Lai et order to obtain more relevant information on the 
al. 1985, Power et al. 1985]. The pathogenesis of IgA immunopathogenesis of IgA nephropathy, we investi-
nephropathy remains unclear but excessive circulating gated the lymphocyte subpopulations, spontaneous 
immune complexes [Woodroffe et al. 1980], defective and stimulated IgA synthesis by peripheral blood 
mononuclear phagocytic system [Lawerence et al. lymphocyte, and expression of interleukin 2 (IL2) 
1983], and defective cellular immuni ty [Sakai et al. receptors in activated peripheral blood lymphocyte 
1979], have been reported. Deranged immunoregulat- during an infection-free interval. Longitudinal studies 
ory activity apparently plays an important pathoge- of the lymphocyte subpopulations during clinical 
netic role in IgA nephropathy. Increased spontaneous quiescence and synpharyngitic macroscopic hematuria 
and stimulated IgA synthesis by peripheral blood were also performed, 
lymphocytes [Bannister et al. 1983] as well as absolute 
reduction in 丁 suppressor cells [Chatenoud and Bach 
1981，Bannister et al. 1983] and increase in 丁 helper Mater ia l and methods 
cells [Egido et al. 1983] have been reported. However, 
Patient 
Received March 9, 1987； in revised form July 29, 1987. F i f ty patients with a clinical and renal im-
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phropathy were studied. IgA nephropathy was dia- Approximately 300-350 cells per slide were 
gnosed by the presence of predominant granular IgA counted. The results were expressed as the pcrccntage 
deposits mainly in the glomerular mesangium and of each T-cell subset or B cells with respect to the total 
occasionally along the peripheral capillary basement number of mononuclear cells presented in each field, 
membrane in immunofluorescent studies and the The ratio between 〇K丁4- and OKTS-stalncd 丁 cell 
presence of mesangial electron-dense deposits in percentages was than deduced and used as the index of 
ultrastructural examination. Systemic lupus ery- the test results in each subject. When duplicate 
thematosus, Henoch-Schonlein purpura and hepatic samples of some patients or control were performed, 
disease were excluded by detailed clinical history, the results obtained agreed within 5% with preceding 
examination and negative laboratory tests for values, 
hypocomplementemia, an t i -DNA antibody or hepa-
titis B virus surface antigen. Significant renal impair-
ment in these patients w i th IgA nephropathy was Lymphocyte stimulation test 
defined as an endogenous creatinine clearance ^ . , , , , , , ,, ,T^r»w广、 
<40 ml/min/1.73 m、All patients had been free f rom Peripheral^ ^ lood mononuclear cells P B M Q 
infections or macroscopic hematuria for at least four 了 e r e separated f rom hepannized whole Wood by 
weeks before the initial investigation. These patients density gradient c e n t r f ga^n二sing F^oU Hypaque. 
were not on corticosteroid or immunosuppressive Af ter three washes m TC-199 (Gibco Chargnn Falls, 
therapy. The studies of T lymphocyte subsets and 〇"，^SA ) , the ee ls were resuspended at a concemra-
functions were performed wi th in 12 months after the ； ; ^ 乂 1。‘亡“;/乂:c二plete culture medium 
diagnosis was made bv renal bio s ( C C M ) consisting of RPMI 1640 (Gibco, Chargnn 
/ P Falls, USA) supplemented with 10% heat-inactivated 
fetal calf serum, 2 mM L-glutamine, 100 u/ml 
Control penicil l in, 100 j ig /ml streptomycin and 2.5 |ig/ml fun-
gizone. One hundred aliquots of this cell suspen-
Thirty-seven healthy subjects wi th normal renal sion were dispensed into 96-well microculture flat-
function were used as donors of control lymphocytes. bot tom plastic plates (Costar, Cambridge, M A , USA) 
and cultured in quadruplicates without mitogen, with 
pokeweed mitogen (PWM) (Sigma Chemicals, St. 
Indirect immunofluorescence assay for lymphocyte Louis, MO, USA) 1 )ig/ml and 5 )ig/ml, phyto-
subsets haemagglutinin (PHA) (Sigma Chemicals, S l Louis, 
T . " . ” c , , , , , M O , USA) 1 l ie/ml and 10 ue/ml, Concanavalin A len milliliters ot venous heparinized blood were ,广 a� /c. • i c t . t re a\ I . 1 1 , , J , , fr (Con A) (Siema Chemicals, St. Louis, M O , USA) 
diluted wi th equal vo lume of phosphate buffer saline ) / i j i n / i c l i /pprx u 7 , , J ^ IT n u 1 ^ ig/ml and lOfig/ml, or Staphylococcus aureus 冗T ) ^  A r. r J a Ficoll-Hypaque ^owan (SAC) [CalBiochem-Behring, La Jolla, CA’ 
[l^yegaard, Oslo, Norway) density gradient. A l l ^ S A ] 10 ng/ml. Incubation was at 37。C in humid 
y o o d samples were processed for the immuno- atmosphere of 5 % CO, in air. After 72 hours incuba-
fluorescence assay on the same day of collection. A f t e r 【 i o n ’ 0.5 ^iCi of methyl-^H thymidine (Amersham, 
centnfugation, the interface layer containing lympho- England) was added to each well and the cultures were cytes was washed thrice in Hank s balanced salt . . /j f i • , , i ^ • 
, . /TiT>rrx /o- . , T . 、,一 terminated atter an additionaJ 6 hours. I h e incorpo-solution (HBSS) (Sigma Chemicals, St. Louis, M O , , , . r 
T Tc A \ J 1 11 •. 省 rated radioactivity, expressed as counts per minute 
UbA) , and the cell count was adjusted to , 、 」 . t l • i . . j 1 � � " / I . . yrr-nr^ n (cpm) , WHS determined. The st imulat ion index was 
10 X 10 cells/m m suspension medium (HBSS con- J c u l a t e d by (stimulated cpm - unstimulated cpm)/ 
tammg 2 / o fetal calf serum). One hundred of the uns t i随u la /ed cpm. The dosage of mitogens was 
lymphocyte suspension was placed in each or tive j . j • l j 
L Ti ， , , , , . determined with a dose-response curve, 
tubes, i he tubes were then incubated for 30 mm at 
4 ®C wi th 5 pi of appropriate dilutions of O K T 4 , 
OKT8, and OKB7 murine monoclonal antibodies . • , JTI . 、 frs 1 T ^ - . . T> • X T T T T C A X Activated Tlymphocytes in vitro (Ortho Diagnositics, Raritan, NJ, USA). 广 : 
After incubation, the cells were washed thrice in The peripheral blood mononuclear cells were 
cold HBSS. Lymphocytes were then labeled wi th cultured in vitro as in the lymphocyte stimulation test. 
100 )il of 1:15 dilution fluorescent goat anti-mouse One ml of lymphocytes at a concentration of 
IgG (Ortho Diagnostics, Raritan, NJ, USA) for 0.5 X lOVml in complete culture medium were cul-
30 min at 4 washed thrice in cold HBSS, resus- tured in triplicates in 24 well culture plates (Costar, 
pended in one to two drops of PBS p H 7.4 containing Cambridge, M A , USA) without mitogen, and with 
30% glycerol (vol/vol), and examined with a Leitz P W M 1 |ig/ml. The cells were incubated for seven 
orthoplan microscope. days before they were centrifuged at 200 g. The cells 
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• ‘ — “ ‘ — 
were washed thrice in C C M , the cell count was standards appropriately diluted in complete culture 
adjimccl to 2.5 X lOVml in HBSS containing 2% fetal medium were then introduced, 100 ^il/well in dupli-
calf scrum, and 100 pi of the lymphocyte suspension cate. Af ter incubation at 37。C for three hours, the 
was placed in microtubes. The tubes were then plates were again washed 20 times wi th PBS-tween 
injrubated for 30 min at 4。C w i t h 10 pi of appropriate The same antisera as used for coating, but conjugated 
dilutions of murine monoclonal anti-interleukin 2 wi th horseradish peroxidase (Dako-immunoglobu-
receptor antibodies (Serotec, Ox fo rd , England). After lins, Copenhagen, Denmark) and diluted 1:6000 
incubation, the cells were washed thrice w i th HBSS. 1:6000, and 1:2000 respectively in PBS-tween were 
Lymphocytes were then labeled w i th 100 of 1:15 then added, 100 t i l /wel l as appropriate. Incubation at 
di lut ion fluorescent goat anti-mouse IgG for 30 min at 37 °C was continued for another two hours and the 
4。C’ washed thrice in cold medium, resuspended washing repeated. A freshly prepared substrate solu-
wi th a Pasteur pipette, and one drop examined tion containing 10 mg urea hydrogen peroxide and 
wi th a Leitz Orthoplan microscope. Approximately 35 mg o-phenylene-diamine dihydrochloride (Sigma 
300-350 cells per slide were counted. Lymphoblas- Chemicals, St. Louis, Mo , USA) In 50 m l 0 20 M 
toid cells wi th immunofluorescence staining for IL-2 phosphate-citrate buffer, p H 5.0 was then added 
receptors were recorded and expressed as the percen- 100 nl /wel l , and the plates incubated at 37。C for a 
tage of total mononuclear cells present. When dupli- further 30 min. Finally, the reaction was terminated 
cate samples of some patients or controls were per- by addition of 50 nl /wel l of 0.10 M citr ic acid 
formed, the results obtained agreed wi th in 5% wi th p H 3.0’ and the absorbances wer measured at 450 nm 
preceding values. wavelength using a Dynatech MR600 Microplate 
Reader (Dynatech Laboratories Inc, Alexandria, VA, 
USA). Immunoglobul in concentrations were deter-
ImmHnoglobulin production in vitro mined by reference to their respective standard curves. 
The cell free supernates prepared from the lym-
phocyte cultures on the 7th day were stored at -40。C Statistics 
unti l assayed. 
A double sandwich ELISA method was used for The results are expressed as mean 土 (s.e.m.) and 
， e quantitation of IgA, IgG, and IgM, Purified Student's paired and unpaired t-test5 were used to 
immunoglobulin fractions of rabbit antisera to human analyze the data. 
JgA, IgG and I g M were purchased f rom Dako-
immunoglobulins (Copenhagen, Denmark) and used 
at 1:5000, 1:2000，and 1:2000 dilutions, respectively. Results 
Microtiter plates were coated by adding 100 ) i l /wel l of 
the appropriate antiserum diluted in 0.015 M sodium Patients and controls 
carbonate-bicarbonate buffer, p H 9.6. The plates 
were incubated overnight at 4 and then washed 20 Fi f ty patients wi th pr imary IgA nephropathy (23 
times wi th phosphate buffer saline, p H 7.4 containing males and 27 females, mean age 32 9 土 12 years 
0.05% (vol/vol) Tween 20 (PBS-tween). Samples and range 18-54) were studied for T cell subpopulations.' 
丁“We 1 Lymphocyte subpopulations in patients wi th IgA nephropathy ( G N ) and control . 
Parameters Controls IgA G N IgA G N IgA G N 
(overall) GFR >40 ml/min GFR <40 ml/min 
N u m b e r 37 50 39 j j 
Lymphocyte count (x lOVl) 1.64 ± 0.05 1.65 土 0.06 1.68 ± 0.10 1.63 土 O.IS 
O K丁4 ( % ) 37.1 ± 1.1 36J ± 1.1 37.7 ± 1.4 30.7 土 3.3*. b 
〇 K丁8 ( % ) 23.5 ± 1.1 27.8 土 0.9' 26.1 ± 1.2 33.8 土 3 . o “ 
丁4爪 K6>7 ± O.CS 1.46 ± 0 . 0 8 1.61 ± 0,12 0.95 ± 0.12'-
The results are expressed as mean ± s.e.m. 
a = p <0.02 as compared with controls; 
b = p <0.05 as compared with IgA G N wi th GFR >40 ml/min/1.73 m^; 
c = p <0.001 as compared with controls; 
cJ = p<0 .01 as compared with IgA G N wi th GFR >40 ml/min/1.73 m:. 
.• .„,,.. ‘、-, . — — — — 一 一‘ —— .—...—. • 一 —一• . — - • 
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E l e v e n pa t i en ts ( 2 2 % ) had s ign i f i can t rena l i m p a i r - 丁able 2 Longitudinal studies of T cell subpopulations in patients 
mcnt (endogenous creatinine clcarance < 4 0 m l / m i n / with IgA nephropathy (n = 9) 
1.7? m ” and four of them were on maintenance ； ^ OKT4 (%) OKT8 (%) OKT4/T8 
dialysis during the time of studies. Serum IgA was 
elevated (above 4 g/1) in 18 patients (36%). Thir ty- 1 32.0 ± 4.5 26.9 土 3.1 1.2 土 0.3 
seven healthy volunteers (21 males and 16 females, 4 35.1 ± 3.5 26.1 土 2.0 1.4 ± 0.2 
mean age 36.1 土 1.9 years, range 22-68) served as 8 28.9 ± 3.7 24.9 ± 2.2 1.3 ± 0.2 
contro l donors for lymphocytes . 20 35.1 ± 2.9 26.7 ± 2.6 1.5 土 0.4 
The results arc expressed as mean ± s.c.m. 
^ ,, , til / T^. /T-rtv . No significant statistical difference is demonstrated between values 
T cell subsets and helper/suppressor (OKT4/T8) ratios , , . . . . . . . 
1) measured during different periods. 
The mean percentages of T helper cells (T4) and 
T suppressor cells (T8), and OKT4/T8 ratio of the difference in mean percentages of T helper and T 
normal control group were 37.1 土 1.1, 23.5 土 1.1, suppressor cells, and mean O K T / T 8 ratios was found 
and 1.67 土 0.08, respectively. The values are similar between male and female controls (36.6 土 1.3 versus 
to those have been reported in other centers using the 38.0 土 1.8, 24.6 士 1.5 versus 22.3 土 1.3’ 1.61 士 0,10 
same quantitation technique [Chatenoud and Bach versus 1.77 ± 0.14, respectively). The 50 patients with 
1981，Linne and Wasserman 1985]. N o significant primary IgA nephropathy did not demonstrate a 
significant difference in the total lymphocyte count, 
percentages of T helper and T suppressor cells, or 
OKT4/T8 ratio as compared wi th the healthy con-
701 trols. In contrast, IgA nephritic patients with signlfi-
八 cant renal impairment showed a highly significant 
gQ / \ mean reduction in OKT4/T8 ratios secondary to both 
/ \ a depression of mean T4 values and elevation of mean 
(%) / \ T8 values as compared wi th healthy controls and IgA 
50 / \ nephritic patients with normal renal function. Tlie 
^•^^jiii^^J；；;^^^^ / \ percentage of B lymphocytes was significantly higher 
40 ^^^^^^^^ / in patients with IgA nephropathy as compared with 
2 ^ J controls. 
2Q The T cell subpopulations were monitored serial-
ly in nine patients with IgA nephropathy over a five-
j . month period during which the patients were clini-
cally quiescent and free of infection. The mean T4 
40 j j ^ ^ values, T8 values and OKT4/T8 ratios remained 
T8 ^ ^ ^ unchanged within this period (Table 2). Four other 
(%) 30 IgA nephritic patients had synpharyngitic macros-
copic hematuria. They demonstrated an elevated 
OKT4/T8 ratio due to an absolute increase in T4 
20 ^ p o s i t i v e cells and a simultaneous reduction in T8 
positive cells during the episode of synpharyngitic 
101 macroscopic hematuria. The T cell subpopulations 
5i returned to pre-infection values when the macroscopic 
4 hematuria and pharyngitis subsided (Figure 1). Eleva-
T4/T8 3 t lon o f OKT4/T8 ratio was no t observed in six control 
Nv subjects during an attack of upper respiratory tract 
2 bacterial infection. 
0 
Cl»n.c*I Ptidfyngitit CI,meal Pharyngiti* Clinic*! LyTTlphoCyte StlTTHil^tlOTl tCSt 
Quiescence Macroscopic Ouiesce<^ce Macroscopic Quiescence * ^ 
Haemaiurin Haematuria 
fig. I The percentages of T4 positive cells and T8 positive cells, L y m p h o c y t e S t i m u l a t i o n test w i t h m i t o g e n s i n -
and OKT4Ar8 ratio in four patients during clinical quiescence and e lud ing P H A , P W N , C o n A and S A C was performed 
synpharyngitic macroscopic hematuria. in 19 patients wi th I gA nephropa thy and 11 controls. 
Studies oj lyrrjphoiytc suhpopuhitions ayid irnrunrwglobulin production in IgA nephropathy 28^ 
T h e degree o f n i i t o g c n - i n d u c c d l y m p h o c y t e s t i m u l a - Table 3 Effects of C O N A, PWM, PHA, and SAC siimulan'on of 
t ion in patients w i th I gA nephropa thy and contro ls lymphocytes expressed as stimulation index. 
did not differ significantly (Table 3), “ “ ； “ 
b ，\ ‘ Parameters Controls IgA G N 
n = 11 n = 19 
Con A 1 ug/ml) 67.7 ± 12.8 73.8 土 10."4 
Con A (10 ug/ml) 188.7 ± 34.1 147.9 ± 27.0 
Activated Tlymphocyte in-vitro PWM (1 ug/ml) 42.1 土 5.8 40.5 ± 6.8 
PWM (5 ug/ml) 43.3 ± 6.8 33.4 土 5.4 
The activated T lymphocytes were determined by PHA (1 ug/ml) 147.4 土 30.6 125.6 土 23.7 
the presence of inter leukin-2 receptors w i t h m o n o - PHA (10 ug/ml) 471.7 ± 77.5 342.6 土 52."4 
clonal ant ibodies o n the surface o f large lymphob las- SAC (10 ug/ml) 21.9 ± 19.7 土 3.9 
toid cells. In contrast to unstimulated lymphocyte 
cultures, the number of activated T lymphocytes was 芥 ' r e s u l t s are expressed « mean 土 s,m. 
• T «•， 1 - J . L . I No significant statistical difference is demonstrated between the signiticantly elevated with mitogen stimulation b 
(Table 4). Nevertheless, the numbers o f activated T ⑴"trols and patients with IgA nephropathy, 
lymphocytes (IL-2 receptor positive lymphoblastoid 
cells) wi th mitogen stimulation were similar in 
patients wi th IgA nephropathy and controls (Table 4). t . » • j t i i . . , , . , r ” r r y 、 / lable 4 Activated T lymphocytes tn patients wuh IgA G N and 
controls. 
Parameters n Unstimulated Stimulated 
(PWM 1 ug/mJ) 
Immunoglobulin production in vitro (Figure 2) ( x 10^  Blastoid cells with I L - 2 
receptors/10* mononuclear cells) 
The in vitro production of IgA, IgG, and IgM “ ； ~ T T T I T ^ rTTTTT^ 
. r . . , T r \ 1 • Controls 10 0.12 ± 0.013 1.5 ± 0.13* was similar in patients with IgA nephropathy in . . , ’^ ^ , , ^ ,』丄 ^ . , . r J . , f , r r IgA GN 20 0.13 土 0.012 1.4 ± 0.12推 clinical quiescence and in healthy controls. This 
applied to both the spontaneous and PWM-induced The results are expressed as mean 土 s.c.m. 
i m m u n o g l o b u l i n synthesis. a = p <0.001 as compared with unstimulated values. 
7001 
. ；S：;：;：；：; No Mitogen 
600 圓 PWM 1 ug/ml 
500 
ng/0.5 X 10® cells IgA IgG IgM 
400 
Fig. 2 Mean amounts (土 s.e.m.) 
of IgA, IgG, and IgM produced 
after PWM stimulation in vitro in 300 ‘ ^ ^ 
patients with IgA nephropathy and ^ L 糧 
in healthy controls. ' = p <0.05 as » » 丁 
compared with unstimulated value. 200 -- ^ ^ ^ ^ • 
patients with IgA nephropathy and Control IgA GN Control IgA GN Control IgA GN 
healthy controls. N = 10 N = 19 N = 10 N = 19 N = 10 N = 19 
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Discuss ion account for the contradictory f i nd i ngs from previous 
reports. The immunorcgulation of 丁 lymphocytes in 
Current consensus classifies IgA nephropathy as IgA nephritic patients with significant renal impair-
an immune complex glomerulonephritis in which ment is abnormal as in patients wi th other causes of 
most of the antibody deposited is IgA. Disorder in the chronic renal failure [Chatterjee 1985]. The derange-
Immunoregulatory activity has been suggested to play ment is characterized by a reduction of 丁 helper cells 
an important pathogenetic role in IgA nephropathy. 丁 and an increase of T suppressor cells and hence 
cell dysfunctions and specific abnormalities in the resulting in a low OKT4 /T8 ratio. We have demon-
regulation of IgA synthesis have been reported by strated the consistency of T lymphocyte subpopula-
several groups. The data, however, are somewhat tions and OKT4 /T8 ratio during clinical quiescence in 
contradictory. A significant elevation of OKT4 /T8 patients wi th IgA nephropathy. However, with active 
ratio due to an absolute reduction in T8 positive cells antigenic stimulation as in upper respiratory tract 
had been reported by separate workers [Chatenoud infection, the T4 positive cells increase with simul-
and Bach 1981, Bannister et al. 1983]. Egido et al. taneous reduction of T8 positive cells resulting in an 
[1983], however, demonstrated an elevated OKT4 /T8 elevation of O K T 4 / T 8 ratio. These alterations of T 
ratio due to an absolute increase in T4 positive cells lymphocyte subpopulations return to pre-infection 
and their patients also had increased 丁8 positive cells, values when the infection subsides. Such changes in T 
Defective suppressor cell activity and B cell hyperac- lymphocyte subsets are not observed in healthy con-
tivity is suggested by a decrease in IgA specific T trols suffering f rom upper respiratory tract infection, 
suppressor cell activity [Sakai et al. 1979] and Similar findings have recently been reported by Feeh-
increased IgA production by stimulated lymphocytes ally et al. [1986]. The reported discrepancies in T 
[Bannister et al. 1983, Egido et al. 1983, Casanueva et lymphocyte subpopulations in IgA nephropathy 
al. 1986, Hale et al. 1986, Waldo et al. 1986]. could well be explained by the different clinical 
Contrary to these findings, Linne and Wasserman circumstances during which these studies were per-
[1985] failed to demonstrate a shift in the immunore- formed. Obviously, studies performed during syn-
gulatory T- lymphocyte subpopulations during an pharyngltic macroscopic hematuria would be different 
infection-free interval. Furthermore, high spontane- f rom those performed during clinical quiescence, 
cms and stimulated IgA synthesis by peripheral blood We have performed functional studies in lympho-
lymphocytes in patients w i th IgA nephropathy was cytes obtained from patients wi th IgA nephropathy 
not observed by other workers [F lor in i et al. 1982, by three different techniques, namely, mitogen-
Cosio et al. 1982，Linne and Wasserman 1985]. induced thymidine uptake by cultured lymphocytes, 
These data f rom literature are apparently con- in v i t ro immunoglobulin production, and quantitia-
tradictory and confusing. Inconsistencies in the IgA t lon of activated T lymphocytes. We did not demon-
immune system abnormalities found in IgA ne- strate a difference in the degree of mltogen-lnduced 
phropathy may have some basis in methodological lymphocyte stimulation between IgA nephritic 
variations although a similar EL ISA method and patients in clinical quiescence and the healthy con-
similar source of monoclonal antibodies have been trols. In accordance wi th other workers [Fiorini et al. 
used in these studies. However, variabil i ty in patients 1982, Cosio et al. 1982, Linne and Wasserman 1985], 
selection, clinical setting and study design may also the differences in the in vitro synthesis of immuno-
contribute. Notably, the earlier series consisted of globul in between the patients and the controls were 
only small sample of patients. As the interindividual not statistically significant, which is probably due to a 
values of the T cell subpopulations and in vitro high interindividual variation of immunoglobulin pro-
immunoglobulin production are extremely variable, it ductlon and indicates that these patients are most 
is understandable that a definite conclusion could l ikely immunologically heterogeneous. We studied 
hardly be drawn. Moreover, no clinical data describ- the number of activated 丁 lymphocytes Indirectly by 
ing the activity of the disease were presented in most measuring the number of lymphoblastoid cells express-
studies and the renal functions were not recorded. ing the IL-2 receptors with mitogen stimulation. 
Longitudinal studies are not available so that the Fol lowing cellular activation, newly synthesized IL-2 
consistency of these findings w i th the clinical progress receptors are expressed on the surface of T cells 
can not be ascertained. [Cantrell and Smith 1984] and B cells [Tsudo et al. 
In accordance wi th Linne and Wasserman [1985]， 1984]. The amount of IL-2 receptors released by and 
our results indicate that the 丁 lymphocyte subpopula- expressed on B cells and monocytes are so small 
tions and OKT4 /T8 ratio in peripheral blood from [Nelson et al. 1986] thai we could consider that the 
patients with IgA nephropathy during clinical quies- majority of these lymphoblastoid cells with IL-2 
cence is similar to normal controls. The present study receptors are activated 丁 lymphocytes. Similar to the 
also reveals additional information which could other functional studies, we failed to demonstrate 
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Predominant synthesis of IgA with lambda light chain in IgA 
nephropathy 
KAR-NENG L A I , SHUI-HON C H U I , FERNAND MAC-MOUNE L A I , a n d CHRISTOPHER W . K . L A M 
Departments of Medicine. Chemical Pathology and Morbid Anatomy, Prince of Wales Hospital, The Chinese University of Hong Kong, 
Shatin, Hong Kong 
Predominant synthesis of IgA with lambda light chain In IgA nephrop- curs in the mesangial immunog lobu l i n deposits in IgA nephrop-
?rA�Jnh/=r/thel^ chahj�r^ esang^ IgA depositsand serum t^hy [9], despite the fact that the normal ratio of kappa to 
IgA was studied m patients with IgA nephropathy. Immunofluores- , , . . . . . . , , ,, . . . ^ ^ 
ccnce (IF) studies using murine monoclonal antibodies, rabbit and goat lambda light chain immunoglobulin in human sera is approxi-
anti-human monospecific antisera were performed in kidney sections rnalely two to one [10】.Since the light chain IF may arise from 
from 15 IgA nephritic patients with only IgA isotype detected in the the concomitant mesangial IgM and IgG deposits, one could 
renal biopsy. Lambda light chain IF was demonstrated in all biopsy argue that a definitive immunochemical characterization of the 
specimens and kappa light chain IF in 11 renal biopsy specimens. The . , ^ • ^ , . , • , a . , 
majority ofrenaJ biopsies showed a predominance oflamMa light chain “ 宕 ^ / h a i n s m he mesangial IgA deposits m IgA nephropathy 
IF staining in the mesangial deposits. The concentration of individual could be d i f f i cu l t . The present study was undertaken to con f i rm 
immunoglobulins and their light chain fractions, and the kappaHambda our previous finding in renal tissues and to determine the 
,ratio were determined in the serum and the supernate from peripheral kappa/ lambda l ight chain rat io o f di f ferent immunoc lobu l ins in 
blood n^ononuclear cells culture of 30 IgA nephrhic patients and 30 serum and lymphocyte culture supernate from normal subjects 
age-matched healthy controls. The IgA nephntic patients had a higher j . -.u t a u . 
serum concentration of total IgA (P < 0.001) and a significantly lower and pat ients w i t h IgA nephropathy. 
IgA kappa/lambda ratio (尸 < 0.001) compared with the controls. The 
kappa/lambda ratio of supernatant IgA from IgA nephritic patients {N = Methods 
20) was also significantly lower than that of the normal subjects {N = Patients 
14)，both in the unstimulated (尸 < 0.01) and pokeweed mitogen 
stimulated, peripheral blood mononuclear-cell culture (尸 < 0.05). Our A total of 15 percutaneous renal biopsy specimens from 15 
results showed that patients with primary IgA nephropathy displayed a patients with primary IgA nephropathy were studied. IgA 
unique immunologic response characterized by a predominance of IgA nephropathy was diagnosed on the basis o f the f o l l ow ing 
with lambda light chain in circulation. , , . . . - , , . „ . . . ^ 
pathologic cntenon: focal or diffuse segmental mesangial pro-
. liferative glomerulonephritis on light microscopy; presence of 
predominant IgA deposits, mainly in the mesangium in immu-
nofluorescence studies; and presence of electron dense deposits 
Primary IgA nephropathy characterized by mesangial depo- in the mesangium and paramesangial areas on ultrastructural 
sition of IgA and C3 commonly occurs in young subjects with examination [3]. These 15 kidney biopsies showed IgA deposits 
synpharyngitic hematuria [1]. This entity of glomerulonephritis alone and formed the basis of our histopathologic studies, 
has now been recognized to be the most common glomerulop- Systemic lupus erythematosus, Henoch-Schonlein purpura, and 
athy in many countries [1-3]. hepatic diseases were excluded by clinical and laboratory 
IgA is present in the circulation as monomelic units, mainly examinations. Renal tissue from 15 patients who died suddenly 
of the A l subclass, but at mucosal sites it is secreted actively as from trauma and other causes where postmortem examinations 
A l or A2 dimers polyroerized by J-chain and transported by failed to reveal neoplastic, hepatic, autoimmune, or renal 
binding to the secretory component [4]. Normal serum IgA diseases were used as control. 
contains approximately 90% IgAl and 10% IgA2 [5]. Recent An additional 15 patients with biopsy-proven IgA nephrop-
reports demonstrate that the glomerular IgA deposits consist athy were included in the studies of light chain ratio in serum 
predominantly of monomeric IgAl with a minor proportion of immunoglobulins and 30 age-matched medical and nursing 
IgA2 [6-5]. These findings suggest that the circulating IgA personnels acted as controls. The studies of immunoglobulins in 
immune complex is deposited in the glomeruli of patients with serum and lymphocyte culture supernate were performed dur-
IgA nephropathy irrespective of antibody subclass. Contrary to ing an infection-free and clinical quiescent period, 
the IgA 1 and IgA2 subclasses, our preliminary data suggest that 
predominant lambda light chain immunofluorescence (IF) oc- Immunofiuorescence studies 
Renal biopsy specimens which demonstrated mesangial IgA 
deposits alone were examined by (a) direct immunof luorcs-
Rcceivcd for publication April 22. 1987 cence costained with 1:10 rhodamine-conjugatcd goat anti-
and in revised form July 9’ 1987 human alpha heavy chain (F(ab')： fragmenlsMTago, Burling-
© 1988 by the International Society of Nephrology ame, California, USA) and 1:15 FITC-labcled rabbit anti-hiimnn 
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lambda or kappa light chain (F(ab ')2 fragments) (Dakopatts, the cells were resuspended at a concentration of 1 x 10''cc!ls/ml 
Copenhagen, D e n m a r k ) ; (b) direct immunofluorescence with in complete culture medium ( C C M ) consisting of R P M I 1640 
1:15 FITC-labcled goat anti-human lambda and kappa light (Gibco) supplemented with 10% heat-inactivated fetal calf se-
chains (F(ab')： fragments) (Tago); and (c) indirect immunoflu- rum, 2 mM L-glulamine, 100 U/ml penicillin. 100 "g/ml sirep-
orescence with 1:15 murine monoclonal antibody against hu- tomycin and 2.5 /ig/ml fungizone. One hundred aliquots of 
man lambda light chain and 1:75 murine monoclonal antibody this cell suspension were dispensed into 96-well microculture 
against human kappa light chain (Becton-Dickinson, Mountain flat-bottom plastic plates (Coslar, Cambridge, Massachusetts, 
View, California, USA) followed by 1:10 FITC conjugated goat USA) and cultured in quadruplicates without mitogen and with 
anti-mouse immunoglobulins (Coulter, Hialeah, Florida, USA), pokeweed mitogen (PWM) (Sigma Chemicals, St. Louis, Mis-
The slides were examined with a coded basis by two observers souri, USA ) at a concentration of 1 /xg/ml. The P B M C were 
(F .M.L . and K . N . L . ) under ultraviolet i l lumination, with an incubated at 37。C in humid atmosphere of 5% CO2 in air. The 
Orthoplan microscope equipped with a Ploem illuminator (Leitz, cell free supernates prepared from the lymphocyte cultures on 
Heidelberg, FRG) . The fluorescence intensity of the slide the fifth day were stored at -40。C until assayed, 
preparations was visually scored semiquantitatively as 0’ 1 +， 
2 + ， 3 + and 4+ by two observers without the knowledge of of immunoglobulins and determination of 
previous immunofluorescence studies and the nature of ami- kappallambda ratios 
human light chain antisera. 
The costained sections were examined in a fluorescence IgA, IgG and IgM in lymphocyte culture supernates were 
microscope with epiilumination equipped with filters for nar- quaniitated by enzyme-linked immunosorbent assay (ELISA). 
row-band excitation and barrier filters LP515 for fluorescein Purified immunogiobulin fractions of specific rabbit antisera to 
and LP580 for rhodamine visualization. Alternated immunoflu- human a , y and /x chains (Dakopatts) were used at 1:2000 
orescence examination was permitted by switching one filler dilution. Microliter plates (Labsystems OY, Helsinki, Finland) 
consecutively to the other. Photographs were taken on standard were coated by adding 100 pdAveU of the appropriate antiserum 
Kodacolor film developed at 100 A S A . diluted in 0.015 M sodium carbonate-bicarbonate buffer, pH 9.6. 
The plates were incubated overnight at 4°C and washed 20 times 
Antisera with phosphate buffer saline, pH 7.4’ containing 0.05% (vol/vol) 
The properties and specificities of fluorescein-conjugated Tween 20 (PBS-tween). Samples and immunoglobulin stan-
(FITC) rabbit anti-human lambda and kappa chain antisera dards (Dakopatts) appropriately diluted in C C M were then 
(Dakopatts) had been tested as described in our previous introduced, 100 ^tl/well in duplicate. After incubation at 37。C 
communication [9]. Briefly, the antisera were purified by gel for three hours, the plates were again washed 20 times with 
filtration and ion exchange chromatography. Their monospeci- PBS-tween. The same antisera as used for coating, but conju-
ficity was ascertained by Ouchterlony double immunodiffusion gated with horseradish peroxidase and diluted 1:2000 in PBS-
in agarose gel against Bence-Jones lambda and kappa chain, tween, were added, 100 /xl/well as appropriate. Incubation at 
purified by gel filtration and immunoadsorption chromatogra- 37°C was continued for another two hours and the washing 
phy (Behringwerke A G , Marburg, F R G and our laboratory), repeated. A freshly prepared substrate solution containing 10 
The monospecificiiy of the goat anti-human lambda and kappa mg urea hydrogen peroxide and 35 mg o-phenylene-diamine 
light chains, F(ab ')2 fragments, antisera (Tago) and murine dihydrochloride (Sigma Chemicals) in 50 ml 0.20 M phosphate-
monoclonal antibodies against human lambda and kappa light citrate buffer, pH 5.0’ was then added, 100 ^I/well, and the 
chains (Becton-Dickinson) were similarly ascertained. These plates incubated at 37。C for a further 30 minutes. Finally, the 
antibodies had been further tested not to show any cross reaction was terminated by addition of 50 /xl/well of 0.10 M citric 
reactions using fresh, human lymphoid tissue. The molar fluo- acid, p H 3.0’ and the absorbances were measured at 450 nm 
rescein/protein ratios of the rabbit anti-human lambda and wavelength using a Dynatech M R 600 Microplate Reader (Dy-
kappa light chain antisera were identical: 2.30. The molar natech Laboratories Inc., Alexandria, Virginia, USA) . Immu-
fluorescein/protein ratio of goat anti-human lambda chain anti- noglobulin concentrations were determined by reference to 
serum was 2.50, and this ratio was lower than the value of 3.08 their respective standard curves. 
for the goat anti-human kappa chain antiserum. The antibody Kappa/lambda light chain ratios of immunoglobulins in sera 
concentrations of the antibodies were determined by radial and lymphocyte culture supernates were determined also by 
immunodiffusion by the supplier. The antibody concentrations E L I S A . Working standards were prepared from a commercial 
of the rabbit anti-human antisera were identical (100 ug/ml), but human serum standard (Behringwerke AG) with known overall 
the antibody concentration of the goat anti-human kappa anti- kappa and lambda chain concentrations, using C C M as diluent, 
semm (0.7 mg/ml) was slightly higher than that of lambda Employing the same procedure as for the immunoglobulin 
antiserum (0.6 mg/ml). The kappa and lambda monoclonal assay, antibodies to a , y, and chains immobilized on micro-
antibody concentration was 125 ptg/ml and 25 Mg^ml, respec- titer plates were used to capture the respective immunoglob-
tively. ulins in these working standards, and 1:500 diluted peroxidase-
conjugated anti-kappa and anti-lambda sera (Dakopatts) were 
Lymphocyte culture and in vitro immunoglobulin production used for quantitation of light chains on the captured immuno-
Peripheral blood mononuclear cells (PBMC) were separated globulins. By calculation of absorbance ratios, the kappa and 
from heparinized whole blood by density gradient centrifuga- lambda chain concentrations of individual immunoglobulins in 
tion using Ficoll Hypaque (Nyegaard, Oslo, Norway). After the standard were determined, and the kappa/lambda ratios 
three washes in TC-199 (Gibco, Chargrin Falls, Ohio . USA) , computed. The reliability of such further calibration was conn-
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Table 1. Frequency of prcsencc of each light chain immunofluorescence and its intensity in the mesangial deposits of 15 patients with IgA 
nephropathy ‘ 
• I 
Kappa positive Lambda positive Intensity of fluorescence" lambda/kappa | 
Antisera number of patients IgA (alpha) lambda kappa ratio 
Rabbit anli-human (direct IF) 12 15 43 38 15 2.53 
Got anti-human (direct IF) 1 1 15 44 38 14 2.71 
Murine monoclonal (indirect IF) 11 15 not done 29 iO 2.90 
• The fluorescence scores were obtained by addition of the points from rena! biopsy of individual patient, on a scale of zero to four. 
』 _ 
Fig. 1. Costained IF of heavy and light chains in a patient with IgA nephropathy. (A) FITC rabbit anli-human lambda IF (3 + ), (B) 
^ Rhodamine-conjugated goat anli-human alpha IF (2+) in the same section as (a), and (C) FITC rabbit anti-human kappa IF (2十）in a serial deeper 
J section, (magnification x 430). 
3 terchecked with IgA, IgG and IgM standards (Dakopatts), the nor IgM was detected in the mesangium or the glomerular 
^ kappa/lambda ratios of which have been determined by EL ISA capillary basement membrane. The frequency with which de-
〕of individual immunoglobulins containing only one light chain posits of lambda and kappa light chain were delected in the 
1 type after the other type had been removed by anti-kappa or renal biopsies with different antisera is shown in Table 1. All 15 
3 anti-lambda antibody coated on microliter plates. renal biopsy specimens (100%) showed mesangial lambda light 
Test samples were appropriately diluted and assayed using chain IF , and 11 (73%) showed mesangial kappa light chain IF . 
‘ t h e now calibrated standard and the same E L I S A . The mesangial IF pattern of lambda and kappa light chains was 
similar to those of the alpha heavy chain when the renal -r 
5 > r讚 immunoglobulin concentration biopsies were costained with the double immunofluorescence 
This was assayed by the rate of immunonephelometry using a technique (Fig. 1). These IF findings confirmed that the light 《 
Beckman ICS-II analyzer and reagents. chain IF came directly from the mesangial IgA deposits, as ‘ 
. . there was no concomitant deposition of IgG or IgM in these I 
tatistics glomeruli. Neither IgA. IgG. IgM, or two subclasses of light ‘ 
The results are expressed as mean ± standard error of the chain was found in any of the 15 control biopsy specimensr 
mean (SEM), and Student's unpaired /-tests were used for The intensity of mesangial immunofluorescence is depicted in 
analysis of the data. Table 1. Wi ih ' the use of three different sources of kappa and 
Results lambda light chain antisera at comparable antibody concentra-
tion, the fluorescence intensity score for lambda light chain was 
Immunofluorescence studies at least one to t w o points higher than thai of kappa light chain 
All 15 kidney biopsies were positive for mesangial IgA in 13 patients, w hile the remaining two showed similar IF score, 
deposits as revealed by polyclonal antibodies, but neither IgG The IF scores for IgA, lambda and kappa light chains from 
•一_^. . , 一 • - ^ ^ 
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Fig. 2. Serum studies of individual immunoglobulins and their light Fig. 3. Supernate studies of individual immunoglobulins and their light 
chain fractions in patients with IgA nephropathy (•，N = 30) and chain fractions in patients with IgA nephropathy (Wi, N = 20) and 
healthy controls ( • , N = 30). The results are expressed as mean ± SEM. healthy controls (D , N = 14). The immunoglobulin concentration is 
* P < 0.001, � � 尸 < 0.01. expressed as ng per 0.5 x 10^ peripheral mononuclear cells. The results 
are expressed as mean ± SEM. * P < 0 . 0 1 , "尸 < 0.05. 
direct immunofluorescence using rabbit or goat antisera were The serum IgG and IgM concentrations of the IgA nephritic 
similar, but lower IF scores were generally obtained in indirect patients were comparable to those of the normal subjects. 
IF studies using monoclonal antibodies. Despite a different kappa/lambda ratio detected between the 
patients and the normal controls, the serum concentrations of 
kappa chain IgM and kappa chain IgG were nevertheless higher 
、咖m studies than those of lambda chain IgM and IgG in both patients and 
The serum concentrations of individual immunoglobulins and controls, 
their light chain fractions are present in Figure 2. Patients with , , 
IgA nephropathy had a significantly higher serum concentration Lymphocyte culture supernates studies 
of total IgA, kappa light chain IgA, and lambda light chain IgA The concentrations of individual immunoglobulins and their 
when compared with healthy controls. The IgA kappa/lambda light chain fractions are shown in Figure 3. There was no 
ratio was 0.91 ± 0.03 in IgA nephrotic patients, and this was difference observed in the numbers of B cells in the peripheral 
significantly lower than the value of 1.20 ± 0.05 measured in blood mononuclear cell cultures from normal individuals and 
normal subjects {P < 0.001). These findings indicated a predom- patients with IgA nephropathy. The individual immunoglobulin 
inance of lambda light chain containing IgA in the serum of concentrations in supernate from the unstimulated (spcnlanc-
patienls with IgA nephropathy. N o correlation was found ous) and the PWM-slimulated lymphocyte cultures were similar 
between the total serum IgA and the kappa/lambda ratio in in the patients and the norma! subjects. The concentrations of 
individual patients (r = 0.1768, not significant). IgG, and IgM in the supernate increased signifiganlly when the 
‘ • • … _ • - - • - - - - _ - . 
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peripheral blood mononuclear cells from IgA nephritic patients specificity to an unidentified antigen leading to excessive oro 
or controls w e r e cultured w.th pokeweed mitogen {P < 0.01 for duction of lambda light chain IgA 口 
ft and P < 0.05 for IgM) Similarly, in vitro production of The kappa/lambda ratio of ind iv idua l immunoglobulins have 
, n the penpheral blood mononuclear cells not been studied in detail in normal subjects or n d eL 
/IT or the controls were stimulated with mitogen, hea l thy subjects, the no睡 1 ratio of serum kapprchain o 
二ut these changes fa. ed to reach s ta t i s t ica l significance. The lambda chain immunoglobulin is approx imate ly two o on [10 
ZT fTuT V f lajj^bda light c h a i n I g A was higher than 13, 14] and this ratio is obtained from either to al s7Jm (usual； 
1 he ’pa light chain IgA in supernate obtained f rom predominantly IgG) or cord s e _ (c o m a n ng onl ^gS : 
，stful”ed lymphocyte c u l t u r e in kappa/lambda ratio of IgG is confirmed in our n o r L subject 
广lents w.th IgA nephropathy. The kappa/ lambda ratio of and patients with IgA nephropathy. H o w e v e ^ the kapp^  
T r l T I f 了 r t s was significantly lower than that of lambda ratio of serum IgA has not been 呂 二 二 p i o u s l y O二 
lymThlS二t丨n both^ ^^  and stimulated present study demonstrates that the kappa/lan/da tj^ l y m p h o c y t e cultures (尸 < 0.05). A significant difference of and IgM in normal subjects a re significantly different f rom that 
kappa^ambda ratio m supernatant I g M and IgG was not dem- o f IgG. Patients wi th IgA n e p h r ^ a t h 二 L e T h i g h S r : 二 = 
o n s t r a t e d b e t w e e n the pa t i en t s and the normal s u b j e c t s . concen t raUon of l a m b d a chain IgA ( P < 0 oo l ) c o r ^ a r e d ^l^t? 
Discussion healthy controls. Furthermore, their kappa/lambda ratio of 
^ , . serum IgA is significantly l ower (P < 0 001) Neverthelesn 
f. y de_stf ed that predominant lambda predominance of serum kappa chain I^ G a d ^ l t t ^ 
二fLt staimng occurred m glomerular immunoglobulin s t ra ted in patients with IgA neph ropa t^ as observed inZ-
^ I ^ s i t s in pnmary IgA nephropathy and these findings inferred trols. These findings indicate L t lambda chain IgA V t h e 
hiT/a: p f ^its 产d predominantly lambda predominant circulating IgA fraction in these p a t i ^ t s Th 
：二m IgA [9] Fifty-e.ght percent of our previous renal biopsies predominance of mesangial lambda I F is. therefore, mainly due 
Ig二 IgG deposits, and the to a non-selective deposition of polyclonal IgA immu e com! 
T.TTl u t mesangial hght chain IF could be difficult plexes f o r m e d by a majority of lambda c h a i n l^. 
^ he light chain IF could anse from the IgG and IgM deposits. In this study, we have further investigated the in vitro 
cLt ffZ .k /k we h^ve repeated these immunofluores- production of immunoglobulin by cultured lymphocytes to 
fnlVif'.^ . ？ different antisera in rena l tissues from determine whether an a l tered antibody response is present n r = me，织“d BA deposits alone to c l a r i fy patients with IgA nephropathy. Although o ther workers had 
化 r n , 广 t 。 f ， I ， c h a i n s of the mesangial demonstrated a significant increase in in vitro production of IgA 
h f L t r : h m b 乂 hght Cham IgA was present in all 15 by patients with I g A nephropathy [1^17], our results had 
n n l T r a严 1 丨ght,?广 1 广 was d e m o n s t r a t e d shown that the IgA production by peripheJal blood mononu-
73% of the biopsy specimens. Although our measurement of clear cells was the same as that of the controls Three o t h e r 
• was.only semiquantitative, i t was apparent that the studies had also failed to d e m o n s t r a t e an increase of in vitro 
mn.t ' ' ' ！"^；；"'；^。r Stronger than the kappa IF in production of IgA in patients with IgA nephropathy [1^20]. 
二 OfP 丨sies I f f T h anti-human antisera. Inconsistencies in the IgA immune system abnormaliiies found 
r f 二 f ， t t that s ， a r results were obtained in IgA nephropathy may have some basis in methodological 
in studies wi th goat am卜human light chain antisera in which the variations, although a similar E L I S A method has been used in 
f 二 a n d fluoresceiiVprotein ratio were higher these s tudies. H o w e v e r, variability in patients selection and 
T an r 瞧 . T h e IF patterns observed with study design may also contribute. It is important to note that in 二 qn^erH f an swere^ ilaMothoseofpolyclo the present study and the other two studies that failed to 
nal antisera despite a less sensitive detect on with monoclonal i … . , u 训 ， " u u idiiea lo 
antibodies than polyclonal antibodies [11]. The h S e T r i d e n c e demonstrate an increase o f ,n v.tro production of IgA [18，19], 
of positivity and the greater intensi ty of lambda tht chain were examined m the quiescent phase of the disease 
over kappa light chain confirm our original observation that tAS 咖 ， t h e cl.mcal status of patients reported by other studies 
glomerular IgA deposits in IgA nephropathy are composed ； U 。 了 】 . A s observed by the other two groups of 
predominantly of lambda light chain IgA. investigators [18’ 19], we have shown that the increase of in 
This observation in the nature of the light chains in IgA vitro production of IgA with mitogen stimulation was insignif-
deposks in IgA nephropathy has an interesting bearing on the 丨 c a n t as compared with that of IgG or IgM. These findings ‘ 
immunopathogenesis of primary IgA nephropathy. A s inferred suggest that the immunoregulatory function of lymphocytes • 
from the findings of glomerular and circulating IgAl and IgA2 varies with the disease activity and these variations probably ‘ subclasses [6-8], predominant kappa chain IgA deposits should contribute to the controversial findings in immune sys tem 
be expected as kappa c h a i n immunoglobulin is the p r e d o m i n a n t abnormalities in patients with IgA nephropathy. Although our 
immunoglobulin fraction in serum of normal subjects [10]. Our study of in vitro IgA production fails to demonstrate an IgA-
findings of predominant lambda light chain IgA deposits in specific B cell hyperactivity as suggested by Hale and cowork-
glomerular mesangium could indicate that the deposition of e r s [15], nevertheless, the immunoglobulin production by cul-
circulating immune complexes in IgA nephropathy is highly tured B cells from our patients during clinical quiescicnce is 
selective due to the differences in the multimeric nature, size o f quite specific as a significant quan t i t y of lambda chain IgA in 
the immune complexes and anionic charge of different sub- response to an unidentified antigen was produced. The^kap-
classes of IgA [12]. The other possible immunopathologic p a/ lambda ratios of supernatant IgA obtained from both unstim-
mcchanism is the altered ratio of light chains with a given ulated and stimulated cultures are significantly different from 
Lai e( al: Light chain in IgA nephropathy 589 
those of healthy controls. Similar changes in supernatant IgG 7 . M U R A K A M I T , FURUSE A , H A T T O R I S , K O B A Y A S H I K , M A T S U D A I : 
and I g M are not observ ed. Glomerular IgAl and IgA2 deposits in IgA nephropathies. Nephron 
In conclusion, we have shown that mesangial IgA deposits in 。35:120-123, 1983 , • , , 广 。 
… . m…，T A U . • I f T A • U I UJ 8. Lomax-Smith j . Z a b r o w n a r n y l a , H o w a r t h G, Seymour 
primary IgA nephropathy consist mainly of IgA with lambda A E . WOODROFFE A J : The immunochemical characterization of 
light chain. These patients display a unique predominance of mesangial IgA deposits. Am J Pathol 113:359-364, 1983 
circulating lambda chain IgA. The distinct reduction of kap- 9 . L A I K N , C H A N K W , M A C - M O U N E L A I F , H O C P , Y A N K W . L A M 
pa/lambda ratio of IgA in serum and supernate from lymphocyte 二 VALLANCE-OWEN J: The immunochemical characterization of 
culture strongly supports that IgA nephropathy is an immune ： ； ^ 二 二 ？ 二 5 二 ' e p o s h s in IgA nephropathy. 
disorder with a specific antibody response. lO. A N D R E W D W , CEPRA J D : Structure and function of immunoglob-
ulins, in Clinical Immunology, edited by PARKER C W , Philadelphia, 
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Light-Ghain Ratios of Immunoglobulins G, A, and M Determined by Enzyme Immunoassay 
S. H. Chui,' C. W. K. Lam," and K. N. Lai， 
We describe a门 enzyme-丨inked immunosorbent assay for 120 Titertek Microplate Washer (Flow Laboratones, Hel-
determination of light-chain ratios for IgG, IgA, and IgM in sinki, Finland) was used to wash plates, 
serum. A commercial serum with known overall k and A 
concentrations was used as standard. To capture the respec- Materials 
tive immunoglobulins, we used antibodies to y, a, and ji Working standards for immunoglobulins’ and for k and 入 
chains coated onto microtiter plates. Peroxidase-conjugated light chains, were prepared from Standard Human Serum 
anti-K' and anti-A chain antisera were reacted with light chains ^^ot No. 041022; Behringwerke AG. Marburg, F.R.G.) 
on the captured immunoglobulins, and the amount of enzyme containing IgG, IgA, and IgM wi th known concentrations 
bound was monitored with o-phenylenediamine and urea- overall k (3.24 g/L) and A (1.72 g/L) chains determined 
hydrogen peroxide as substrates. Calculation of absorbance manufacturer by radial immunodifEiision with use of 
ratios allowed determination of k and A chain concentrations Wi^U retejence ^atenals . 
of individual immunoglobulins in the standard and samples. u s j pui^fi^d immunoglobulin fractions of specific 
Within-run and between-run CVs (n = 25) ranged from 5.9% ' T Dpn^ 'v/Vn'"’ ) ，‘卩呂 D^P^^ts ‘ «^ , ..u- u M .. ,.. .... ",� 息. X ,广 a/s, Cilostrup, Denmark) to coat microtiter plates Lab 
。J3.0 ：^  0:广丨•？广：瞧丨 and ow k/A ratios for IgG. Systems OY. Helsinki, Finland) or 12 x 75 mm polvst>Tene 
IgA, and IgM. The thoroughness of light-chain detection, tubes (Elkav Products Inc., City of Commerce, CA 90040). 
expressed as, e.g., (IgAx + lgAA)/(total IgA), for 150 sera The same antisera, conjugated with horseradish peroxidase 
was 91-110%. The detection limit was 1 /^g/L. Reference (EC 1.11.1.7; Dakopatts). were used to determine I ^ , IgA, 
intervals (mean ± SD) for k/A ratios in sera from 100 and IgM, as well as x and 入 light-chain concentrations. Al l 
apparently healthy adults were 2.34 ± 0.80 for IgG, 1.59 二 antisera were checked for specificity by OuchteHony double 
0.40 for IgA, and 1.86 ± 0.76 for IgM. immunodiffusion and immunoelectrophoresis. They were 
stored at 4 ®C and diluted before use. 
Immunoglobul in light chains comprise K and A isotypes. For the ELISA, we used 50 mmo lL sodium carbonate-
Unlike the heavy chains, they have no recognized adjunc- bicarbonate, pH 9.6, as the coating buffer. The assay buffer 
tive functions besides idiotypic antibody specificity. About was phosphate-buffered saline (PBS; 10 mmolL K2HPO4, 
65% of immunoglobulins in normal serum are of the K type 150 mmol/L NaCl, pH 7.5) containing 100 niL of fetal calf 
and 35% are of the A type, a TC'X ratio of 2 ⑴.Abnormal KJX serum (Flow Laboratories, North Ryde, NSW, Australia) 
ratios have been reported in light-chain deficiency and per liter. Bovine serum albumin (BSA; Sigma Chemicals, 
acute lymphoblastic leukemia, and have been used for St. Louis, MO 63178), 100 g per l i ter of PBS, was used to 
detection of monoclonal paraproteinemia (2-4). However, block the nonspecific binding sites on the microtiter plates. 
these studies, which involved quantifying light chains by The wash solution was PBS containing Tween 20 surfac-
radioimmunoassay (5), immunodiffusion {6, 7), and immu- tant (Sigma), 5 mlVL. The peroxidase substrate solution 
nonephelometry (8, 9), measured only the total k and A contained 20 mg of urea-hydrogen peroxide (BDH Chemi-
chain concentrations of all immunoglobulins. Their results cals Ltd., Poole, Dorset, U.K.) and 70 mg of o-phenylenedi-
therefore represented essentially the light-chain ratio of amine dihydrochloride (Sigma) in 100 mL of substrate 
the most abundant serum immunoglobulin, usually IgG. buffer (per l iter, 100 mmol of citric acid and 200 mmol of 
Moreover, the lack of a suitable standard calibrated for the Na2HP04, pH 5.0). K and A concentrations of individual immunoglobulins has 
hindered the development of assays to determine individ- Assay Procedure 
ual K/A ratios of IgG, IgA, and IgM. We describe below an Microtiter plates were coated by overnight exposure to 
enzyme-linked immunosorbent assay (EUSa) for the deter- iqO ^ L per well of rabbit antisera to human IgG, IgA, and 
rmnation of the light-cham ratios of individual immuno jgM, diluted 2000-fold in coating buffer, at 4。C. Before use, 
globulins, wi th use of a commercial human-serum with ^he plates were washed 10 times with wash solution, 
known overall k and A concentrations as standard. unbound sites were blocked with the BSA solution at 37。C 
for 1 h, and the plates were washed again. Samples and 
Materials and Methods standards appropriately diluted (from 0 to 200 ^ lg L for IgG. 
Apparatus IgA, and Ig^D in assay buffer were introduced, 100 iiL per 
^ , , ^ , , , . , well, in duplicate. After incubation at 37 ’C for 3 h. the 
To read t^^eabs义rba^ 二 of develop j microtiter plates, we 如 were washed, then peroxidase-conjugated anti-K and 
used a Model 2oo0 E l A Reader (B i^Rad Laboratories, antisera, both diluted 500-fold m wash solution. 
Richmond, CA 94804) equipped with a Microplate M e a g e r 听 「 e added to appropriate wells. After further incubation 
software and linked to an IBM personal computer. A Model at 37。C for 2 h. the washing was repeated. We then added 
100 ^L of the substrate solution, let the reaction proceed for 
, 15 min at room temperature, then stopped ic bv acdiRh： 50 Depanments or Chemical Pathology and - Medicme, Pnnce of ^ of 4 mol L H.SO,. The color developed m each -.vel： wai 
a es Hosp i ta l . The Ch inese L n ivers i tv of Hong Kong , Sha t i n . 广 , 广 
Hong Kong measured at 4.�U nm. 
3 Address correspondence to this author. By calculation of absorbance '.A , ratios—e.g.. A i^,. i.Ai^ -^,^  
Received July 14. 1989; accepted December 13. 1989. 卞 A j^^^ - AIKN“口ve determined the percentage of x and A 
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chains for each immunoglobulin class. From that we calcu- Table 1. Assay 
huod the N and A chain concentrations of individual immu- I G i 众 
noglobulins in the standard. The reliability of such further — -
calibration was counter-checked with pure IgG, IgA, and Within run 
l^M standard? Dakopatts'. the k A ratio of which had been k a ratio 3.77 2,28 l 40 2 56 i 64 0 97 2 40 1.60 ‘ 00 
determined by ELISA of individual immunoglobulins contain- CV。c 9.5 5.9 7 2 '2 3 6 9 5 2 '3 0 '"& ' 0 2 
ing orilv one light-chain tvpe after the other type had been Between runs j 
removed bv imiminoadson^ tion with anti-K or anti-A anti- “ratio 2.35 1 90 l 41 2 30 i.50 ”6 2 33 i.60 V'O 
body (DakoparU) coated on polyst>Tene tubes. CV,。/c 9.4 7.5 8.4 12.8 8 5 iO.£ '3.6 '2.8 7.3 
To measure IgG. IgA. and IgM concentrations, we used r, = 25 eacn. 
t h e s a m e ELISA b u t w i t h pe rox ida se - con juga t^d an t i - IgG 
( d i l u t e 1:6000), anti-IgA (diluted 1:6000), and anti-IgM Discussion 
(d i lu ted 1:2000) instead of a n t i - K and anti-A conjugates. Q u t method should be an improvement on previous 
assays, because it measures K and A chain concentrations of 
Resu l t s ind iv idua l immunog lobu l ins ra ther than the overal l l igh t -
, p . , , , chain concentrations. As indicaUd by our study of normal 
Standard curves. F i gu re 1 i l lust rates ELISA standard subjects, the KJX ra t ios of the three major serum immuno-
curves for k and A chains of IgG, IgA, and IgM. The globul ins di f fer. Under normal circumstances, the overal l 
measurable ranges were f rom 1 to approximately 100 j x g ^ . ra t io i n sen im is dictated by tha t of IgG (2.34 ± 0.80) 
We found tha t use of bovine serum a lbumin blocking and because i ts concentrat ion far exceeds those of I gA and IgM. 
100 m l V L fetal cal f se rum i n the assay buffer were essential Our method therefore offers a more specific and sensit ive 
to suppress the nonspecific b a c k ^ o u n d b ind ing reaction. means of s tudy ing diseases tha t involve predominant syn-
Within^run and between-run reproducibilities. The coef- thesis of one type of l i gh t chains (e.g., IgA nephropathy) or 
ficiente of va r ia t ion (CVs) for 25 measurements at "h igh , " P : 。 巧 on of monoc lo jpa^Spro t ^ i i ^、入 e have used 
； n _ a l ， ” 二 。 w ， ’ - r a . o s a . e s u n ^ a ^ e d m Table 1. ： ^ ^ 
I n general，IgG k'A ra t ios had the lowest and I g M /c A rat ios ^^ hepat ic cirrhosis UO): sera containing monoclonal para-
the h ighest CV. proteins ( I I ) ; and lymphocyte cul ture supemates i n IgA 
Detection limits. These l im i t s were al l about 1 ii^'L for nephropathy, 
bo th K and A chains as we l l as for IgG, IgA, and IgM. Thus 
the assays were also suitable for quant is ing immunoglob- This work was support^ by a grant from the Croucher Founda-
ulin production in our lymphocyte^culture work, because 【ion，Hong Kong, 
immunoglobulin concentrations in culture fluids seldom References 
exceeded 100 /xg'L. 1. Andrew DW, Cepra JD. Structure and function of immunoglob-
Cumulative accuracy. We studied the cumulative accu- ulins. In： Parker CV, ed. Clinical irniiiuno)Gg}.. Philadelphia: WB 
racv of the method—(IgGK - IgGAV(tota】 IgG)，（IgAx 丄 Saunders, 1980:1-18. 、 . 」 ： 
IgAA)/(total IgA), and (IgMx _ IgMA) (tota] IgM)-for 150 2. Gunderman JR, R u y m垂 FB. Kappa-cham defi-
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total individual immunoglobulin class concentrations. ^heavy, and Hght-cham measurements compared 似 二 • ^ 二 n g 
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ages 18 to 32 years. Mean ± SD values were 2.34 二 0.80 for serum and urine determined by radioimmunoassay. Scand J Clin 
IgG, 1.59 二 0.40 for IgA, and 1.86 ± 0.76 for IgM. Lab Invest 1975:35:407-10.‘ 
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LIGHT CHAIN RATIOS OF SERUM IMMUNOGLOBULINS IN DISEASE 
卜 Shatin, Hong Kong. fj 
immunoglobul in light chains comprise k and X i ^ ^ ：^：；：^: 二 ^ h ^ ^ ? ^ 二;^：；：^ ； ^ T ^ n | 
adjunctive functions besides idiotypic spec.f.city. A b n o : 丄 e 二 二 X r a二 have b 二 p /ntrations, 
deficiency and acute lymphoblastic l e u k a e : • 二 二 v e r l^ese immunoglobulin, 
with results therefore essentially representing the 'ght chain =。【工二二M in norma! subjects (NS) and 
(AN) — 40 in each group. electroDhoresis to exclude paraproteinaemia before assay for IgG, IgA 
bent assay. Results are presented below as mean (SD). 
NS RA LE CR AN 
101 oc^A、 1ft 1 (56。•傘 191 (9.52)*傘 21,6 (736)** 13.3 (3.12) 
IgG (g/L) 13.1 (3.56) •！』•二 • . 1 71 * 5 40(2 62) - 3.26 (0.99广 
IgA (g/L 2 . 3 9 ( 1 . 0 0 ) .3 2.15 . 6 1 5.40 2 . 6 ^ ) 】 叨 ( 。 ？ 。 ） 
丨彭r ；:lis ： ： 二溫；i二丨；：⑵二 
* compared with NS, p < 0.05 (t test) 
“ c o m p a r e d with NS, p < 0.01 (t test) 
and the four groups of patients studied ( f q ^ O f ^ . ^ ^ ^ K / X 二 二 normal subjects. However, patients 
a unique a - 。 d y response in the 
immunopathogenesis of this disease. 
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Plasma fruCosa.ine measurement 卜 ： 二 二 二 工 丨 二 二 二 ： ^ 二 二 ^ ： ^ 
during p r e g _ c y ' Plasma�uctosamme 二=?ator o 二 出at plasma albumin concentration 
； t o examine the relationship of plasma 
n o ^ ^ n K T c S l L n deceases 二 
sh�uld no. be co.eCd for 
plasma albumin concentration. 
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暴 ABSTRACT | | | ‘ 
逢 A high-performance liquid affinity chromatographic method for the purifica-
79)服 舊 tion of serum immunoglobulin A (IgA) using a jacalin column is described. The ；: 
書 automated procedure takes about 2 with minimal manipulation. The yields of the | | | 1 : 
言 isolated IgA and of its IgG and IgM contamination were studied by enzyme-linked t | | g ： 
盡 immunosorbent assay (ELISA) of 30 sera. Purity was assured by immunoelectropho- p 誦 讓 ； 
I resis. The ratio of I g A , to total IgA was unchanged after purification, as verified oy j. 
240 1 ELISA. The results showed that >90% IgA could be recovered with <0.5% total i： | | 
.’ g IgG and >2.0% total I gM remaining in the fractions containing punfied IgA. . | | p 
aphy in g — •？ 1 | j i 
ies. Vol. 着 - -I； H • •r ni 4 
号 I N T R O D U C T I O N ：丨 i < 
I . i: 
I Immunoglobulin A (IgA) is the second most abundant immunoglobulin in | | i 
t human serum. Circulating IgA is usually monomeric whereas the secretory form is | | : 
t predominently dimeric or polymeric\ with the presence of a secretory component- | | ！ 
I and the J chain). Studies of IgA are usually carried out with the secretory form because | | ： 
: it can be obtained with a reasonable degree of purity. The isolation of immuno- | | 〕 
: chemically pure IgA from serum has been difficult，with relatively low yields and heavy 丢{ 
contamination with I gG^ Moreover, the purification procedure requires several steps， ；! 
such as ammonium sulphate precipitation, ion-exchange chromatography and gel 
nitration5.6. Mestecky et alP reported an immunoprecipitation method for serum IgA ) 
0021-9673/90/S03.50 © 1990 Elsevier Science Publishers B.V. :: 
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h m jack如it seeds^ . r. £: 
and Campos-Ne t o⑴.They alsH ed mmnhT h reported by Roque-Barreria 爬 
graphic purification of 二 」 ， 。 【 h e affinity chromato- , 
t e c h n i ^ e over the metho^dl I m i o n e T a b r " ^ colostrum，a much improved g 
a high-S^ir^H；^!^^!^ s : IgA using a jaca 丨 in column on 
p p h i c， F P L C ) system 二 t ^ ^ ^ ^ ' ^ F a s t Protein liquid chromato- = 
being deten^ined by e n z — i 二 = = = : 【 : 二 二 ; i ^ g IgG and IgM) | I ^H 
e x p e r i m e n t a l ： Stan 
； w e n 
Chemicals and reagents ； 
Immobi l ized jacalin attached to cross-linked . . , - 1.60< 
was obtamed from Pierce (Rockford, I L U " a ) beaded agarose (No. 20395) appr 
ihe binding buffer was 0 02 M NaR Pn 。 - A fn 
containing 0.15 .V/ sodium chlonde (^a) a^ d 0 •，U.S.A.) f 
^ '^Uh the pH adjusted to 7.4 usin. 0 M sod^m hvH “ 。 丨 a z i d e (Sigma), 盧 oo 
elution buffer was 0 i M m e l i b i 。 p o d i u m hydroxide solution (Sigma) The : ， 
were filtered with 二 丄 。 ^ ⑴ 山 〒 buffer. Before use, t ie b u f S 经 ^ ^ 
？ U-S.A.) and degassed wi^ ^ ^^^^�^�厂（細！广^，Bedford，mI f S r 
Hohentwiel, F.R.G.). iranssomc T460 ultrasonic bath (Elma, Singen/ ^ = 
Equipment | calibr 
(Uppsala, was manufactured by Phannacia i 加勤 
7 ， m n g two P-500 r e c i p ^ S j J ^ s 二 ： ： 二 y ^ 〒 • programmer 1 electn 
a v-7 injection valve for introdnrfinn ^ r t , ^ ^ ^ ^ ™ buffers passed through 
jacalin column. A n H 二 (；? = 。 = 二 ne sample via a 10-ml superloop onto the ' T Z 
m^obiiizedj^ alin s u s p e / d ^ r ^ ufftr wasred^^iref _ �.^ ^ 
l � - m 猫 二 i 二 : 
Fractions ( 一 w e r 二 ： J ^ T ^ ^ O ^ ^ 二 = 瞭 ' f S 
Sample preparation 
tt'cf mg of IgA) was diluted 1:1 with binding : S T : 
binding o f about 3 ^ g o f I n / 八 ^ ： " 』 . ， " , 。 ? ; ^ 。 ] jacalin has a maximum “】出 cc 
recovery, it is recommended t h = s a l f e ize shn 。 。 【 贿 爪 purification and [ L I S A 
IgA load on the c o ‘ . less S ^ ^ r S ： ： ： ； ^ ^ ^ ^ ^ 
^ puriHcii 
excep t I 
ami bod 
P L W ^ • 、 、 ’ 、 . • 》 , _ . •、考、 . • 
t 、 \ . … - V . , J， 
. 、 、 ， 1 J 、 、 】 r , 、 . ..-、， 
RL V 々、〜.二‘ •、 •、、-’，〜‘- . , . .， «、---、、…crr.rt- r 、• •..•• 
、 « - » . . 、 . • - 、 . I 、 、 - • 'V •• * 、_• - 、 • 
丨 敌 - . . 
？ I I 
, ； i 
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* 
ELISA of purified IgA j� 
Fractions of the eluted protein peak were pooled and the concentrations of the i i ’ 
：― isolated I2A and the starting serum were determined by EL ISA as described I!' ！ ！ 
.- 。 ^ I) •； 
(previouslyti. The amount of IgA loaded onto the column and the amount recovered ； ； 
were calculated. ’ 
.、 r ‘ 
A brief description of the ELISA method is as follows. Purified immunoglobul in 
fractions of rabbit antisera to human IgA, IgG and I g M (Dako Immunoglobulins, _ : 
Copenhagen, Denmark) were used at l :2000 dilut ion. Microt i t re plates were coated by _ 
adding 1 0 0 "1 per well of the appropriate antiserum diluted in 0.015 M sodium 云；运尾 
… carbonate-hydrogencarbonate buffer (coating buffer) (pH 9.6). The plates were | | | 
incubated overnight at 4:C and washed ten times wi th phosphate-buffered saline | | | 1 • 
之. （ p H 7.4) containing 0.05% (v/v) of Tween 20 (Sigma) (PBS-Tween). Samples and | | | ； 
三 standards appropriately diluted in PBS containing 10% (v/v) fetal bovine serum (FBS) ； 
r were introduced at 100 per well in duplicate. After incubation at 37°C for 3 h, the ‘ 
：， plates were again washed ten times with PBS-Tween. The same antisera as used for i i ^ :. 
、— coating, but conjugated wi th horseradish peroxidose (Dako) and diluted 1:6000 ( IgA), f i ； 1 ； 
1:6000 ( IgG) and 1:2000 ( IgM) in PBS-Tween, were then added at 100 /i l per well, as ！：贊； 
：；: appropriate. Incubation at 37。C was continued for 2 h and the washing repeated. 纖 . 
5 A freshly prepared substrate solution containing 20 mg of urea hydrogen peroxide 靜 觀 ； 
(BDH, Poole, U .K . ) and 70 mg of o-phenylenediamine dihydrochloride (Sigma) in | | | \ 
s 100 ml of 0.20 Af phosphate-citrate buffer (pH 5.0) was added at 100 per well and the | l l 
_ plates left at room temperature for 15 min. Finally, the reaction was terminated by 
# adding 50 per well o f 4 M sulphuric acid and the absorbances were measured at | | | — … 
450 nm using a Model 2550 E IA reader (Bio-Rad Labs., Richmond, CA, U.S.A.). | | | 
Immunoglobul in concentrations were determined by reference to the respective 權 ； 
calibration graphs. ； r 
Immunoelectrophoresis of purified IgA [ 
一 The purity of the jacalin-isolated IgA was investigated by a standard immuno- ； ^ 
electrophoresis technique 12，using Ti tan FV lEP plates (Helena Labs., Beaumont, T X , ;;:f 辑墨 _ L ,, 
U.S.A.), rabbit anti-human serum (Dakopatts) and rabbit ant i- IgA (Dakopatts) j： ； 
antisera. Three serum samples [one from NS and two f rom I g A N patients (where NS is [• | | | i 
一 a Normal Subject and I g A N patients are patients with IgA nephropathy)] together 1 •墨 g ； 
with the corresponding purif ied IgA solution (concentrated) were examined. Volumes ;；； | | | 
云 o f 5 ul of each sample and the albuipin marker (Helena Labs.) were applied to • | | - - : 
appropriate wells in the agarose gel plate. The electrophoresis was carried out with 羞霞【 、 
barbitone buffer (pH 8.2) at 150 V for ca. 90 min. After electrophoresis, 90 "1 of the 請 | 
appropriate antisera were added to the appropriate trough. The plate was allowed to | | | 
stand overnight at room temperature in the moist chamber. Precipitin arcs were I 
observed. Excessive antisera in the gel were removed by washing the plate with PBS 
with constant shaking for 48 h. The plate was then stained wi th Coomassie blue. 
：丨 I.] 
EUSA of IgA ^ ' I [ 
i The I g A l concentrations in eight serum samples before and after jacalin 1 ： 
j purif ication were determined. The same ELISA protocol as described above was used 1 ； 
except that microtitre plates were coated with mouse anti-human I gA i monoclonal 1 | 
antibody (Becton-Dickinson Immunocytochemistry Systems, Mountain View, CA, | 
J I 1 I 
vJEfc. 
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RESULTS A N D DISCUSSION 1 FR 
... 萄 — 
i 30 二 s e r u . IgA. A total of | “ 
, obtained for all 
samples. … … L c m ana similar chromatograms were f igA 
； ( f ^ a n i l l ! ！"h=rr，r"f hy consisted of three stages lasting 2 h. During the first hour 義 ！ 
-i B S ^ 二 二 ； ? = = = = = = = i — 
• : i P peak should contain most serum proteins J bound | 
r o S for ELISA 二 T A ^ r f monitored at 280 nm. Fractions 13-17 were 菜 bet 
— &二 =二Se二〜:TcSJfiS K � = n t n u i 狐 她 r e.u.on, the | prc 
.-x ..1 _ - J t f f c i 
•二 
•，《 ； 
「-- 霍 • 
一一’ I t^v^  ^^H 
丨 丨 r^St -r r - • I 
• 、 - , . - • 一 . I '•Tas' 
'X. • 
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i • ^ 4 • 
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Fig. I. FPLC Punncation of human IgA from serum. The dashed line represents the gradient shape. ：^：：； 
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TABLE 1 
R E C O V E R Y OF IgA F R O M S E R U M SAMPLES A N D AMOUNTS OF IgG A N D IgM IN P U R I F I E D 
F R A C T I O N S ‘ 
Ininiuiu^^lohulin Anuiuni injccldl Anionn! iwmcrcil Recovery 丨''•丨 > 
ni”�' ； • n = jn : •川乂 >1 =-川: ’mean j： S. D.) 
leA 0.^ -^5.93 0.90-5.16 93.49 二 3.^)1 lie 卜：tvJU 0.0i-0.i)‘< 0.：： ± 0.09 
IgM 0,71-3 .34 0.01-0.05 ± O.SO 
Table I shows the recovery of IgA from 30 serum samples ranging from I to 3 ml. 
Al l samples showed a yield of IgA of “/ . 90。o or above. These results demonstrate that 
the F P L C procedure offers an efTective purification of IgA. 
Fig. 2 shows :he results of immunoelectrophoresis of three sera with corre-
sponding purified IgA solutions. Mult iple precipitin arcs were observed in areas 
between" serum samples and antiserum raised against human serum. The only 
prominent precipitin arc was observed in areas between the purified IgA and antiserum 
I 
• 
n丄：.Ininn:nodcciroph..rc.!> of punt lcd I . A An i i . cn uc!U ：. 5 and 了 coniai iuxl unpunl ied samples ucll�； 4 and (�conunnod convsp. pm.ilkd A： ucll�1 and s conla.ncd albu�m nwker. Antiserum inui.h^  V C .�and (. OM^ia.ncJ a.lucrum to human I.A Tr.uidis B.【）and I.�m�muxl 
anlisci'uni ……irpk.丨八、luini.m�c!.丨.丨m pi-> 'ion> 
• - -• * 二-二_ .广.. .•m ： •.•-:-;、 
…，'T. ‘ '-J. icr-r-Xi w 
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, S. H. CHUI er at. 剛 table II …L, 
t o t a l I . A IN EIGHT S 刚 M SAMPLES BEFORE A N D AFTER 而 e 
^ ^ ^ ；inke 
Purificaticm (�/�) purification (%) tO 
"j takej 
-7 89.6 84.0 can t 
3 63.9 67.2 
^ 80.4 ACK: 
‘ 97.2 93.6 
7 90.1 93.6 
8 68.4 Func 71-4 70.8 
80.3 ± ,1.3 79.6 土 iO.5 REFE 
； ： ： ^ 二 ： ； ^ ^ ^ 二 t ^ r single arc fenced .o. l i；'： 
c o n s i s g predominant!； that the purified IgA solutions ^ ^ 丨 
also 二 r e s p e c t to other immunoglobulin classes was — ^ f :’ 
the eluted peak f r a c t = = T h e res j t s t V ^ e ；^，。“^ ⑴ both the starting serum and g、 
0.03 o f I g M were b o u S n ^ ^ j ^ r ^ ^ s h o : that only ca. 0.04 o f I g G and 9 S. 
1.88% IgM in the rePrese?tmg an average of 0.22% IgG and 10 M. 
very Httl^contam IgA • highly purified with ‘ ‘ 》 
the study or the p h y s i c o - c h i S ^ S ^ ^ ^ 12 
Table]?：^：：^^：^^^^ 斤 ， 二 S o l o g y was studied. 丨3 t t 
and after jacalin 二 = 二 : ^ 二 ‘ ⑴ the total IgA of eight serum samples before ^^  H. i 
b，e 二 art. ？S：；；：：：； I'e 二 二 。 Je.^.ple gro， 丨 t 
= 二 r the r - ongAi to _ f.A 二 = 二二.：；^^^； . ^^^  
18 N. 5 
CONCLUSION I 20 K. t 
T andBcd l and selective stimulator of distinctive human ‘ 
of h _ n seru二 
specificity of jacalin towards IgA due to L p/esence o f n T ’ apparent 
sugar only in IgA has been elucidatedlo i^hf^P s二ce of d lactose terminal 
apparently binds only three semm n r L - . c f 。demonstrated that jacalin 
not yet having been L ^ e d = : • = ， T 。 ( 【 h e m being IgA and the other two 
results showed that the ^ l r c o l " : 二 , t non-immunoglobulin proteins-. Our 
recovery of I^A 二 t 二 仏 v h ” s， t e d protein fraction was IgA. The 
- p o r t e d t h a t , a c 二 h a s been 
IgAl ELISA results that the ratio of t . r . , r \ demonstrated by our 
purification. g^i【。total IgA remained unchanged after 
丨:丨1 I 
I CT al. H P L A C OF IgA 225 “ 丨 ’ 
署 Previously, jacalin affinity chromatographic procedures for isolating serum IgA 1,1 , 
FTER , 纏 were not automated. The availability of an immobilized jacalin attached to cross- i | 
遷 l inked beaded agarose prompted us to pack our own affinity chromatographic column j ： 
——纏 to be used in the fully automated FPLC system. The whole punfication procedure 丨 ^ 
m takes only 2 h. Hence prolonged manual operation and the necessity for a cold room . 
- 覆 can be avoided. : 
纖 湖： 
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. 一 - . - — - . _ —> ‘ • _  - — ― ― J I ••“ — - ••i^ - 、- • 1 
.hntis .a. induccd in rabbits by anti-GBM antibody administration. anli-FxlA globulin (SAFG) (Clin [xp !嶋二1 品:629^:6), 
Knimals were studied at ihc time of maximal glomerular macrophage charactcnscd bygranular glomerular cap,llary wall 二 
Accumulation (Dav 6). Intraglomerular monocytes (glom _ ) were fluorcscencc small subcpuhchal dcpos. s peak bmdmg of 
btaincd from the cdlular outgrowth of macrophage infiltrated globulin at 24 hrs, and protcmuna ： ： ： 二 玨 : h r 。 N 二 R 
tr ibuting to macrophage mediated glomerular injury. • rat. j 
TaWe 1 Proteinuria 
Experimental „ m(/ml mi/24 hrs 丨 
PROCOAGULANT ACTIVITY OF ISOLATED 9 Group 丨 18SD40 丨 
GLOMERULAR MACROPHAGES IN NSC 0 0.15 SD 0.02 l l i l ^ ^ l 
EXPERIMENTAL GLOMERULONEPHRITIS S^A^G^^^ (1(『）022 SD 0-03 17.8 SD 1.4 
P.G. Tipping*, S.R. Holdsworth C V F / S A F G (12) 0.32 SD 0.07 23.7 SD 2.6 
Monash University Department of Medicine. Prince Henry 's H ospital. ！ 
Melbourne Table 2 SAFG dose respons* at 24 hrs 
Glomerular procoagulant activity (PCA) is augmented in macropha^ ^ 、 ！ 二 二 ： 、 | dependent models of glomerulonephritis (GN), but not m models (mt/ks) Binding (mj/a , | 
where glomerular injury is macrophage independent. Previous studies (ui/8) | 
have suggested a role for augmented PC A in the init iat ion of 1.6 0.27 SD 0.03 厂 | 
glomerular fibrin deposition. The cellular source of this augmented 10 3.6 SD 0.21 17.8 SD \ A 
PCA is unknown, although glomerular macrophages arc likely 30 11.35 SD 1.2 45 SD 10 • 
candidates. 
In order to study the expression of PCA by inf i l t rat ing glomerular 
macrophages, a technique (involving graded sieving and short-term 
glomerular culturc) was developed which allowed isolation of 4.8 x lO* P R E D O M I N A N C E O F L A M B D A L I G H T C H A I N 11 
macrophages, within 90 minutes of sacrifice, f rom rabbits developing I A P R O D U C T I O N I N I g A N E P H R O P A T H Y 
anii-glomerular basement membrane antibody induced GN. These 
macrophages were characterized by morphological and functional K.N. La i . , F .M . Lai, S.H. Chui, C W . Lam criteria.TheyexpressedmarkedlyaugmemedPCA(2.8±0.7mU/10^  ！ 
cells) compared to peripheral blood monocytes (0.05 mU/ICP cclls) Deparimems of Medicine and Chemical Pathology. Chinese • 
and alveolar macrophages (0.09 ± 0 . 0 2 m u / 1 0 3 cells) iso la ted f r o n n h e University of Hong Kong. Hong Kong \ 
same rabbits under similar condi t ions. The PCA of isolated ^ ^ . , . n^^onaial IsrA 丨 
glomerular macrophages had the same functional characteristics as The immunochemical nature of the l.ght chains of t hem^anga l gA j 
fhc PCA of sonicatcd'whole glomeruli, and was consistent with the deposits were studied in 13 !於二 '二二n:? 二 e ( H u ing ； 
characteristics of Tissue Factor. isotypc in their renal biopsies. Direct immunonuorescencc ( i r j us ng i 
二 二 s s low that glomerular macrophages express aug- rabbi tand goat anti-human mono,pec.fic 广 “ 二 n r d 
mcnicd PCA, indicating they are functionally activated. Glomerular lambda (X) light cham IF in all \ b i o p s i « ( l。『c )丄,P二K )丄g二 
Lc roDhaec PCA may contribute significantly to the augmented chain IF was detected in 10 renal biopsies by the rabbit anti-human gT二=fpg�:r fibrin related model ofGN, and may be the anti-sera and in 8 renal biopsies by 化 二 二 ^ ： ， 这 。 二 二 
fngser for macrophage initiated glomerular HbHn deposition. • ^ ^ ^ , 
of lambda light chain IF staining in the mesangial deposits. Double 
immunofluorescence technique with ant i-human alpha heavy chain ‘ 
TUBULAR.ANTIGEN ASSOCIATED RENAL ⑴ 二 二 二 = ； ； = ? ； ； 二 二 S : ^ ； ? ^ 二 ? 
D I S E A S E I N N E W Z E A L A N D W H I T E R A B B I T S ？ r u r ^ r r ^ i ^ o g l o b u l i n (mean ± SD) in 30 patients and 32 controls 
(0NF%LR(i;;;VL||T|lNGjAuT#NLgm，sDi;^ 0^NRS_ — - - b/an ELISA method: 
CHARACTERISATION OF THE GLOMERULAR „ I^A igC igM 
CAPILLARY WALL ANTIGEN Controls 32 l.2±0.24 2.2±0.22 1.2±0.45 r^A ncDhroDalhy 30 0.9±0.17 I.9±0.50 1.5±0.41 
T J . NcalcV N. Boycc, N. Fernando, J . C Mui r , M J . Nicol, Pvahic <0.001 <0.01 <0.01 
S .R . Holdsworth 
The K /X ratio of leA from in vitro lymphocyte culture was reversed in 
Depanment of Medicine. Wellington School of Medicine. Wellington '"^‘；；^ ( < 0 01) but not in controls. Our results indicate that 
Nev, Zealand, and Department of Medicine. Prince Henrys Hospital. 【ithough IgA antibody production in IgA nephropathy is polyclonal. 
Melbourne a unique antigenic stimulus leading to cxccssivc production of lambda 
Wc have produced glomerulonephritis (GN) in N Z W R with sheep light chain containing IgA is demonstrated. • 
12 
•… , 一 
一 一 •辛 _ . … . ^ ^ — - . - - • — — - • 一 . . _ _ __ _  . . 
. . . , . .— 、 . • • - 、 
‘ - . ‘ • 
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；• • • ‘ . . . . . . . • , . 
；0 signiHcant increase in IgA rheumatoid factor was demonstrable in Tissue Factor,, and implicates cxtrinbic pathway activation in 
nv group. Twelve patients wi th IgA nephropathy and 12 with HSP intraglomcailar deposition of fibrin. Activated monocytes, known to 
cphritis were followed over the coursc of a mucosal infection. No be a potent source of PCA and seen in large numbers within glomeruli 
veraII association between IgA rheumatoid factor activity and f rom these patients, arc a likely source of this augmented glomerular 
iscasc cxaccrbation was demonstrable although some individual PCA. 
丨aticnts showed a rise in IgA rheumatoid factor. Our data do not References 1. J Clin Invest 76:1367, 1985 
uppor i an important role for IgA rheumatoid factor in the 2. A m J Pathol 124:10. 1986 
»athogcncsis of IgA nephropathy or HSP nephritis. • • 
CELLULAR 丨 M M U N O R E G U L A T I O N DURING 28 QUANTITATION OF GLOMERULAR ANTIBODY 30 
5 工 E X A C E R B A T I O N DEPOSITION IN HUMAN ANTI-GBM DISEASE 
N IgA NEPHROPATHY … ， . , ^ „ „ … ^ N .W. Boyce', R . C Atkins ' . S.R. Holdsworth^* 
C.N. Lai* , F.M. U i , S.H. Chui, Y .M . Chan, C W . U m ^ . , _ . „ . , 
Departments of Nephrology' and Medicine^, Prmce Henry s Hospital, 
Departments of Medicine. Morbid Anatomy and Chemical Melbourne 
Pathology. Chinese University of Hong Kong. Hong Kong • . j , j ‘” . ^f tv,-
A quantitative technique was developed to allow estimation of the 
This work was undertaken to examine the immunorcgulation of T amount of antibody bound to antigenic targets within nephritic 
iymphocvtcs in patients with IgA nephropathy. Fifty patients and human glomeruli. Methodologies applied by Groggd et alia in 
thirty-seven control subjects were studied in an infection-free interval. experimental glomerulonephritis were modified to examine human 
T lymphocytc subpopulations were determined using O K T mono- renal t issue. A pat ient w i th rapid ly progressive, crescentic 
clonal antibodies against helper ( 0 K T 4 ) and suppressor (0K.T8) T glomerulonephri t is due to anti-glomerular-bascmcnt-membrane 
cell subsets. The proportions of T lymphocyte subpopulations did not (ant i -GBM) antibody deposition was studied. Isolated ncphntic 
differ between patients and controls. Patients with significant renal glomeruli were exposed in vitro to radiolabellcd anti-human-IgG 
impairment demonstrated a reduced O K T 4 / T 8 ratio (p < 0.001) due antibody under incubation conditions designed to achieve binding 
to an absolute reduction of T helper cells (p < 0.02) and an increase of equi l ibr ium and antigen saturation. Paircd-labcl radioligand binding 
T suppressor cells (p < O.OOl). Longitudinal studies performed in 13 techniques allowed quantitation of the anti-human-IgG antibody 
patients revealed consistent findings during clinical quiescence. bound to isolated nephritic glomeruli. These values were converted to 
However, synpharyngitic macroscopic haematuria was associated units of human immunoglobul in bound to nephritic glomeruli by 
with a rise in T4 positive cells and a simultaneous reduction of T8 construction of a series of standard curves using isolated normal 
positive cells; these changes reverted to prc-infection values when the human glomeruli containing known quantities of specifically bound 
infect ion subsided. Funct ional studies assessing 丁 lymphocyte human ant i -GBM antibody. There was 12.4 土 0.7 Mg anti-GBM 
activities including in vitro immunoglobul in synthesis by cultured antibody globul in per 10^  nephritic glomeruli. By comparison to 
peripheral blood mononuclear cells，thymidine uptake by cultured experimental ant i -GBM glomerulonephritis, this is a relatively large 
lymphocytes and T lymphocytes activation with expression of quantity of glomerular bound antibody. It is likely that such levels of 
interleukin-2 receptors were measured in unstimulated and mitogen antibody binding are capable of producing direct glomerular injury in 
stimulated cultures. No significant difference between patients with addit ion to recruiting and activating other inflammatory mediator 
IgA nephropathy in clinical quiescence and the control subjects was systems in human glomerulonephritis. Similar techniques may be 
demonstrated. Our results failed to support a shift in the immuno- utilized to quaniitate glomerular antibody deposition in other forms 
regulatory T lymphocyte subpopulations during clinical quicscencc of immune renal injury. • 
but a more profound defect in immunorcgulation may probably occur 
during clinical exacerbation, • 
QUANTITATION OF INTRAGLOMERULAR 31 
MONONUCLEAR PHAGOCYTES IN EXPERIMENTAL 
GLOMERULAR PROCOAGULANT ACTIVITY 29 GLOMERULONEPHRITIS THE RAT USING 
IS AUGMENTED IN HUMAN PROLIFERATIVE SPECIFIC MONOCLONAL ANTHBODIES 
GLOMERULONEPHRITIS 。r> i … … A t i ^ 
N.W. Boyce', S.R. Holdsworth^, R .C Atkins'* 
P.G. T ipp ing^ , J.P. D o w l i n g 丨，S.R. H o l d s w o r t h Departments of Nephrohgy' and Medicine^, Prince Henry's HospUal, 
Department of Medicine. Monash University, and Department of Melbourne 
Tissue Pathology', Prince Henry's Hospital, Melbourne • 
^ J r Intraglomerular mononuclear phagocytes were quantitated in normal 
Recent studies (1,2) have implicated augmented glomerular pro- Sprague Dawlcy rats and in animals with d i f f u ^ proliferative 
coagulant activity (PCA) in the init iation of f ibrin deposition in glomeniloncphritis, using recently descnbcd specific monoclonal 
experimental glomerulonephritis (GN). The mechanisms for initiation antibodies ( E D I , ED2, ED3: Dijkstra C D ct al. Immunology 
of f ibrin deposition and the role of glomerular PCA in human GN is 54:589-599, 1985) and immunoperoxidase techniques. Resul^ obtained 
unknown with the immunoperoxidase technique were compared with estimates 
Renal tissue was obtained f rom two patients with rapidly progrcs- of glomerular mononuclear cellularity based upon histochemistry and 
sive, crcsccntic GN, who died before receiving substantial immuno- glomerular cell culture. Normal animals (n=12) had no signi l i^nt 
suppressive treatment. Histological examination showed extensive glomerular mononuclear phagoc>ie population by immunopero.xidasc 
glomcnilar monocyte infiltration and f ibrin deposition in both patients; (0.01 macrophages per glomenjlar cross-section [MO/gcs]), histo-
however Factor VI I I related ant igcnjan index of intrinsic coagulation chemistry (+0.2 土 0.1 staining intensity) or glomenilar ccl cu p re 
pathway activation) was not present. Sonicated suspensions of isolated (0.10 ± 0.02 MO/glomerulus [MO/g lom])^ Evolution of diffuse 
glomeruli from these two patients showed markedly augmented levels proliferative glomerulonephntis was associated wuh a progressive nsc 
of PCA (220 and 10 mU/10^ glomeruli) compared to normal levels in glomerular mononuclear phagoc>'tc in^ tration using all three 
f0.2±0.03 mU/ICP glomeruli). This PCA was functionally dependent techniques. Immunoperoxjdase staining (E l^ l^a 二 h e tjme of ijia二 m 二 
on the prcscncc of coagulation Factors V I I and V’ independent of macrophage inf.ltrat.on of glomeruli revealed ^ 2 1 土 M O / g « 
Factors VI I I and X I I . inhibitablc by Concanavalin A and Phos- ( n : l 2 ) using the E D I macrophage marker This corrcla ” unth 
pholipas. C, and ccll membrane bound. h istochcml^I (；3 8 ±0.2 stammg mtcnsUy) and glomerular ccH cu tu c 
P T h L characteristics suggest this augmented glomerular PCA is (17.6 土 4.：5 MO/g lom) estimates of the glomerular mononuclear 
17 
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LIGHT CHAIN COMPOSITON OF IgA IN IgA NEPHROPATHY 
•j (GN). K, N,. ‘ Lai , F.M. Lai, S.H.Chui. Dept of Medicine 
The Chinese University of Hong Kong, Hong Kong. 
The immunochemical nature of the light chains | 
d of the mesangial IgA deposits were studied in 13 
；- IgA nephritic patients with only IgA isotype in 
」 their renal biopsies. Direct immunofluorescence 
(IF) using rabbit and goat anti-human monospecific 
::: antibodies demonstrated lambda (>0 light chain IF 
、丨： in all 13 biopsies (100%). Kappa (K) light chain 
IF was detected in 10 renal biopies by the rabbit 
！ anti-human anti-sera and in 8 renal biopsies by 
•i the goat anti-human. anti-sera. Monoclonal 
antibodies studies showed lambda IF in all 13 
• i biopsies and kappa IF in 8 biopsies. Twelve 
biopsies showed a predominance of lambda light 
chain IF staining in the mesangial deposits. 
！ Double immunofluorescence technique with rhodamine-
conjugated anti-human alpha heavy chain anti-serum 
and fluorescein conjugated anti-human light chain 
：! anti-sera confirmed that the light chains IF 
arised directly from the IgA deposits. The K/X 
ratios of serum immunoglobulin (mean + SD) in 30 
patients and 32 controls were studied by ELISA. 
yi n IgA IgG IgM 
'：丨 Controls 32 1.2+0.24 2.2+0.22 1.2+0.45 
V； IgA GN 30 0.9+0.17 1.9+0.50 1.5+0.41 
p value 0 . 0 0 1 < 0 . 0 1 c 0 . 0 1 
The ratio of IgA from in vitro lymphocyte 
:: culture was reversed in patients (P -=^0.01) but not 
.-；. in controls. Our results indicate that although 
: IgA antibody production in IgA nephropathy is 
polyclonal, an unique excessive production of 
i lambda light chain containing IgA occurs. 
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388 X t h I N T E R N A T I O N A L CONGRESS OF N E P H R O L O G Y 
nephritis (GN). F.M. Lai.* K.N, Lai. J.S. Tarn.* ^ F M jlT ' 3 H " r v / ? ? , I (。,"）. Chinese University'^ fli^ g Kong. HONG KONG. Univer^ lVv h ^ • ' . 
Replication of hepatitis B virus was examined The ^ n o c h '^ ^ong Kong, 
in five patients with different for.a of primary = 二 ' 广 ” of the light chalna 
glomerulonephritis associated v U h hepatitis B La nephr tic oatlfnt/'T/h'" 
surface antigene.la using the HBV-DNA hybridi.at- their . ^ ^ ^^ 
ion probe [Enzo. EBP-854. U.S.A.]. Frozen renal � � 二 广 a n d 二 l-unonuoreaceoce 
sections from these patient, were U8ed and also B D e c l H ^ / ^ anti-h咖扣 n.ono-
ex.mined for hepatitis B surface antigen (HBsA.l X ^ / . t / tI ? demonstrated lambda (；.) and hepatitis core antigen (HBcAg)\y ^  no- uf li.ht chal^ " iV ^^ ^^  
fluorescence* Liver section fro. three'patients M o p i e a ' by the r a b b i r i n . i ' h " ' ' ' i � r e n a l 
— � S i c re.Us are�epicted as f � 丄 . 二 I 二 f u 二 t 二 : 工 二 
GN# Glon^erular Glomerular Glomerular Serum o'fTlld： ” � 厂 ^ ^ Predominance 
HBBAg HBcAg HBV-DNA . HBeAg L l " p o a l ' D^ub • in the .esang-IgA + + + * 1 “ depoaits. Double Icmunofluoreacence technl-MGN + + + . with rhodamlne-conjugatcd anti-human alph* IgA + + . jj: heavy chain «nti-geruin and fluorescein conjug-
Mgn + • ated anti-human light chain anti-sera conflnaed 
MCGN + + . that the light chains IF arleed directly froa 
the I&A depoalta. The K/X ratio* of serua 
‘職 了 e二 n CH. IgA-IgA nephropach,. HCCK- ^ 二 ? 二 ： 〜 ± SD) in 3� p a t i e n t , and 32 
mesangiocapilUry GN. NA-not available. n * 
Our findings Indicate that hepatitis B viral Controls 32 1 . 2 ^ . 2 4 2 . 2 ^ 22 1 45 
replication occura in kidneys of these patients. IgA GN 30 0 M 11 In 化 〒 
not in c o n t r o U . Our results Indicate that 
although IgA antibody production in IgA nephro-
pathy polyclonal, «n unique excessive product* 
ion of lambda light chain containing IgA occurs. 
眷 二 二 : y r 二 ：：： ； ^ ” 。 , ^ ^ i� L r 二 T 二 〜 ： ” 
U n l v e . s i c r ^ g K o n g . 讓 画 . ^ ^ � � ? . 二 • : � : ； “ 
This work vas undertaken to examine the t k < � . ； . , , ® “fo产f 产 ， 广 • ! A ,, , This work vas undertaken to examine the 
， f f e c t of cyclosporin A on the cellular i _ n o r e g u l a c i o a of T lymphocytes in patients 
W a o r e g u l a t i o n in patients with IgA ^ith IgA nephropathy. T l^^phocyte s u b - ‘ 
？ ” 一 pathy. 19 patiente vere randomly divided populat ions'vere deter.ineTusing OKT monoclonal 
n i l I ' l Z l V i . \ receiving anabodles in 50 patients and 37 'control L b ec 
二 ： 丄 ？ 二 二 / 产 Z f ? 。： 1 1 兆 r e studied in an infection-free Interval. The mWK./Z/i A Jti rec^iv Dg placebo (0.05 proportionB �f T lyinphocyte subpopulations did 
ml/Kg/day and acting as controls T lymphocyte not differ between patients and controls. 
Bubpopula lone were detennined using OKT Patients with .Ignlflcant renal impainnen 
monoclonal antibodiea and functional studies demonstrated a reduced o m / T 8 ratio ( P ^ O . O O U 
Z l ^ J T l Vitro W n o g l o b u l i n due to an absolute reduction of T helper el 
二 ？ W 二 cultured peripheral mononuclear (P«==0.02) and an increase of T .uppressor cell. 
i T ， ， � u p t ” e by cultured lymphocytes ( P < r 0 . 0 0 1 ) . Longitudinal studies perfonned in 
？ 二 T lymphocytes activation vlth expression of 13 patients revealed consistent finSlngs during 
interleukln-2 receptors A fall in the nuxnber clinical quiescence. However. eynpharyngi t Ic 
of activated T lymphocytes with expression of macroscopic haematuria vas aasoclated with a rise 
interleukin-2 receptors (P-c0.05), a decrease of m T4 positive cells and . simultaneous reduction 
^p v^it二、ISA production by cultured lymphocytes of T8 positive cells, these changes reverted to 
二 ^ a n d a reduction of thymidine uptake by pre-infection values when the infection 
Staphylococcus aureus CowaD-s C insula ted cultured subsided. Functional studies including in vitro 
ly^phocytee ( P < 0 . 0 5 ) were observed in patients ioununoglobu 1 In synthesis by cultured peripheral 
after 12 weeks of cyclosporin A therapy. The blood mononuclear cells, thymidine uptake by 
� f 0KT4 and 0KT8 lymphocytes .nd cultured lymphocytes a n d ' T lymphocytes 
ratios vere not altered with therapy. A activiCatlon vith expression of intLleukic-2 
simultaneous reduction of proteinuria and a receptors vere measured in unstimuleted and 
t^anaiest iinpalnnent of renal functions vere mitogen stimulated cultures. No 丨 ignificant 
observed Similar changes In cellular — u n i t y 1 difference between patients with IgA nephropathy 
and clinical findings were not observed in the in clinical quiescence 5nd the control subjects 
controls. Our study Buggests that tumiunoregulaC- was demonstrated. Our results failed to support 
ion of the cellular immunity by cyclosporin A a shift in the immunoregulatory T lymphocyte 
c o u ” be a potential therapeutic approach in IgA subpopulations during c l i n U l quiescence but a 
nephropathy provided the nephrotoxicity due to more profound defect in Innunoregulatlon nay 
the therapy i. carefully monitored. probably occur during clinical exacerbation. 
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D E T E R M I N A T I O N O F I M M U N O G L O B U L I N L I G H T C H A I N R A T I O S 
BY E N Z Y M E I M M U N O A S S A Y 
SH Chui, CWK Lam and KN Lai* 
Dcpjrtmcnts of Chemical Pathology and •Med/c/ne, Prince of Wales Hospital The Chinese University of Hong Kong, 
Shalin, Hong Kong. 
We have developed a method for the determination of k/入 chain ratios of serum IgG, IgA and IgM by enzyme-
linked immunosorbent assay (ELISA). 
Working standards were prepared from a commercial human serum standard with known overall K and 入 chain 
concentrations. Antibodies to y , a and /i chains were immobilised on microtitre plates to capture the respective 
immunoglobulins in these working standards. Peroxidase-conjugated anti-K and anti-入 chain sera were then used for 
quantitation of light chains on the captured immunoglobulins. The enzymatic reaction was developed with 
o-phenylene-diamine-dihydrochloride and urea hydrogen peroxide in pH 5.0 citrate buffer, and absorbance read at 
450 nm. By calculation of absorbance ratios, the K and 入 chain concentrations of individual immunoglobulins in the 
standard were determined. Test samples were assayed using the now calibrated standard and the same ELISA. 
Intra-assay coefficients of variation (CV, n - 25) at "high" "normal" and " low" k/X ratios are shown below. 
Immunoglobulin 
k/入 ratio 3.77 2.28 1.40 2.56 1.64 0.97 2.40 1.50 1.00 
CV(%) 9.5 5.9 7.2 12.3 6.9 8.2 13.0 11.8 10.2 
Additivity of the method, eg. (IgA/c + lgAX)/(total IgA), was studied for > 150 sera and found to range within 
91-110%. Detection limit was down to 1 ng/ml immunoglobulin suitable for cell cufture work. 
Our method should be an improvement on previous assays by radial immunodiffusion，and immunonephelome-
try2 since they only measured total K and 入 chain concentrations of all immunoglobulins. Their results therefore 
represented essentially the light chain ratio of the most abundant serum immunoglobulin, usually IgG. We have used 
this method to study the KI\ ratios of IgG, IgA and IgM in (i) normal human sera, (ii) serum of patients with 
immune-complex disease, (iii) sera containing a paraprotein, and (iv) lymphocyte culture supernates. 
References 
1 Barandun S, Skvarill F and More" A. Clin Imunol Biol. 1976; 3:57-69. 
2 Renckens ALJM, Jansen MjH, van Munster PJJ el al. Clin Chem. 1986; 32:2147-9. 
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USE OF IMMUNOGLOBULIN LIGHT CHAIN RATIOS FOR DETECTION AND 
IDENTIFICATION OF OBSCURE MONOCLONAL PARAPROTEINS 
CWK Lam, NWY Leung% SH Chui, WHP Lewis" and KN lai* 
Departments of Chemical Pathology and *Medicine, Prince of Wales Hospital, 
The Chinese University of Hong 
Kong, Shatin, Hong Kong and 
“Institute of Medical and Health Care, Hong Kong Polytechnic, Hong Kong. 
S,rum protein electrophoresis has been regarded capable of detecting 99% of cases of paraproteinaemia and it is 
usually not justified to pursue negative findings'. We report a case in which the presence of a monoclonal paraprotein 
was demonstrated only by use of more sensitive techniques. 
A 40-year-old woman presented with anasarca, hyperpigmentation, hepatosplenomegaly, peripheral neuropathy 
and endocrmopathy. Initial biochemical and haematological investigations, including electrophoresis of serum and 
pncentrated urine, revealed no abnormality except for an elevated serum IgA concentration of 10 g/L (reference 
[n te - f l : 0.8 — 4.0). Further examination of serum by immunofixation electrophoresis showed a broad paraprotein 
band m the y region with IgAA antigenicity. Determination of the K/\ ratio of individual immunoglobulins yielded 
二m a l values for IgC and IgM but an exceedingly low IgA fc/入 ratio of 0.006 (reference interval: 1.00 — 2 47) This 
fin巧g strongly indicated the presence of a monoclonal IgAX paraprotein. A skeletal survey revealed two osteoscle-
•rotic lesions in the pelvis. Biopsy of one of the lesions demonstrated a plasmacytoma with X chain immunohistochem-
ical staining. 
The clinical and laboratory findings are consistent with the diagnosis of Crow-Fukase syndrome. In a recent review 
of 102 patients, 76 (75%) had a monoclonal paraprotein; in 26 ( 4 1 % ) of these it was an IgAAA 
[^iffusp, "polyclonal" appearance of a monoclonal paraprotein, which makes it less amenable to detection by 
routine electrophoresis, may be due to: 
a. variation in carbohydrate content, 
b. molecular aggregation, or 
c. immune-complex formation. 
Preliminary characterisation of this patient's paraprotein using isoelectric focusing and immunoblotting techniques 
wi出 or without urea pre-treatment, did not support possibilities b and c. 
In summary, the initial electrophoretic results in this case were negative. However, further investigations were 
；:ar r ied out ^cause of strong clinical suspicion of monoclonal gammopathy. This was confirmed by determination of 
immunoglobulin light chain ratios, a test which may be useful in similar cases. 
References 
1 Whicher j l , Calvin J, Riches R e( al. Ann Clin Bichem. 1987; 24:119-32. 
2 Nakanishi T, Sobue I, Toyokura Y et al. Neurology 1984; 34:712-20. 
EVALUATION OF THE PHADIATOP^" TEST FOR ALLERGY 
AM Wootton and AE Gale* 
D/ws/on of Human Immunology, Institute of Medical and Veterinary Science, Frome Road, Adelaide, SA 5000, and 
*58 Brougham Place, North Adelaide, SA 5006. ‘ 
Phadiatop is a new screening test for atopy due to inhalant allergens. Coupled to the Phadiatop disc are a range of 
allergen^ including grass and weed pollens, house dust mites, moulds and other important allergens which commonly 
caus? al ergic symptoms. The IgE bound to the disc is compared to a reference preparation and expressed as either 
positive (suggests atopy) or negative (does not support a diagnosis of atopy due to inhalant allergens). 
We have compared the performance of Phadiatop to total IgE measurement and RAST multidisc screening (using 
grass pollen, house dust and animal epithelia mixes) in patients referred to a busy allergy practice. Skin prick testing 
was performed on all patients to classify the patients as atopic or non-atopic and the blood test results were judged 
correct or incorrect on this basis. 
Comparison of Allergy Tests with Skin Prick Test (n = 23) 
Sensitivity (%) Specificity (%) Efficiency (%) Predictive Value 
+ve result (%) 
IgE 92 90 91 92 f^ ST 100 50 78 72 
Phadiatop 100 80 91 87 
There was no statistical difference between the groups of data using x^ matched pairs binary data. However these 
data indicate that Phadiatop has a similar diagnostic accuracy to both IgE and RAST multidisc screening. 
These figures are in good agreement with several large European studies. 
We conclude that Phadiatop is a useful screening test for the diagnosis of inhalant allergy and that it may be used as 
a satisfactory alternative to RAST multidisc screening. 
Phadiatop is a trademark of the Pharmacia Company. 
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BETA-2-MICROGLOBULIN IN CEREBRO SPINAL FLUID 
K Byron and S Ratnaike 
Department of Biochemistry, Royal Melbourne Hospital, Parkville, Victoria 3050. 
We measured the cerebrospinal fluid (CSF) bela-2-microglobulin (BMC) concentration in 105 patients. In 
47 of these we were also able to measure the concentration of serum BMG. 
Patients were categorised into one of seven groups: 1: Normal subjects (42), 2: Cerebral infections (1 7), 3: 
Malignancy (15), 4: Acute Brain Syndrome (5), 5: Mult iple Sclerosis (7), 6: Cuillian-Barre Syndrome (3) and 7: 
Miscellaneous (16). 
CSF lymphocyte and neutrophil counts were obtained to ascertain their relationship with CSF BMG. From 
the group of normal subjects, a reference range was established (1.0-2.8 mg/l). 
Normal results were seen in the groups of Guillian-Barre Syndrome, Acute Brain Syndrome as well as 
Mult iple Sclerosis, this contradicts a recent report', although, our numbers are small and no staging of the 
disease was attempted. 
The group with the highest concentrations of CSF BMG was cerebral infections, where eleven out of 
seventeen patients had values raised above the reference range. From this group of patients, our data shows that 
both lymphocytes and neutrophils are possibly major contributors to raised levels of CSF BMG. 
With in this group, increased numbers of neutrophils were seen in 90% of the cases with increased CSF BMG. 
Recently^ it has been shown that BMG is an intragranular protein of the neutrophil and that BMG may serve as an 
indicator of neutrophil degranulation. 
References 
1 Bjerrum OW. Acta Neurol Scand. 1988; 78:72-75. 
2 Bjerrum OW, Bjerrum Oj and Borregarrd N. j Immunol" 1987; 1383913-3917. 
FAST PROTEIN LIQUID CHROMATOGRAPHY FOR THE PURIFICATION OF IgA 
FROM HUMAN SERUM USING JACALIN 
SH Chui, CWK Lam傘,WHP Lewis and KN La i " 
Department of Health Sciences, Hong Kong Polytechnic, Kowhon, Hong Kong and Departments of 
*Chemical Pathology and **Medicine, Prince of Wales Hospital, The Chinese University of Hong Kong, 
Shatin, Hong Kong. 
A Fast Protein Liquid Chromatography (FPLC) method for the purification of serum IgA using a jacalin 
column and a Pharmacia FPLC system is described. 
The column was packed with 10 ml of immobilised jacalin attached to cross-linked 6% beaded agarose. One 
to three ml of serum (containing 1 to 6 mg IgA) was diluted 1:1 with binding buffer (20 mmol/L NaHjPO-, 150 
mmoI/L NaCI, pH 7.4) prior to its introduction into the column. The column was washed with binding buffer for 
1 h and switched to elution buffer (100 mmol/L melibiose in binding buffer) for 30 min. Five ml fractions were 
collected and their absorbance was measured at 280 nm. The chromatography was performed at room 
temperature. Finally the column was regenerated by washing with distilled water for 30 min. 
This FPLC procedure takes about 2 h with minimal manipulation. The yield of isolated IgA as well as the 
concentrations of IgG and IgM contaminants were measured by enzyme-linked immunosorbant assay (ELISA)' 
in 30 sera. Results showed that > 90% IgA could be recovered with < 0.5% total IgC and < 2.0% total IgM 
remaining in the fractions containing purified IgA. 
This method has been used by us in a study of circulating immunoglobulins in IgA nephropathy. 
Reference 
1 Lai KN, Chui SH, Lai FMM and Lam CWK. Kidney InL 1988; 33:584-589. 
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